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Abstract 
In the last eighteen years there has been the identification of a novel photopigment, 
melanopsin, and its subsequent localization to human intrinsically photosensitive retinal 
ganglion cells (ipRGCs). Since melanopsin’s peak sensitivity is in the short wavelength 
portion of the visible spectrum (from 447 nm to 484 nm), there has been a steady increase in 
studies investigating the physiological effects of blue light. This thesis examines 
polychromatic light mixtures of blue light for circadian, neuroendocrine and neurobehavioral 
effects in humans. 
 
White blue-enriched fluorescent lamps were tested at equal photon densities for increased 
efficacy for melatonin suppression, increased alertness, and circadian phase shifting. Results 
demonstrated that compared to white fluorescent light, blue-enriched fluorescent light was 
significantly stronger for suppressing melatonin and resulted in significantly reduced 
subjective sleepiness. Blue-enriched light, however, was not significantly stronger in eliciting 
circadian phase-delay or increasing objective measures of alertness. 
 
Next, blue-appearing narrowband solid-state light was examined for its ability to acutely 
suppress nocturnal melatonin as well as enhance cognitive performance and alertness in 
healthy men and women when compared to dim white lighting. The results demonstrated that 
narrowband blue solid-state light was significantly stronger for melatonin suppression 
compared to dim white light. Subjective and objective assessments of alertness, however, 
were not significantly increased by blue-enriched light exposure. 
 
The final study tested the hypothesis that certain combinations of light wavelengths are 
additive or opponent to the photoreceptor system that mediates the melatonin suppression. 
The results demonstrated that the melatonin suppression responses to dual narrow bandwidth 
light combinations were not significantly different from single wavelength exposures. 
 
Taken together, the results suggest that melanopsin sensitivity is not the sole consideration 
for predicting the efficacy of white polychromatic lighting. The different effects of blue light 
on alertness, circadian phase-shifting and melatonin suppression imply a either a context 
dependent sensitivity and/or differential involvement of the classical photoreceptors in these 
light responses. 
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 CHAPTER 1 INTRODUCTION 
 
1.1 Light and the circadian system 
 
Light is a key component to life on earth. The sun’s irradiance provides the biosphere with 
warmth, energy for photosynthesis, and provides signals that all living organisms use to link 
themselves to the natural day/night rhythm generated by the rotation of the planet (Devlin and 
Kay, 2001).  Light supports vision and allows organisms to navigate their surroundings but it 
also operates at a level below consciousness controlling the daily hormonal rhythms that 
control homeostasis.   
 
Rhythms range in length from microseconds such as heart rate (Bonnemeier et al., 2003) to 
yearly or circannual such as the fattening and hibernation of the ground squirrel (Pengelley, 
1974).  There are internal biological cycles such as menstrual as well as other cycles 
controlled by the moon or tides. Light can play a role in these other non-circadian rhythms 
but this review will not delve into the specifics of this. 
 
Throughout nature, a range of physiological responses oscillate with the 24 hour rhythm of 
the day or a circadian rhythm.  The circadian timing system controls daily rhythms such as 
sleep and wakefulness, body temperature, hormonal secretion, and other physiological 
parameters. These inherent rhythms persist even when the organism’s environment remains 
in a constant state.  This indicates that these rhythms are under the control of endogenous 
oscillators or the circadian timing system. The circadian timing system allows the organism 
to anticipate and prepare for the profound changes in its natural environment at dawn and 
dusk.  Although light is the primary stimulus for regulating the circadian system (Czeisler, 
1995), other external stimuli such as the timing of sound, temperature, and social cues may 
also influence physiological functions (Aschoff, 1981; Wetterberg, 1993).   
 
A rhythm can be represented as a repeating waveform on a continuous line running from the 
past on the left to the future on the right.  A rhythm that continues unabated in constant 
conditions is described as freerunning. For example, if you were able to live in a time-free, 
light and temperature constant condition environment you would have a rhythm of sleeping 
and waking that would continue or freerun (Aschoff, 1981).  The length of time in between 
15 
 
 consecutive awakenings would be the period length of the freerun or a measure of your 
personal internal clock represented by the Greek letter tau (Binkley, 1990).  
 
 
 
 
Figure 1. A representation of the waveform of a circadian rhythm.  (Modified from Binkley, 
1990) 
 
When the timing of a freerunning rhythm is synchronized by a repeating external time signal, 
the rhythm is entrained (Aschoff, 1981).  This signal that gives time cues is known by the 
German definition of zeitgeber or “time giver”.  Light is the primary zeitgeber for most 
organisms on Earth (Czeisler, 1995).  A particular time point on a rhythm can be used to 
mark circadian phase and the length between identical timepoints on a rhythm is known as 
period tau.  The time difference between two phases is called the phase angle.  When a 
rhythm is altered such that its peaks occur later in time then the phase of the rhythm is said to 
be delayed; when a rhythm is altered so that it peaks occur earlier in time then the rhythm is 
advanced (Binkley, 1990). 
 
Circadian clocks all have the ability to respond to light at dusk and dawn.  The appearance of 
light at dawn or diminishment of light at dusk causes changes to the phase of the clock to 
keep it synchronized. Light detected in the early morning advances the circadian oscillator 
16 
 
 while light of an equal amount in the evening causes a delay.  This response to light 
information given at different times of the day results in a phase response curve (PRC).  The 
existence of a light PRC is evident in the vast majority of terrestrial plants, insects and 
animals studied but varies greatly in shape between organisms (Johnson, 1990). The PRC 
often is skewed to morning or evening with the appearance of dead zones or insensitivity to 
light during the course of the day.  However, a carefully controlled laboratory study dispelled 
the notion of a dead zone and showed no evidence of clock insensitivity (Khalsa et al., 2003). 
More recently, light PRCs have been constructed for a short, 1 h pulse of bright white light 
(St. Hilaire et al., 2012) as well as for blue light (Revell et al., 2012).  
 
 
1.1.1 Input pathways 
 
1.1.1.1 Intrinsically photosensitive retinal ganglion cells 
 
Intrinsically photosensitive retinal ganglion cells (ipRGCs) are the initial interactive point for 
nonvisual responses between the nervous system and the light environment. Studies have 
confirmed that the suprachiasmatic nuclei (SCN) receive environmental photic input from a 
specialized subset of ipRGCs (Provencio et al., 2000; Gooley et al., 2001; Berson et al., 2002; 
Hannibal et al., 2002; Hattar et al., 2002).  Using immunohistochemistry and double labeling 
studies, murine ipRGC anatomy has been described by multiple laboratories (Berson et al., 
2010; Ecker et al., 2010) and five types of ipRGCs, which have differing locations, dendritic 
processes and cell bodies, have been identified.   
 
In rodents, monkeys, and humans, melanopsin has been found in a specific subtype of 
ipRGCs which have an expansive dendritic network and project to a number of nonvisual 
nuclei, including the suprachiasmatic nuclei, intergeniculate leaflets, olivary pretectal nuclei, 
preoptic nuclei and subparaventricular zones (Provencio et al., 2000; Gooley et al., 2001; 
2003; Berson et al., 2002; Hannibal et al., 2002; Hattar et al., 2002; 2006; Provencio et al., 
2002).  IpRGC's respond to light on their own when separated physically or blocked by drugs 
from receiving input from other neurons (Berson et al., 2002; Hattar et al., 2002; Lucas et al., 
2003; Dacey et al., 2005).  These unique cells comprise 1-3% of all retinal ganglion cells, and 
17 
 
 their light responses appear to parallel those for circadian entrainment and melatonin 
suppression (Berson et al., 2002; Hattar et al., 2003).  
 
In humans, these ipRGCs are found within the inner retina and have an extensive dendritic 
tree that forms a photoreceptive network (Rollag et al., 2003; Hannibal et al., 2004; Dacey et 
al., 2005).  IpRGCs comprise approximately 0.2% to 0.8% of all ganglion cells present in the 
human retina (1-3% in rodents), and their dispersion of dendritic processes seems to 
encompass the entire retinal area as observed in earlier rodent studies (Hannibal et al., 2004; 
Dacey et al., 2005).   
  
 
Figure 2. The diagram above provides a simplified layout of the neuroanatomy that is 
responsible for mediating both the sensory capacity of the visual system and the nonvisual 
regulation of circadian and neuroendocrine functions.  Abbreviations:  POT - primary optic 
tract; RHT - retinohypothalamic tract; ipRGC - intrinsically photosensitive retinal ganglion 
cell; IGL - intergeniculate leaflets; VLPO -ventrolateral preoptic nuclei; SCN - 
suprachiasmatic nuclei; PTA -pretectal areas; vSPZ -ventral subparaventricular zones. 
(Graphic design by Benjamin Warfield) 
 
 
1.1.1.2 Retinohypothalamic tract 
 
Projections from the ipRGCs form the origin of the retinohypothalamic tract (RHT).  The 
mammalian RHT is the primary neural projection to the circadian oscillator entraining 
circadian rhythms to the light-dark cycles of the environment (Moore, 1983).  This pathway 
acts to convey information about external light conditions from the retina to several areas of 
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 the hypothalamus, including the SCN, a primary site of the biological clock or central timing 
system in the brain.  The RHT terminates primarily in the ventrolateral aspect of the SCN 
(Moore and Lenn, 1972; Moore et al., 1995).  Even though it is known that the RHT projects 
to other areas of the hypothalamus (Pickard and Silverman, 1981) and that the SCN receives 
inputs from other visual areas of the brain, the retinal projection to the SCN via the RHT 
seems to be the primary pathway for photoperiod entrainment in mammals.  This neural 
pathway is also directly involved in the suppression of melatonin production in the pineal 
gland in response to light (Klein and Moore, 1979).  The retinal projection to the SCN has 
been studied for its role in synchronizing the endogenous oscillator which mediates circadian 
physiology. 
 
Although the RHT has its densest projection in or around the SCN, this pathway has diffuse 
projections to other areas including the preoptic nuclei, anterior and lateral hypothalamic 
areas, retrochiasmatic area, dorsal hypothalamic nuclei, the intergeniculate leaflets, and the 
midbrain periaqueductal grey (Klein et al., 1991; Card, 1994; Hattar et al., 2006). Some of 
the functional roles of the other nonvisual projections from the retina have been elucidated 
(Gooley et al., 2003; Hattar et al., 2006).  The ventrolateral preoptic nucleus (VLPO) is 
known to be integral in sleep/arousal state (Lu et al., 2002). Projections to the intergeniculate 
leaflet (IGL) are involved in regulation of circadian phase shifting and other integration of 
photoperiodic information (Morin, 1994).  Projections to the ventral subparaventricular zone 
(vSPZ) are thought to be involved in the circadian and photic modulation of sleep and 
locomotor activity (Moore and Danchenko, 2002). The pretectal area (PTA) receives 
projections from the RHT and which contributes to the control of the pupillary light reflex in 
the absence of classical photoreceptors (Lucas, et al., 1999; 2003).  Hattar and colleagues 
(2006) report a substantial projection to the dorsolateral area of the lateral habenula but this 
functional role is not well understood.  In summary, these projections are thought to form an 
irradiance detection system providing photic information to several brain regions controlling 
numerous functions separate from areas of the brain that are involved in forming vision 
(Gooley et al., 2003). 
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 1.1.1.3 Intergeniculate leaflet and geniculo-hypothalamic tract 
 
The SCN receive a projection, the geniculo-hypothalamic tract (GHT), from neurons in the 
intergeniculate leaflet (IGL) and portions of the ventral lateral geniculate nucleus (vLGN) of 
the thalamus. When examined, the responses of putative GHT neurons to diffuse illumination 
using extracellular electrophysiological recordings the great majority of IGL neurons showed 
sustained ON responses to diffuse retinal illumination.  These results indicate that GHT 
neurons may provide information about ambient light intensity to the suprachiasmatic nuclei 
(Morin, 1994).  Although it is clear that the IGL is not necessary for photic entrainment, 
some changes on the ability of light signals effect phase and period control of the clock have 
been observed (Moore and Card, 1994).  In addition to it being a secondary source of photic 
signaling to the circadian clock, the IGL plays a major role in the nonphotic regulation of the 
circadian system (Rosenwasser, 2003). 
 
 
1.1.1.4 Other afferent inputs to the suprachiasmatic nuclei 
 
A third major afferent projection to the SCN comes from the median raphe nucleus of the 
midbrain.  These projections to the SCN are thought to have two functions.  The first is the 
modulation of photic effects on the circadian pacemaker during the subjective night and the 
second being the mediation of nonphotic, behavioral state–related effects on the pacemaker 
during subjective day (Rosenwasser and Turek, 2005). For instance, photic entrainment is 
inhibited in the presence of high levels of arousal or locomotor activity, apparently through 
arousal related release of endogenous serotonin (Morin, 1999).  In addition, it has been 
reported, in the rat, much like the hamster, over 40 brain regions have cells that project to the 
SCN (Krout et al., 2002) whose functions remain largely unknown. 
 
 
1.1.2 Suprachiasmatic nuclei 
 
The SCN are situated in the anterior part of the hypothalamus immediately dorsal and 
superior to the optic chiasm and bilateral to the third ventricle of the brain.  They serve as the 
chief pacemaker of the circadian system controlling circadian rhythms in mammals (Klein et 
al., 1991). If this area is lesioned, the length and timing of sleep episodes become erratic 
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 while the total amount is maintained (Mistlberger et al., 1983).  Other studies using metabolic 
mapping, tissue transplantation, and molecular rhythm analysis have shown the SCN to be 
able to maintain sustained rhythm as well as maintaining rhythms in peripheral tissues (Klein 
et al., 1991; Stokkan et al., 2001; Rossenwasser, 2003). 
 
In mice, each of the two “pear-shaped” suprachiasmatic nuclei contains about 10,000 neurons 
(Abrahamson and Moore, 2001). The SCN can be subdived into two parts: a ventrolateral 
(vlSCN, or core) and a dorsomedian part (dmSCN, or shell). Although early studies 
suggested that all SCN neurons were cell autonomous clocks (Welsh et al., 1995), recent 
studies demonstrated that they are not identical in function (Honma et al., 2012). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.  The flowchart above provides a simplified representation of the major inputs and 
outputs of the SCN. (Graphic design by Benjamin Warfield) 
 
 
1.1.3 Output pathways  
 
There are three major output pathways leading from the SCN.  The largest portion of the 
efferent pathway travels through the regions just above the SCN (the ventral 
SCN 
IGL 
Light Raphe 
PVN SPZ 
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 subparaventricular zone (vSPZ)) and along the paraventricular hypothalamic nucleus (the 
dorsal subparaventricular zone (dSPZ)) with a small portion ending in the dorsomedial 
nucleus of the hypothalamus.  Another pathway runs along the third ventricle, into the medial 
preoptic area and then up into the paraventricular nucleus of the thalamus.  The third pathway 
runs along the base of the third ventricle, to the retrochiasmatic area and the capsule of the 
ventromedial nucleus of the hypothalamus (Saper et al., 2005).  These pathways are thought 
to be necessary for body temperature regulation, locomotor activity, sleep-wake cyclicity and 
feeding behavior.  
 
A relatively small number of SCN axons also directly innervate areas also involved in 
melatonin production.  This pathway carries nonvisual information about light from the SCN 
to the pineal gland via a multisynaptic pathway with connections being made sequentially in 
the paraventricular hypothalamus, the upper thoracic intermediolateral cell column, and the 
superior cervical ganglion.  By way of this neuroanatomy, cycles of light and darkness which 
are perceived through the eyes entrain SCN neural activity which, in turn, entrains the 
rhythmic synthesis and production of melatonin from the pineal gland (Klein and Moore, 
1979). 
 
 
1.2 Circadian photoreception 
 
Living organisms vary in their capacity to use visible and near-visible electromagnetic energy 
for survival, however, a fundamental principle shared by all species is their ability to respond 
to light stimuli: all photobiological responses are mediated by organic molecules that absorb 
light quanta and then undergo physical-chemical changes.  These light-induced changes 
subsequently evoke broader physiological responses within the organism.  This process is 
termed phototransduction, and the specific organic molecules that absorb light energy to 
initiate photobiological responses are called chromophores or photopigments.  As a rule, 
these photoactive molecules do not absorb energy equally across the electromagnetic 
spectrum.  Photopigment molecules or molecular complexes have their own characteristic 
wavelength absorption spectrum that depends on their atomic structure (Grossweiner, 1989; 
Coohill, 1991; 1999; Horspool and Song, 1994).  A photopigment’s pattern of wavelength 
sensitivity, or its absorbance spectrum, is unique to that molecule.  
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1.2.1 Classical photoreceptors and opsins 
 
Photoreceptors reside in a thin sheet of neural tissue located in the lining of the back of the 
eye called the retina.  This layer extends forward toward the optical components of the eye 
which include the cornea, iris and lens.  The retina was thought to be composed of five 
classes of neurons; photoreceptors, horizontal cells, bipolar cells, amacrine cells and ganglion 
cells (Rodieck, 1998).  More recently, a sixth set of cells, the ipRGCs, have been identified 
and described (Hattar et al., 2002; Provencio et al., 2002). These cells are a small percentage 
all ganglion cells, and their light responses will be discussed in detail later in this chapter.  
Each of the cell types, for the most part, occupies a layer in the retina as shown in Figure 4.   
 
The retina contains over 100 million photoreceptors which serve, as their name suggests, to 
capture and to send information about the outside visual world to the brain.  In vertebrates 
there are two general forms of visual photoreceptors called rods and cones.  Rods are always 
cylindrical while cones, when found in the peripheral part of the retina are conical, hence 
their name.   
 
The photoreceptors lie in the outer portion of the retina in the very back of the eye which 
results in light having to pass through the entirety of the retina in order to reach the outer 
segments of the photoreceptors.  This may be due to the origins of the photoreceptors from 
neural tissue but it does have the advantage that they lay near the retinal pigment epithelium 
and choriocapillaris on either side of them. Thus, the photoreceptors, which are very 
metabolically active, have a rich supply of oxygen and nutrients.  It is in these outer segments 
where the visual pigment molecules or opsins are located (Rodieck, 1998).  
 
The membranous photoreceptor protein or opsin contains a pigment molecule called retinal. 
In rod cells, these together are called rhodopsin. In cone cells there are different types of 
opsins that combine with retinal to form pigments called photopsins. In humans, three 
different classes of photopsins (see Figure 5 in the cones react to different ranges of light 
frequency, long wavelength (red), middle wavelength (green) or short wavelength (blue).  
This number of photopsins and their sensitivity vary among species yet all serve to allow the 
visual system to distinguish color. 
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Figure 4.  The basic cell types of the vertebrate retina.  Light passes through the transparent 
ganglion layer to reach the rods and cones.  The rods (R) and cones (C) convey visual 
information to the ganglion cells (G) through the bipolar cells (B).  Horizontal cells (H) allow 
lateral connections between rods and cones.  Amacrine cells (A) allow lateral connections 
between bipolar and ganglion cells.  The optic nerve is formed from the axons of all the 
ganglion cells.  A subset of ganglion cells (ipRGCs) also detects light directly and contain the 
mammalian photopigment melanopsin.  (Modified from Foster, 2005) 
 
Other alternate photoreceptors that were investigated to have a role in regulating the circadian 
system included both opsin-based molecules such as vertebrate ancient (VA) opsins (Philp et 
al., 2000) RPE-retinal G protein-coupled receptor (Jiang et al., 1993), peropsin (Sun et al., 
1997), encephalopsin (Blackshaw and Snyder, 1999) as well as non-opsin molecules like 
biliverdin (Oren, 1996) and cryptochrome (Miyamoto and Sancar, 1998).  An excellent 
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 overview of nonclassical opsin photopigments found in the mammalian eye has been written 
by Kumbalasiri and Provencio (2005).  
 
 
 
 
Figure 5.  The approximate spectral sensitivity functions of the rods (rhodopsin) and three 
cones (short wavelength –blue; middle wavelength –green; and long wavelength –red) in 
humans. Peak sensitivities are 507 nm for rhodopsin, 440 nm for short wavelength cone, 540 
nm for the middle wavelength cone and 565 nm for the long wavelength cone (Stockman and 
Sharpe, 1999). 
 
 
1.2.2 Melanopsin 
 
Melanopsin, a molecule found originally in frog-skin melanophore cells which sense and 
respond to light, was an early leading contender for the mammalian circadian photopigment, 
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 since it is expressed in anatomical areas where nonvisual photoreceptors are likely to be 
present (Rollag, 1996; Provencio et al., 1998).  Melanopsin shares predicted structural 
similarities with all known opsins, including seven transmembrane domains with a lysine 
residue in the 7th transmembrane domain needed for linkage of the retinoid chromophore.   
 
Provencio and colleagues (2000) cloned both human and mouse melanopsins and showed 
predicted amino acid sequences of the transmembrane and loop domains to be 86% identical 
between mouse and human homologs and  57% identical to the frog homolog. Notably, 
human and all vertebrate melanopsins have a great sequence homology to invertebrate opsins.   
 
This structural similarity also translates into functional harmony in that melanopsin is likely 
to operate with a biochemical independence allowing it to be located separate from 
chromophore regenerating tissues, such as the retinal pigment epithelium (RPE).  In the 
human retina, it has been shown that melanopsin is co-stored with pituitary adenylate cyclase 
activating peptide (PACAP) which is a marker for the RHT (Hannibal et al., 2004).  This 
identification and localization of melanopsin has ultimately led to a major change in our 
understanding of circadian photoreception.   
 
Melanopsin is not required for normal circadian photoentrainment, and that other 
mechanisms for light input to the clock also play a role as concluded Panda and colleagues 
(2002) in the following study.  Melanopsin-null (Opn4-/-) mice were generated and exposed 
to constant darkness (DD), a 12-hour white light (800 lux)/12-hour dark (LD) cycle, and a 
normal LD cycle with 1 hour of 300 lux of white light during the dark phase.  There were no 
significant differences between wild-type and Opn4-/- mice regarding functioning of the SCN 
or the locomotor activity output of the clock in any of these conditions.  However, when a 15-
min pulse of monochromatic blue light (λmax = 480 nm, 10-nm half-peak bandwidth) of 
varying irradiance was administered 3 h after the onset of activity under constant darkness (a 
period when normal mice exhibit robust phase delays in response to light), it was found that 
there was a significant attenuation of phase delays compared to wild-type mice.  Also, when 
placed in constant light (LL) cycle, Opn4-/- mice exhibited a shorter period length than wild-
type, though both were lengthened the LL cycle.   
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 In contrast to rods and cones, melanopsin is thought to act as both a photopigment and a 
photoisomerase (Provencio et al., 2000).  Following activation of melanopsin by light, a 
different portion of the light spectrum regenerates the chromophore and restores melanopsin 
photosensitivity (Melyan et al., 2005; Panda et al., 2005).  Although it is well-established that 
melanopsin photopigment is most sensitive to short-wavelength light, recent studies suggest 
that melanopsin photoisomerase activity may increase this sensitivity by prior exposure to 
long-wavelength light (Koyanagi, et al., 2005; Mure et al., 2007; 2009).  This potentiation by 
long wavelength (620 nm) light prior exposure to blue (480 nm) light as measured by ipRGC 
cell firing rates in mouse retina was not exhibited in a study be Mawad and Van Gelder 
(2008) and the physiological significance of melanopsin bistability remains in question. 
 
 
1.2.3 Classical photoreceptor-rod/cone interaction  
 
Abundant evidence shows that the melanopsin containing ipRGCs provide primary input for 
circadian and neuroendocrine regulation. It has also been shown, however, that rod and cone 
photoreceptors still play a role in this physiology (see Figure 5). Melanopsin- and cone-
knockout mice show that the classical rod and cone photoreceptors can compensate for the 
loss of melanopsin and, at least partially mediate, light-induced circadian, neuroendocrine 
and neurobehavioral responses (Panda et al., 2002; Lucas et al., 2003; Dkhissi-Benyahya et 
al., 2007). By contrast, when both melanopsin is knocked out and the classical visual 
photoreceptors are compromised, animals lose all visual and nonvisual photoreceptive 
functions of the eye (Hattar et al., 2003; Panda et al., 2003). Further, cellular recording 
studies from nonhuman primate retinas have demonstrated that rod and cone cells can 
directly activate ipRGCs (Dacey et al., 2005). Data from human studies also suggest that the 
visual rods and cones may be involved in nonvisual light responses (Hebert et al., 2002; 
Figueiro et al., 2004; Jasser et al., 2006; Revell and Skene, 2007).  Similar to classical retinal 
ganglion cells ipRGCs receive ON and OFF light signals from rods and cones (Belenky et al., 
2003: Perez-Leon et al., 2006).  Using mice where cone or rod photoreceptors were 
destroyed, rods were found to operate in two distinct retinal circuits to provide circadian 
photoentrainment over an extensive range of light intensities (Altimus et al., 2010).  Using 
mice where human red cone opsin was expressed in the mice green cones, it was shown that 
rods drive circadian responses at very low irradiances and some circadian responses can be 
rod driven at even higher light intensities (Lall et al., 2010).  In humans, interestingly, cones 
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 are suggested to contribute substantially to circadian photoentrainment at low intensities and 
at the initiation of light exposure as described in a series of experiments where spectral 
content and irradiance were manipulated (Gooley et al., 2010).  Different models of 
interaction between the melanopsin ganglion cells and classical rod and cone visual 
photoreceptors have been proposed, including the ideas that these photoreceptors are 
additive, stimulatory, opponent, or dynamic over time and intensity (Lucas et al., 2003; 
Lockley et al., 2003; Figueiro et al., 2004; Gall and Bieske, 2004; Rea et al., 2005; Dacey et 
al., 2005; Dkhissi-Benyahya et al., 2007; Revell et al., 2007; Zaidi et al., 2007; Pechacek et 
al., 2008; Mure et al., 2009; D.I.N, 2009; Gooley et al., 2010).  Gooley and colleagues (2010) 
best summarize the current thinking that, much like other sensory systems such as touch and 
vision, multiple receptor subtypes respond differentially to the strength, frequency, and 
timing of stimuli to ensure appropriate physiologic responses. 
 
 
1.3 Circadian physiology 
 
Circadian physiology is essential in the daily functioning of animals, including humans. 
Biological activities such as body temperature, brain wave activity, hormone production, cell 
regeneration show regular patterns. The circadian timing system is integral to timing these 
biological events to the external light environment (Dunlap et al., 2004). 
 
 
1.3.1 Primary oscillator – Suprachiasmatic nuclei 
 
The SCN of the hypothalamus are the primary pacemakers for the human and mammalian 
circadian systems. The SCN distributes information about light, darkness, and biological time 
to other major central nervous system control centers including the limbic system, 
diencephalon, midbrain and spinal cord.  The paired, bilateral SCN are heavily 
interconnected. Afferent projections from a multitude of nuclei reach the SCN, while efferent 
projections from the SCN influence endocrine responses, autonomic activity, and behavioral 
regulation (Klein et al., 1991; Dunlap et al., 2004). 
 
As described earlier (section 1.1.2) cycles of light and darkness stimulate the retina, signals 
are sent from the retinohypothalamic tract (RHT) to multiple nuclei indicated in Figure 3.  
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 While the SCN receives approximately 60% of the RHT afferents, other nuclei receive RHT 
afferents for other regulatory purposes.   
 
 
1.3.2 Peripheral oscillators 
 
Many tissues and organs in the body are able to generate circadian rhythms independently 
from the SCN (Yamazaki et al., 2000; Yoo et al., 2004). Liver cells, for example, appear to 
not need innervation from the SCN to maintain their rhythmicity and recent work has shown 
the inherent rhythms are sufficient to maintain functional significance (Atwood et al., 2011; 
Mohawk et al., 2012). There is evidence that the rhythms many of the peripheral oscillators 
are regulated both to each other as well as the external environment (Pezuk et al., 2010).  
 
Humoral and neural signals are generated by the SCN which regulate the phases of peripheral 
oscillators (Kalsbeek et al., 2006; Prasai et al., 2011). Humoral signals in the form of 
melatonin or cortisol secretion as well as temperature changes have the capability of reaching 
every cell in the body. The autonomic nervous system has influence over rhythmicity in 
several organs including the liver, adrenals, pancreas, the gastrointestinal tract and adipose 
tissue (Buijs et al., 1999; 2001; Cailotto et al., 2009; Kreier et al., 2002; Malloy et al., 2012). 
This network of oscillators is quite complex and remains an area of intense research. 
 
 
1.4 Pineal gland 
 
The pineal gland is a small (in humans about the size of a pea) secretory organ located at base 
of the brain at the border between the mesencephalon and the diencephalon resembling a pine 
cone and closely associated with the 3rd ventricle. There are large variations in size and 
position even within species and this can vary according to time, age and physiological status 
(Arendt, 1995). It consists of two types of cells, the pinealocytes, which produce 
indoleamines and neuroglial cells (Vollrath, 1981). 
 
During the development of some fish, reptiles and amphibians the pineal forms in two areas, 
an extracranial parietal organ and an intracranial pineal organ. The parietal organ in some of 
these lower vertebrates lies directly below the dorsal surface of the head and is often referred 
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 to as the “third eye.” Thus, it can be directly photosensitive in some amphibians and fish.  
The pineal maintains a dual role in avian species as well as reptiles as it maintains a self-
generated rhythm that serves as a biological clock and is a secretory gland under the control 
of light input via the retina (review Arendt, 1995). The mammalian pineal gland acts as a 
secretory organ only, with the role of a self-sustaining rhythm generator being served by the 
SCN. 
 
 
1.4.1 Anatomy 
 
The structure of the pineal gland has been classified according to its form and relationship to 
the 3rd ventricle (Vollrath, 1981). Three types have been identified: (A) where the majority of 
pineal tissue lies near the 3rd ventricle; (AB) where the gland is elongated; and (ABC) where 
a substantial portion of the pineal lies superficially near the cerebellum. 
 
The most important innervation of the mammalian pineal arises from post-ganglionic 
sympathetic fibers emanating from the superior cervical ganglion and is essential for the 
rhythmic production of melatonin, the primary hormone secreted from the pineal.   
 
 
1.4.2 Indoleamine synthesis 
 
There have been fifteen or more known 5-methoxyindoles described in the pineal gland.  
Their physiological significance is minor compared to melatonin. (Smith, 1983) Tryptophan, 
in addition to forming serotonin, undergoes decarboxylation to tryptamine and O-methylation 
by hydroxyindole-O-methyltransferase (HIOMT) to 5-methoxytryptamine.  5-
methoxytryptamine may have some physiological role as it is photoperiod controlled with a 
day-night rhythm with high levels in the pineal during the day (Klein and Moore, 1979; 
Galzin et al., 1988). Some of the effects are similar to melatonin which may be due to N-
acetylation and subsequent conversion to melatonin.  5-methoxytryptamine is metabolized by 
monoamine oxidase to 5-methoxindoleacetic acid and 5-methoxytryptophol.  These indolic 
acids have similar concentrations and rhythms as 5-methoxytryptamine and may play a role 
in the retina (Skene, 1992). 
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 1.5 Primary neuroendocrine hormone affected by light - melatonin 
 
Melatonin, or N-acetyl-5-methoxytryptamine, is an indoleamine hormone synthesized and 
released by the pineal gland during the hours of darkness in all species studied to date. 
Melatonin was first isolated by dermatologist Aaron Lerner who was interested in skin 
pigmentation issues and the ability of pineal extracts to lighten frog skin (Lerner et al., 1958; 
Brainard, 1978). Numerous physiological functions are associated with melatonin, chief 
among them circadian rhythm regulation and seasonal reproduction (Arendt, 1995). Other 
physiological roles of melatonin include protection of tissues from oxidation (Reiter et al., 
1994) and oncostatic effects (Blask et al., 2002). It is used as a therapeutic agent for jet lag 
following rapid time-zone changes, shiftwork sleep disturbances (Skene et al., 1996; Arendt 
et al., 1997) as well as metastatic cancer (Lissoni et al., 1995). Marketed as a dietary 
supplement, it is widely available in a number of countries including the USA (Bonn, 1996).  
 
 
1.5.1 Melatonin synthesis and metabolism 
 
The initial step in the production of melatonin is the uptake of the amino acids tryptophan or 
5-hydroxytryptophan from the general circulation into the pineal gland. From there 
tryptophan is converted to 5-hydroxytryptophan by tryptophan-5-hydroxylase and/or -5-
hydroxytryptophan is then decarboxylated to serotonin. Serotonin is then converted to 
melatonin by sequential actions of the enzymes arylalkylamine-N-acetyltransferase 
(AANAT) which provides the N-acetylation and HIOMT which provides the O-methylation 
(Ganguly et al., 2002). There is much species differentiation in the transcriptional and post-
transcriptional mechanisms of regulation of AANAT and this enzymatic reaction is 
considered to be the rate limiting step in the synthesis of melatonin (Klein et al., 1997). 
 
The liver breaks down melatonin into 6-sulfatoxymelatonin using 6-hydroxlation by the P450 
enzyme CYP1A2 which is then excreted in the urine (Arendt et al., 1985; Skene et al., 2001; 
Ma et al., 2005).  The half-life of melatonin in plasma is about 10 minutes due to this rapid 
hydroxylation in the liver (Iguchi et al., 1982).  Melatonin is not stored anywhere 
systemically in the body and as a result melatonin levels in the blood directly mimic the rates 
of production and metabolism.  This very precise and changeable rhythmic production and 
degradation of melatonin proves to be a very efficient way for transmitting the message of 
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 darkness throughout the body.  The target tissues mount their own responses to this chemical 
messenger of darkness.   
 
 
1.5.2 Melatonin rhythm 
 
As the signal for darkness to the organism, melatonin rhythm in all species studied is 
invariant in that it rises with periods of darkness and falls to low levels during periods of 
light.  In this way, it acts as the hormonal message of darkness (Arendt, 1995).  This holds 
true despite the species differences in the mechanisms regulating the production of melatonin.  
The duration of melatonin secretion at night varies in proportion to the length of dark phase 
and in this way propagates the signal of season to the organism.  The timing of the melatonin 
rhythm is considered to be the best physiological marker of circadian phase and its normal 
rise in concentration during an evening dim light exposure, named dim light melatonin onset 
(DLMO), is used both clinically to characterize circadian rhythm disorders and 
experimentally as you will read in Chapters 3 and 4 (Lewy et al., 1999). 
 
 
1.5.3 Melatonin receptors 
 
The identification and localization of melatonin receptors with use of the radioligand 2-[125I] 
iodomelatonin became widely used for identification of sites with high affinity for melatonin 
(Weaver, 1999).  Two types of 7-transmembrane G-protein coupled receptors have been 
identified and cloned in mammals and have labeled MT1 and MT2 formerly designated with 
other nomenclature such as Mel1a and Mel1b (Reppert et al., 1995). These two types of 
receptors have distinct molecular structures and pharmacological characteristics with 
differential affinity for certain ligands (Dubocovich, 2007). High affinity receptors are highly 
variable among species yet not surprisingly they are present in the SCN of most mammalian 
species studied (Weaver, 1999). Sites with high density of melatonin receptors in mammals 
include various brain regions including most importantly, the SCN, the pars tuberalis (PT) of 
the pituitary gland as well as the retina, and several regions of the cardiovascular system. 
Melatonin receptors located in the SCN are thought to mediate circadian response to 
melatonin while those located in the PT are believed to contribute to reproductive responses 
(Weaver, 1999).  Other regions containing melatonin receptors have been identified with their 
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 putative functions, including biological roles and clinical relevance, currently being 
elucidated (Chan and Wong, 2013).  
 
 
1.5.4 Light effects on melatonin 
 
A well-defined neural pathway carrying photic information extends from the SCN to the 
pineal gland via a multisynaptic pathway with connections being made sequentially in the 
paraventricular hypothalamus, the upper thoracic intermediolateral cell column, and the 
superior cervical ganglion (Moore, 1983).  By way of this neuroanatomy, cycles of light and 
dark which are perceived through the eyes entrain SCN neural activity which, in turn, 
entrains the rhythmic synthesis and secretion of melatonin from the pineal gland.  In virtually 
all species including humans, high levels of melatonin are secreted during the night and low 
levels are secreted during the day (Arendt, 1995). 
 
 
1.5.4.1 Acute suppression 
 
In addition to entraining melatonin synthesis by the pineal gland, light can acutely suppress 
melatonin synthesis.  Specifically, exposure of the eyes to light during the night can cause a 
rapid decrease in the high activity of the pineal enzyme AANAT and subsequent synthesis of 
melatonin.  This reduction in AANAT activity has been shown to be paralleled by reduction 
in protein amount which, in turn, is mediated by the rapid, reversible process of proteasomal 
proteolysis (Gastel et al., 1998).  The acute light-induced suppression of nocturnal melatonin 
synthesis was first observed in rats (Klein and Weller, 1972) and has been used in numerous 
animal studies to help determine the neural and biochemical mechanisms of melatonin 
regulation.   
 
 
1.5.4.2 Intensity and duration of light 
 
There is a well-known dose-response relationship between the intensity of light and the 
resultant magnitude of melatonin suppression.  (Lynch et al., 1981: Brainard et al., 1983; 
1988; Bojkowski et al., 1987; McIntyre et al., 1989; Aoki et al., 1998; Zeitzer et al., 2000).  
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 Zeitzer and colleagues (2000) performed a study examining the sensitivity of the circadian 
pacemaker to a single nighttime exposure (6.5 h) of dim broadband fluorescent lighting (~100 
lux) using a 9 day phase shift protocol.  Exposure to a single 6.5 h episode of ~100 lux of 
light generated half of the response observed for a stimulus that is nearly 100-fold brighter 
(~9000 lux). Lighting was provided by overhead cool white fluorescent designed to provide 
uniform illuminance to the whole experimental room. In a recent retrospective comparison 
study using similar lighting conditions of cool white fluorescent at either a typical room light 
(<200 lux) versus dim light (<3 lux) given over long durations (8 h or 16 h) as part lengthier 
circadian study, melatonin was shown to be suppressed by more than 50% in the majority of 
subjects (Gooley et al., 2011). 
 
 
1.5.4.3 Timing of light 
 
As mentioned earlier in section 1.1, light is the most important zeitgeber for entraining 
circadian oscillators.  The effect of light on melatonin production can be compared to the 
effect of light on other circadian oscillators which respond differently to light presented at 
different phases of its cycle. These phase responses can be plotted as a curve of phase shift of 
a circadian rhythm, such as melatonin production, as a function of the circadian phase that a 
stimulus, or zeitgeber, is given.  Khalsa and colleagues (2003) elegantly presented the PRC 
for single lengthy (6.7 h) bright light exposures in a carefully controlled laboratory setting 
using fluorescent light. Recently, a comparison using a similar fluorescent light source but of 
a shorter duration (1 h) showed a PRC whose magnitude was 40% of that for the 6.7 h PRC 
of Khalsa and colleagues (St. Hilaire et al., 2012). When comparing a monochromatic blue 
(480 nm) light PRC, this was shown to be 75% as strong of that for the bright polychromatic 
light PRC of Khalsa and colleagues (Ruger et al., 2013). Another blue light PRC with the 
source being from a small, portable, commercially available device has been published 
(Revell et al., 2012). 
 
 
1.5.4.4 Previous light history  
 
In an initial important study by Lynch and colleagues (1981) that showed that with 
adaptation, rats could respond to a dim stimulus as either light or dark in terms of circadian 
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 regulation depending on what light intensity was available for the rest of the day.  In this 
study, urinary melatonin rhythms were studied in rats housed individually in metabolism 
cages. For 17 days one group was exposed to alternating 12-hour periods of dim light and 
total darkness (dim:dark) while a second group was exposed alternately to dim light and 
bright light (dim:bright).  Both groups were then exposed to constant dim light for 15 days, 
returned to their original lighting conditions and 18 days later, half of each group was 
sacrificed at the midpoint of the dim light phase, and the other half 12 h later. Both groups 
excreted melatonin when exposed to daily cycles in light intensity; the dim:bright rats 
excreted 69%; of the total daily melatonin output during the dim light phase while the 
dim:dark group of rats excreted 70% during the dark phase.  
 
Additionally, studies in animal models show high sensitivity to phase shifting by light after 
exposure to extended periods of darkness (Shimomura and Menaker, 1994; Refinetti, 2003).  
Two human studies showed that a higher intensity light history over a given period of time 
dampens the magnitude of subsequent melatonin suppression by acute light exposure.  In one 
study, one week of controlled dim light (less than 200 lux) resulted in 53% subsequent 
suppression of melatonin by 500 lux white light compared with only 41% after a week of 
bright light (5000-7000 lux) exposure (Hebert et al., 2002).  In another study, a light history 
of 0.5 lux for over 63 h prior to a 6.5 hour 200 lux white light exposure resulted in a mean 
melatonin suppression of 85.7%, compared with 71.2% after a constant light history of 200 
lux over an equal period (Smith et al., 2004). 
 
Aggelopolous and Meissl (2000) showed that light acting via rod and cone pathways could 
have state-dependent, opposing actions on the electrical activity of SCN neurons and thus 
potentially influence the response of these neurons to light stimuli.  Using an endpoint of 
electrical activity as measured by extracellular electrodes, the investigators found that the 
sensitivity of SCN neurons to light became proportionally higher, with a lower threshold for 
excitation, with increased time of dark-adaptation to scotopic conditions.  They also 
concluded from the significantly divergent sensitivities of SCN neurons to 505 nm light 
under dark- and light-adapted pre-conditions that there are separate cone and rod inputs to the 
SCN, and that most SCN neurons receive both rod and cone input.  Their extensive findings 
suggest a complex, dynamic interrelationship between the traditional visual photoreceptors 
and SCN cell sensitivity to light stimuli, relative to various adaptive lighting conditions 
(Aggelopolous and Meissl, 2000). 
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Jasser et al. (2006) demonstrated that exposure to white light at levels as low as 18 lux for 2 h 
at night can significantly decrease the magnitude of subsequent melatonin suppression by 460 
nm monochromatic light up to 46% in healthy male and female volunteers.  Thus, pre-
exposure to photopic light levels appear to diminish phototransduction as measured by 
plasma melatonin suppression.  This finding supports the observations by Aggelopolous and 
Meissl (2000) in rats.  
 
 
1.5.4.5 Wavelength 
 
Several years after Lewy and colleagues discovered that light at 2500 lux can suppress 
melatonin in humans (Lewy et al., 1980), Brainard worked with Lewy and others to more 
precisely determine the dosages of light needed to suppress melatonin in normal volunteers 
(Brainard et al., 1988).  In that study, six healthy males were exposed to carefully controlled 
intensities of monochromatic light at 509 nm for one hour during the night.  The data 
demonstrated that light at 509 nm affects melatonin in a fluence-response (dose-response) 
fashion (i.e., the brighter the photic stimulus the greater the suppression of melatonin). 
 
Studies using monochromatic light exposures in humans, monkeys and rodents have shown 
that nonvisual responses are maximally sensitive to blue light (between 459-483 nm) 
(Brainard et al., 2001a; Brainard et al., 2001b; Thapan et al., 2001; Foster, 2005; Gamlin et 
al., 2007).  This sensitivity is different than that of the combined photopic response of 
classical photoreceptors for vision which peak in the green part of the spectrum (λmax 555 
nm). 
 
 
1.6 Other neuroendocrine and neurobehavioral responses to light 
 
Earlier sections have addressed how light affects the neuroendocrine and circadian systems 
primarily through melatonin suppression. Another neuroendocrine hormone with a clear 
circadian rhythm is cortisol (Buijs et al., 1999; Kudielka and Kirschbaum, 2003). Light 
exposure during the morning has been shown to accentuate the normal daily morning rise in 
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 cortisol levels (Scheer and Buijs, 1999; Leproult et al., 2001). Two other physiological 
responses to bright light include heart rate and core body temperature. When bright white 
light is presented during the night, heart rate increases (Scheer et al., 1999) and core body 
temperature elevates (Badia et al., 1991; Ruger et al., 2006). 
 
Neurobehavioral responses such as alertness also have a circadian rhythm (Dijk et al., 1992), 
but the exact mechanism behind the acute alerting effects of light is not known.  Measures for 
alertness include neurobehavioral performance testing, subjective sleepiness scales, and 
electroencephalogram (EEG) via polysomnography.  Exposure to a sufficient light stimulus 
often results in increasing performance on neurobehavioral testing, lower subjective 
sleepiness ratings, and increased EEG frequencies in the alpha range, all pointing to increased 
alertness (French et al., 1990; Badia et al., 1991; Cajochen et al., 1999; Wright et al., 2002; 
Phipps-Nelson et al., 2003; Cajochen et al., 2005; Lockley et al., 2006)  
 
Melatonin was thought to mediate part of the alerting effects but Ruger and colleagues (2005) 
showed that there is only a weak relationship between suppression of melatonin and 
reduction of sleepiness. Other laboratories (Krauchi et al., 1997; Krauchi and Wirz-Justice, 
2001) have demonstrated a functional link between the degree of heat loss (distal 
vasodilatation) and subjective sleepiness and the link between core body temperature and 
alertness continues to be elucidated (Wright et al., 2002).   
 
Alerting effects of light may use the afferent pathways leading from the SCN to other areas of 
the brain. Indirect projections to the locus coeruleus (LC), an area of the brain associated with 
arousal and sleep-wake regulation, are relayed via the dorsomedial hypothalamic nucleus 
(DMH) have been shown in rodents (Aston-Jones et al., 2001). By lesioning these 
connections, the circadian variation in the LC was eliminated (Usher et al., 1999; Aston-
Jones et al., 2001).  In humans, the LC is influenced by bright light exposure during the night 
in blood flow studies performed by Perrin and colleagues (Perrin et al., 2004). The DMH also 
projects indirectly and directly to the ventrolateral preoptic nucleus (VLPO) (Chou et al., 
2002) which is also a target region for ipRGCs identified by Gooley and colleagues (Gooley 
et al., 2003). Taken together, these indirect projections from the SCN, as well as direct 
projections from the ipRGCs, are the more likely mechanism by which bright light exposure 
transduces alerting affects. 
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1.7 Action spectra for circadian, neuroendocrine and neurobehavioral responses 
 
In the field of photobiology, an action spectrum is one of the principal tools for identifying 
the chromophore or photopigment that initiates a light-induced response.  The concept of an 
action spectrum was first introduced in the 19th century when biologists observed that plant 
growth depended on the spectrum of light to which plants were exposed.  Strictly defined, an 
action spectrum is the relative response of an organism to different wavelengths of visible 
and near-visible electromagnetic radiation. Over the years, photobiologists have evolved a set 
of refined approaches for determining action spectra that are applicable to all light responsive 
organisms  (Grossweiner, 1989; Coohill, 1991; 1999; Horspool and Song, 1994). 
 
Throughout the photobiological literature, there are two basic types of action spectra: 
polychromatic and analytic (Coohill, 1999).  In general, when investigators begin exploring 
light sensitive biological reactions, they typically begin by determining polychromatic action 
spectra.  Such action spectra are developed using broader bandwidth light stimuli that either 
have half-peak bandwidths greater than 15 - 20 nm or by emphasizing particular wavelengths 
against backgrounds of "white" artificial or natural light.  These types of action spectra are 
useful for: 1) identifying interactions of biological responses to multiple wavelengths; 2) 
elucidating how organisms respond to light in more natural settings; and 3) guiding the 
development of the more sophisticated analytic action spectra.  By themselves, however, 
polychromatic action spectra have limited utility for identifying the specific chromophores or 
photopigments that initiate photobiological responses (Coohill, 1999).   
 
Beginning in the latter half of the 20th century, several advances led to the development of the 
first mammalian neuroendocrine and circadian action spectra.  A series of discoveries 
determined that light detected by the eyes was the primary stimulus that regulated pineal 
gland morphology and melatonin biosynthesis (Quay, 1961; 1963; Wurtman et al., 1964). 
Soon after that, it was shown that light detected by the eyes regulated robust pineal-
reproductive photoperiodic responses in hamsters (Hoffman and Reiter, 1965).  Following 
those advances, a discrete, light sensitive neural pathway extending from the retina into the 
SCN for circadian regulation was described (Moore and Lenn, 1972; Hendrickson et al., 
1972).  These discoveries were built on a growing understanding that environmental light 
played a fundamental role in regulating homeostasis, and quickly fostered further advances 
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 that elucidated many important aspects of how light regulates neuroendocrine and circadian 
physiology (for reviews, see Brainard, 1978; Oksche, 1991). Cumulatively, those early 
scientific breakthroughs enabled investigators to begin using the tools of photobiology to 
explore neuroendocrine and circadian physiology.  
 
 
1.7.1 Polychromatic 
 
As in other fields of photobiology, the earliest action spectra studies on neuroendocrine and 
circadian responses to light utilized polychromatic stimuli.  Table 1 summarizes the methods 
and results of both early and more recent polychromatic action spectra.  Across this set of 
publications, both humans and rodents were studied in terms of pineal melatonin synthesis, 
circadian phase shifting or photoperiodic responses.  
 
The polychromatic action spectra in Table 1 are reasonably consistent in suggesting that the 
general spectral region between 450 nm and 550 nm provides the strongest stimulation of 
circadian and neuroendocrine responses in mammals.  These action spectra, however, are 
limited in determining refined peak sensitivities for given responses because the test light 
stimuli have broader bandwidths. 
 
 
Table 1. Selected polychromatic action spectra for mammalian neuroendocrine and  
 circadian responses 
      Peak   First  
Species Biological response Stimuli tested sensitivity * author Year 
Rat Pineal gland  Single irradiances of 5 restricted 508-553   Cardinali 1972 
 HIOMT reduction bandwidths (1/2 peaks 19-80 nm)  
 
Deer mouse Photoperiodic reproductive Single irradiances of 3 restricted No peak  Vriend 1973 
 development (juvenile) bandwidths (1/2 peaks 45-50 nm) detected 
 
Rat Core temperature Single irradiances of 5 restricted 508-553  McGuire 1973 
 rhythm phase shift bandwidths (1/2 peaks 19-80 nm)  
 
Hamster Pineal gland  Two to 4 irradiances of 5 restricted 435-500  Brainard 1984 
 melatonin suppression bandwidths (1/2 peaks 15-78 nm)  
 
Hamster Photoperiodic reproductive  Single irradiances of 5 restricted 350-555  Brainard 1986  
 response (adult) bandwidths (1/2 peaks 15-90 nm) 
 
Human Salivary melatonin Single irradiances of 5 restricted 455-539  Wright 2001 
 suppression and   bandwidths (1/2 peaks 18-35 nm) 
 phase shift (delay) 
* Half peak domain (s) of the stimulus (i) producing the strongest responses in nm.  
HIOMT = hydroxyindole-O-methyltransferase 
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 1.7.2 Analytic 
 
The first analytic action spectrum developed in the circadian field was the groundbreaking 
work of Takahashi and colleagues (1984) who tested the effects of monochromatic light on 
wheel-running behavior of hamsters. Following their lead, other circadian and 
neuroendocrine researchers began employing monochromatic wavelengths and increasingly 
sophisticated photobiological techniques for determining analytic action spectra. The earliest 
analytic action spectra are listed in Table 2. In 1998, the seminal discovery of melanopsin in 
frog skin, and in the mammalian retina, created a major breakthrough in our understanding of 
human circadian phototransduction (Provencio et al., 1998; 2000). Analytic action spectra 
published during and after discovery of melanopsin are shown in Table 3. 
 
Analytical action spectra are determined comparing the effects of two or more 
monochromatic light stimuli with half-peak bandwidths of 15 - 20 nm or less.  It is optimum 
to develop analytic action spectra by establishing a set of dose-response curves (fluence-
response curves) at different wavelengths for a specific biological response.  An action 
spectrum is then formed by plotting the reciprocal of incident photons required to produce the 
biological response versus wavelength (Grossweiner, 1989; Coohill, 1991; 1999; Horspool 
and Song, 1994).  This approach can become very labor intensive as more and more 
wavelengths are compared.  An acceptable, although potentially less definitive alternate 
technique is to compare the effects of different wavelengths at an equal photon density.  Two 
principal advantages of analytic action spectra over polychromatic action spectra is that they 
bring greater precision to defining the wavelength sensitivity of a given biological response 
and they permit a better opportunity to identify the photopigment molecules that mediate 
phototransduction.   
 
The analytic action spectrum for circadian regulation described by Takahashi and colleagues 
(1984) utilized the classic photobiological approach of establishing fluence-response 
functions for a set of monochromatic wavelengths and then forming an action spectrum from 
the half-saturation constants of those functions.  The resulting action spectrum had a λmax 
around 500 nm and seemed similar in shape to the absorption spectrum for rhodopsin.  
Although Takahashi and colleagues found these data supported the hypothesis that a 
rhodopsin-based photopigment and rod cells in the retina mediate circadian entrainment in 
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 hamsters, they were careful to point out that the participation of a cone mechanism could not 
be ruled out. 
 
Table 2. Early (pre-1998) analytic action spectra for mammalian neuroendocrine and 
circadian responses 
 
     Peak    First 
Species Biological response Stimuli tested  sensitivity* author  Year 
Hamster Locomotor rhythm 3 full and 4 partial fluence 469-522  Takahashi  1984 
Mesocricetus  phase shift response curves  7 monochromatic  (Est λmax   
auratus   bands (1/2 peaks 9-16 nm) =500)†  
 
Hamster Pineal gland 2 full fluence response curves 495-505  Podolin  1987 
Mesocricetus  melatonin 2 monochromatic bands 
auratus suppression (1/2 peaks 10 nm) 
 
Rat Pineal gland 2 partial fluence response curves 455-465  Bronstein  1987 
Rattus  AANAT suppression 2 monochromatic bands (Est λmax  
norvegicus   (1/2 peaks 10 nm)  =495)† 
 
White-footed  Pineal gland Single irradiances of 6 monochromatic 355-565  Benshoff  1987 
Mouse melatonin bands (1/2 peaks 9-10 nm)   
Peromyscus  suppression 
leucopus   
 
Human Plasma 1 fluence response curve and 504-514  Brainard  1988 
Homo sapiens melatonin  5 single irradiances of 6 monochromatic 
 suppression bands (1/2 peaks 9-16 nm) 
 
Mouse Locomotor 6 full fluence response curves (+/+)  475-521  Provencio 1995 
Mus musculus rhythm  of 6 monochromatic   (Est λmax = 
 phase shift bands (1/2 peaks 6-12 nm) 506-511)† 
     
   7 full fluence response curves (rd/rd)  454-521 
   of 7 monochromatic  (Est λmax = 
   bands (1/2 peaks 6-12 nm) 506-511)† 
 
Mouse Locomotor 6 full fluence response curves (+/+)  395-555  Yoshimura 1996 
Mus musculus rhythm  of 6 monochromatic   (Est λmax = 
 phase shift bands (1/2 peaks 7-11 nm)  500) † 
     
   6 full fluence response curves (rd/rd)  445-520 
   of 6 monochromatic   (Est λmax = 
   bands (1/2 peaks 7-11 nm)  480) † 
* Half peak domain (s) of the stimulus (i) producing the strongest responses in nm.      
AANAT = serotonin-N-acetyltransferase     
† Estimated (Est) λmaxfrom fitting data to spectral sensitivity curves or to visual photopigment nomograms.   
Wild type and retinally degenerate strains are indicated by (+/+) and (rd/rd), respectively. 
 
 
The studies in Table 3 indicate shorter wavelength peak sensitivities in the blue portion of the 
visible spectrum.  This was first demonstrated prior to the discovery of melanopsin and 
ipRGCs when Yoshimura and Ebihara (1996) showed that circadian phase shifting of rd/rd 
mice had a peak response at 480 nm.   Given the differences in laboratories, animal models, 
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 physiological endpoints and specific investigative techniques, this consistent identification of 
peak responses across the 459 nm to 484 nm range in the blue spectrum is remarkable.   
 
 
Table 3. Recent (post-1998) analytic action spectra for circadian, ipRGC and ocular 
responses 
 
 Biological Stimuli  Peak  First 
Species Response  Tested  Sensitivity Author  Year 
Human Plasma  8 fluence response curves Est λmax = Brainard 2001b 
 melatonin  (1/2 peaks 10-15 nm) 464 nm, 
 suppression    (446-477 nm)  
 
Human Plasma  6 fluence response curves Est λmax = Thapan 2001 
 melatonin  (1/2 peaks 5-13 nm) 459 nm, 
 suppression    (457-462 nm) 
 
Mouse Pupillary light 6 fluence response curves (+/+) Est λmax =  Lucas   2001 
 reflexes  (1/2 peaks ≤ 10 nm) 498 nm or 508nm 
     
     (rd/rd cl) Est λmax = 
     479 nm 
 
Human Cone cell  7 fluence response curves Est λmax = Hankins 2002 
 ERG -wave  (1/2 peaks ≤ 10 nm) 483 nm 
 
Rat ipRGC cellular 6/10 fluence response curves Est λmax = Berson  2002 
 depolarization (1/2 peaks 10 nm) 484 nm 
   
Mouse Circadian  7 fluence response curves (rd/rd cl) Est λmax =  Hattar  2003 
 phase shift   (1/2 peaks 10 nm) 481 nm 
 
Monkey ipRGC cellular 10 fluence response curves Est λmax = Dacey  2005 
 depolarization (1/2 peaks 15-20 nm) 482 nm 
 
Monkey/ Pupillary light 9 fluence response curves Est λmax = Gamlin 2007 
Human reflexes  (1/2 peaks 8-10 nm) 482 nm 
 
Human Pupillary light 8 fluence response curves Est λmax = Zaidi   2007 
 reflexes  (1/2 peaks 10 nm) 480 nm 
 
Wild type and retinally degenerate strains are indicated by (+/+) and (rd/rd cl), respectively.   
Intrinsically photosensitive retinal ganglion cells (ipRGC). 
 
 
The only study in Table 3 that does not identify a λmax in the blue part of the spectrum is the 
action spectrum that identifies a peak at 498 nm to 508 nm in pupillary responses of wild type 
mice (Lucas et al., 2001).  Earlier analytic action spectra with wild type mice and hamsters 
also showed peaks in the 500 nm to 511 nm range for phase shifting locomotor activity 
(Takahashi et al., 1984; Provencio and Foster, 1995; Yoshimura and Ebihara, 1996).  It may 
be that the intact rodent retina combines input from ipRGCs and classical visual 
photoreceptors for circadian phase shifting and pupillary responses.  In contrast, when mice 
do not have functioning visual photoreceptors (such as in the rd/rd and rd/rd cl models), their 
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 retinas appear to shift to the shorter wavelength sensitivity for circadian and pupillary 
responses (Yoshimura and Ebihara, 1996, Lucas et al., 2001; Hattar et al., 2003).   
 
Other lines of evidence described earlier in section 1.2.3 support the concept that ipRGCs are 
not the exclusive photoreceptors involved in circadian regulation.  Despite rapid experimental 
progress on ipRGC physiology, it is currently unknown precisely how these newly 
discovered photoreceptors work with the classical visual photoreceptors in transducing light 
in the dynamic, complex polychromatic light environments where humans carry out their 
daily activities. 
 
 
1.8 Light source comparison studies 
 
On the heels of defining the spectral sensitivity of the melanopsin photopigment in the 
ipRGCs, multiple laboratories embarked on wavelength comparison studies on melatonin 
suppression, circadian phase changes and alertness using narrowband (15 nm or greater 
halfpeak bandwidth) or monochromatic (less than 15 nm halfpeak bandwidth) light sources. 
 
 
1.8.1 Narrowband or monochromatic source comparisons 
 
Exposure to 6.5 h of monochromatic light at 460 nm induced a two-fold greater circadian 
phase delay than 6.5 h of 555 nm monochromatic light of equal photon density.  Also, 460 
nm light caused twice the amount of melatonin suppression as 555 nm light, dependent on the 
duration of exposure (Lockley et al., 2003).  Therefore, it was concluded that the efficacy of 
light in phase shifting human circadian rhythms is wavelength dependent, with a blue-shift in 
sensitivity.  
 
A four hour pulse of very low levels of short-wavelength (combined 436 nm and 456 nm) 
presented immediately after habitual wake time was shown to produce a phase advance 
similar in size to very bright polychromatic light despite the large (185-fold) difference in 
light photons (Warman et al., 2003).  
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 Revell and colleagues (2005) tested a phase advance protocol and compared 440 nm, 470 nm 
and 600 nm monochromatic light. Although the results were not entirely clear, 470 nm light 
was more effective than 600 nm light and perhaps, though not statistically significant, more 
effective than 440 nm light in phase advancing the offset of the human melatonin rhythm. 
 
Wright and colleagues (2004) performed a study which falls into both monochromatic and 
polychromatic source comparisons since the wavelengths used (470, 495, 525, 595 and 660 
nm) were between 10-18 nm.  The lights used were portable light emitting diode (LED) 
devices mounted on spectacle frames. A 2 h light pulse was administered starting at 06:00 on 
two consecutive mornings.  DLMO, using saliva, showed that shorter wavelengths of 470, 
495 and 525 nm had greatest DLMO advances ranging from approximately 40-65 min while 
the longer wavelengths (595 nm and 660 nm) produced no significant phase advance.  
 
Like melatonin suppression and phase changes, monochromatic blue light has been shown to 
increase subjective and objective measures of alertness, improve performance measures and 
affect waking EEG over monochromatic green light (Cajochen et al., 2005; Lockley et al., 
2006). Specifically, 460 nm monochromatic light was either compared with 555 nm 
monochromatic light over a 6.5 h exposure (Lockley et al., 2006) or with 550 nm 
monochromatic light over a 2 h exposure (Cajochen et al., 2005).  
 
Finally, a study from our laboratory using the identical light source studied in Chapter 4 
results demonstrated that increasing irradiances of narrowband blue light can elicit increasing 
plasma melatonin suppression in healthy subjects (p<0.0001) (West et al., 2011).  The data 
were fit to a sigmoidal fluence-response curve (R2=0.99; ED50= 14.19 µW/cm2).  A 
comparison of with 40 µW/cm2 from 4,000 K broadband white fluorescent light, still 
currently used in most general lighting fixtures, suggests that narrow bandwidth blue LED 
light may be stronger than 4,000 K white fluorescent light for suppressing melatonin (West et 
al., 2011). 
 
 
1.8.2 Broadband fluorescent light source comparisons 
   
Fluorescent lighting still remains the standard in many indoor environments, including the 
workplace.  Broadband, white fluorescent light sources have been studied for comparison 
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 studies on alertness, neurobehavioral testing, melatonin suppression, and circadian phase 
changes. Early studies have shown that bright white polychromatic light exposure has been 
shown to acutely increase alertness and reduce fatigue during light exposure (French et al., 
1990; Dawson and Campbell, 1991; Badia et al., 1991). Bright, overhead, white 
polychromatic light (Philips FB40/CW/3 cool white fluorescent) at 3,000 lux, when 
compared to 100 lux dim white light, increased measures of subjects’ performance on seven 
of ten neurobehavioral tests during a 16 hour overnight light exposure in 9 male subjects 
(French et al., 1990).  A similar study, simulating night shift work, compared a four hour 
period of 6,000 lux white light to dim white light at less than 200 lux throughout an 8 hour 
shift in 13 male and female subjects. The group that received the four hours of bright light on 
the first night of the study exhibited a smaller decline in alertness during the second half of 
the night shift than the group that received dim light the entire time (Dawson and Campbell, 
1991). Another, larger, study compared 43 male subjects in a between subjects design in four 
different lighting conditions. An increase in brain wave frequencies associated with alertness 
and improvement in performance on the neurobehavioral test battery were found for the 
bright light exposures (Badia et al., 1991). In all of these studies the light source was not 
highly characterized if described at all. 
 
Many investigators continued to perform acute dose-dependent alerting effects to broadband 
fluorescent light sources presented to subjects at night.  Measures taken include subjective 
sleepiness, psychomotor vigilance reaction times, reduced lapses, reduction of attentional 
failures indicated by electrooculogram-derived slow rolling eye movements, and suppression 
theta-alpha activity in waking EEG (Burgess et al., 2001; Campbell and Dawson, 1990; Badia 
et al., 1991; Daurat et al., 1993; Myers and Badia, 1993; Campbell et al., 1995; Wright et al., 
1997; Cajochen et al., 2000; Lavoie et al., 2003).  One study compared daytime broadband 
fluorescent light exposure presented to subjects for 5 h and reported enhanced alertness and 
performance as well as reduced incidents of slow eye movements (Phipps-Nelson et al., 
2003).   
 
Broadband fluorescent light sources are described in terms of correlated color temperature or 
CCT.  CCT is a specification of the color appearance of a lamp in reference to a heated 
referenced black surface. It is measured in degrees Kelvin (K), and only gives information 
about the color of the light, not the spectral power distribution. Most of the studies described 
above do not report CCT but only describe the kinds of lamps used. A cool white fluorescent 
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 lamp, for example, would have a color temperature of approximately 4,100 K, while a warm 
white fluorescent lamp would have a CCT of approximately 3,000 K (DiLaura et al., 2011). 
The CCT of fluorescent lamps not only influences visual discrimination, but it can alter 
neuroendocrine and neurobehavioral effects.  CCT is commonly used in architectural 
lighting, but is just now being used in photobiological research to classify light sources. Table 
4 presents a partial listing of light sources in terms of approximate CCT (DiLaura et al., 
2011). 
 
 
Multiple studies carried out at the same time in Japan, manipulating numerous parameters, 
have documented neuroendocrine and neurobehavioral effects using different color 
temperature lamps.  Specifically, higher color temperature lamps evoked stronger melatonin 
suppression than lower correlated color temperature bulbs (Morita and Tokura, 1998; Sato et 
al., 2005).  Further, core body temperature, blood  
 
Table 4. CCT of typical light sources. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
pressure, and EEG frequency increased under higher color temperature when compared to 
lower color temperatures (Morita and Tokura, 1998; Yasukouchi et al., 2000; Noguchi and 
Sakaguchi, 1999; Yasukouchi and Ishibashi, 2005).  Reductions in deep, slow-wave sleep 
have also been observed in the first half of the sleep period when subjects are exposed to high 
Light Source CCT  
North, Light Blue Sky 8,000 K  
Daylight Fluorescent 6,500 K   
Clear Mercury Lamp 6,000 K  
Sunlight at Noon 5,500 K  
Cool White Fluorescent 4,100 K  
Warm White Fluorescent 3,000 K  
High Pressure Sodium 2,200 K  
Incandescent 2,800 K  
Sunset 2,500 K  
Candlelight 1,900 K  
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 color temperature lamps and when these lights were given (Kozaki et al., 2005).  Generally, 
these results are complementary to our understanding of the analytic action spectra in that 
higher color temperature (richer in blue wavelengths) fluorescent bulbs induce stronger 
neurobehavioral and neuroendocrine effects than lower color temperature lamps. These 
studies are summarized in Table 5. 
 
More refined studies comparing polychromatic light with more short-wavelength energy 
(8,000 K CCT) to typical fluorescent lighting (4,100 K CCT) for melatonin suppression 
revealed differences but only at one of several low light levels that were compared (Figuero 
et al., 2006).  Smith and Eastman (2009) compared 4,100 K and 17,000 K CCT lamps at 
equal photon densities for its phase-delaying effect.   
 
Table 5. CCT effects on neurobehavioral, neuroendocrine, and circadian responses. 
 
 
 
 
Bedtime, 2 h bright light exposures were scheduled according to each subject’s baseline 
melatonin offset phase or circadian time versus typical studies that employ clock time.  Light 
Parameters Measured CCT Comparisons Citation 
Reaction Time 7500 K, 5000 K, 3000 K Deguchi and Sato, 1992 
Heart Rate Variability 6700 K, 5000 K, 3000 K Mukae and Sato, 1992 
 
Core Temperature, Melatonin 
 
6500 K, 3000 K 
 
Morita and Tokura, 1998 
 
Heart Rate Variability, EEG, 
Subjective Drowsiness 
5000 K, 3000 K 
 
Noguchi and Sakaguchi, 
1999 
 
Skin Temperature, Rectal 
Temperature, Expired Gas 
 
7500 K, 5000 K, 3000 K 
 
Yasukouchi et al., 2000 
 
Polysomnography, EEG, EOG, 
EMG 
 
6700 K, 5000 K, 3000 K 
 
Kozaki et al., 2005 
Rectal Temperature, Salivary 
Melatonin 
 
6480 K, 3150 K 
 
Sato et al., 2005 
Arousal Level, Heart Rate 
Variability, Blood Pressure, 
Body Temperature Reg., Sleep 
Architecture 
7500 K, 6700 K, 5000 K, 
3000 K 
 
Yasukouchi and Ishibashi, 
2005 
 
Heart Rate Variability 6700 K, 5000 K, 3000 K Ishibashi et al., 2007 
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 exposure and bedtime moved 2 h later sequentially each day with no greater phase delays 
seen in the 17,000 K CCT condition.  Smith and colleagues (2009) compared 4,100 K and 
17,000 K CCT lamps at relatively equal irradiances (commonly used light therapeutic lux 
levels) for its phase-advancing potential.  Early morning bright light exposures were 
scheduled according to each subject’s baseline melatonin onset phase or circadian time versus 
typical studies that employ clock time.  Light exposure and wake-up moved one hour earlier 
sequentially each day with no greater phase advances seen in 17,000 K CCT condition 
observed (Smith et al., 2009).  
 
In a combined field and laboratory study, the laboratory portion examined five polychromatic 
fluorescent light conditions for effects on the evening rise of melatonin, subjective measures 
of sleepiness as well as EEG measured sleep parameters. The field observations allowed a 
comparison of the laboratory-controlled  polychromatic exposures and suggests that typical 
illumination used in the evening has the potential to disrupt sleep (Santhi et al, 2011). 
 
 
1.8.3 Mixed light source comparisons 
 
Several other studies have compared the efficacy of light emitted from LEDs versus 
fluorescent lamps for neuroendocrine, circadian and neurobehavioral regulation.  An early 
study with rats found no significant differences in pineal melatonin suppression between 
broad spectrum white LEDs and cool white fluorescent lamps across five different 
illuminances (Heeke et al., 1999).  A human study compared 2,000 lux light emitted by broad 
spectrum white LEDs, blue/green LEDs, and white fluorescent lamps (Wright et al., 2001).  
The results showed no significant differences between light from white LEDs and white 
fluorescent lamps for acute melatonin suppression and phase delay of the melatonin rhythm, 
but broad spectrum blue/green light appeared to be stronger than both white light sources.  In 
a follow up to that finding, it was shown that 65 µW/cm2 of narrow bandwidth LED light 
with peaks at 470, 495, and 525 nm could phase advance human circadian rhythms, but 
longer wavelength peaks of LED light at 595 and 660 nm had no effect at this same intensity 
(Wright et al., 2004).  A different study with 4 healthy human subjects showed that narrow 
bandwidth blue LED exposure was a stronger than clear mercury vapor lamps for melatonin 
suppression (Figueiro et al., 2004).  Finally, an experiment testing four illuminances of 
narrow bandwidth blue LED light peaking at 470 nm showed that increased illuminances 
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 evoked increased acute alertness in volunteers in both objective and subjective assessments 
(Figueiro et al., 2007).  Paul and colleagues (2007) compared several commonly marketed 
phototherapeutic devices that emitted enhanced light in the blue-green portion of the 
spectrum.  All devices produced significant phase-delays with no one device producing a 
more significantly phase response.   
 
 
1.8.4  Light source comparisons of typically used polychromatic light 
 
A recent study compared typical domestic and workplace lamps over a short term exposure as 
one might experience in an extended bathroom visit prior to bed for effects on melatonin and 
subjective measures of alertness.  Data revealed that the evening rise in salivary melatonin 
was reduced by lamps containing an abundance of blue wavelengths and subjectively 
measure alertness was increased (Wahnshaffe et al., 2013). 
 
In the past few years there has been an emphasis on examining light sources more typically 
encountered in the home or office for their neuroendocrine, circadian and neurobehavioral 
regulatory effects. As LED technology is likely to become a greater presence in our homes, 
work, and general environment, many of the studies used LEDs as the light sources. In a 
fascinating study, given the huge use of electronic devices in the evening, the spectral 
composition commonly used in computer screens which employ a LED backlight was 
compared to computer screens back illuminated with a cold cathode fluorescent lamp 
(CCFL). The photon flux of blue light of the LED backlit computer screen was three times 
higher than that of the CCFL computer screen. A 5 hour evening exposure resulted in a 
significant suppression in the evening rise of salivary melatonin levels as well as EEG 
measures of objective sleepiness (Cajochen et al., 2011). 
 
 
1.9 Aims and Hypotheses 
 
Since the discovery of ipRGCs and the photopigment, melanopsin, with its wavelength 
sensitivity in the blue portion of the visible spectrum, there has been a steady increase in 
studying blue light for its circadian, neuroendocrine and neurobehavioral effects. The aim of 
this set of studies is to study the effects of blue light, either in combination with other light 
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 wavelengths, or refined to specific blue wavelengths, in experiments to test the immediate, 
alerting or longer term, circadian effects. 
 
The initial study (Chapter 3) will test the hypothesis that white polychromatic fluorescent 
lamps will have increased efficacy for melatonin suppression, alertness, and circadian phase 
shifting when they are enriched in the blue portion of the spectrum. This will be done by 
comparing the magnitude of melatonin suppression, changes in alertness, and phase resetting 
of circadian rhythms in healthy male and female subjects following exposure to equal photon 
densities of blue-enriched fluorescent lights compared to standard white fluorescent lights. 
 
The overall aim of the second project (Chapter 4) is to test the ability of blue-appearing 
narrowband solid-state light for its ability to acutely suppress nocturnal melatonin as well as 
enhance cognitive performance and alertness in healthy men and women. The specific 
hypotheses tested were that compared to dim light exposure, blue narrowband light would: 1) 
suppress nocturnal melatonin, 2) decrease reaction time and lower number of lapses in a 10-
min auditory psychomotor vigilance task, 3) increase number of correct responses in two 
working memory tasks (Digit symbol substitution task (DSST), digit span forward and 
reverse entry (DS)), 4) lower subjective levels of sleepiness as measured by the Karolinska 
sleepiness scale (KSS), and 5) show differences in EEG in delta-theta frequency band (0.5 – 
5.5 Hz) and high alpha frequency band (9.5 – 10.5 Hz) during the Karolinska drowsiness test 
(KDT). 
 
The third study (Chapter 5) will test the hypothesis that certain combinations of light 
wavelengths are additive or opponent to the circadian receptor system that mediates the 
suppression of nighttime synthesis of the pineal hormone, melatonin, in healthy human 
subjects.  Specific wavelength combinations will be given under highly controlled 
experimental conditions to healthy men and women and plasma melatonin concentration will 
be determined.  
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CHAPTER 2 GENERAL METHODS 
 
2.1 General human use/ethical approval 
 
All human use protocols used in this thesis were submitted and approved under my 
collaborative supervisor and the study’s Principle Investigator, Dr. George Brainard, and 
followed the Institutional Review Board (IRB) guidelines in place at Thomas Jefferson 
University (TJU). The IRBs are established and empowered under the authority of the 
President of TJU and the University’s Federal Wide Assurance with the U.S. Department of 
Health and Human Services. TJU requires that all research involving human subjects, or 
material or personal information from living humans, be reviewed and approved by one of 
the TJU’s IRBs prior to initiation of any research activities. This includes recruitment and 
screening activities. 
 
Each protocol in this thesis was done at TJU and all human subjects research was designed 
and carried out in a manner that protected the rights, welfare and privacy of the subjects.  
Each protocol was approved after modifications to secure approval, and underwent annual 
reviews to insure compliance to all TJU IRB guidelines.  
 
 
2.1.1 Consent process 
 
Subjects were recruited by a member of the laboratory on an individual basis after some 
general invitation to join the study (i.e. poster, classroom announcement, personal referral, 
media advertisement, etc.).  Each potential subject was interviewed by phone and asked 
questions concerning their current and past health status, sleep/wake habits, travel history and 
job description.  If their answers did not exclude them immediately from further 
consideration then a brief description of the protocol was given. Initial questions and 
concerns were addressed and a copy of the TJU approved IRB stamped consent form was 
then forwarded to the potential subject.  A follow up email or phone call was initiated after a 
few days to schedule a laboratory visit. Potential subjects then received a lengthy and detailed 
explanation of the special procedures involved in the study.  They were given a tour of the 
laboratory, the area in which they were to be studied and shown the lights, needles, meters 
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and the like, before making a commitment to participate.  Subjects were informed that a 
camera would be present.  Every attempt was made to acquaint each prospective subject with 
all of the procedures involved in this study in order to minimize the possible effect of 
uncertainty about the experimental procedures on the results.  They were informed that they 
were free to discontinue participation in the experiment at any time, should they wish to do 
so.  Written informed consent was then obtained from subjects before the pre-study screening 
began. 
 
 
2.1.2 Screening process – acute study 
 
In order to be included in the protocol, volunteers underwent ophthalmological and 
psychological assessments, and a toxicological screen for drugs of abuse.  Evaluation of 
ophthalmologic condition included visual acuity test, measurement of intraocular pressure, 
slit lamp exam, external exam, fundus exam, and ophthalmological and self-reported medical 
history of the subject.  Color vision and color discrimination of all subjects was tested by the 
Ishihara and Farnsworth Munsell D-100 tests. Female subjects were interviewed with the 
study psychologist to screen for premenstrual dysphoric disorder before being admitted into 
the study. Subjects with no history of drug or alcohol dependency were instructed to avoid 
prescription or non-prescription drugs, over-the-counter drugs, recreational/street drugs, and 
other foreign substances before entering and during the running of the studies. The Jefferson 
Hospital Clinical Testing Service verified compliance with urine toxicology screens for 
common drugs of abuse. 
 
Sleep:wake cycle screening consisted of a minimum of ten days and a maximum of three 
weeks of self-reported sleep:wake times on paper sleep logs and calls into a voicemail box 
just before going to bed and just after waking. Subjects also wore an actigraph (BASIC 
Motionlogger, Ambulatory Monitoring, Inc., Ardsley, NY) to verify routine bedtime and 
wake time of eight hours allowed sleep time. The voice mailbox recorded the time and date 
of each call and these messages were compared to the subjects' sleep/wake logs and 
actigraphic data at least one day before they began any light exposure protocol.   
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2.1.3 Screening process – multiday studies 
 
In order to be included in the multiday protocols, volunteers underwent the same sleep:wake 
verification, ophthalmological, psychological, and toxicological screens for drugs of abuse 
described above as well as a full history and physical given by the study physician. 
Furthermore, subjects underwent toxicological screening of blood and urine for caffeine, 
pregnancy in females, basic metabolic panel, alcohol, thyroid function, and a complete blood 
count (CBC). Physical screening by the study physician included an eye exam, 
electrocardiogram (ECG), general health exam, and verification of lack of medications, as 
well as acute, chronic, or debilitating conditions.  Additional psychological screening was 
performed for the subjects in the multiday study consisting of the Minnesota Multiphasic 
Personality Inventory (MMPI) II, Beck’s Depression Inventory (BDI) II, and an interview 
with Brenda Byrne, Ph.D., the study clinical psychologist (Butcher et al., 1989; Beck et al., 
1996).  
 
 
2.1.4 Inclusion criteria – acute study 
 
Subjects must have passed a urine screen for common drugs of abuse and reported no history 
of drug or alcohol dependency. Subjects must have had a consistent and stable sleep:wake 
cycle verified by call-ins and actigraphy. Subjects must have had a sleeping pattern with 
routine bedtime starting at midnight or earlier, have had no plans to travel outside the time 
zone during the length of the active protocol, or engaged in evening or night-time shift work.  
This was initially discussed and emphasized during the phone screen.  Sleep-wake stability 
and timing of sleep were critical requirements in our recruitment since our melatonin 
suppression protocols are based on fixed clock times (section 5.3.3).   
 
Subjects’ age was limited to 18-30 years old to avoid a confound of reduced short wavelength 
transmission to the retina due to aging of the lens of the eye after age 30 years (Brainard et 
al., 1997). Normal color vision was a requirement. Ishihara and Farnsworth Munsell D-100 
tests were administered and scored to quantify subject's color discrimination or to discern if a 
color anomaly is present.  Female subjects were interviewed with the study psychologist and 
had to show no evidence of premenstrual dysphoric disorder. If a female subject was using 
birth control medication, she must have been using it consistently for at least three months 
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prior to the beginning of the study and continued use during the study. Evaluation of 
ophthalmologic condition included passing a visual acuity test, normal intraocular pressure, 
normal slit lamp exam, normal external exam, normal fundus exam, and reviewing 
ophthalmological and medical histories of volunteer and volunteer’s family.    
 
 
2.1.5 Inclusion criteria – multiday studies 
 
Inclusion criteria for the multiday studies included all of the criteria from the acute studies 
described above (section 2.1.4).  Furthermore, subjects had to have no caffeine or alcohol in 
their blood and urine, no pregnancy hormones detected in females, basic metabolic panel 
results were to be at normal levels, thyroid function results to be normal, and CBC results to 
be in normal ranges. Normality was established on the basis of clinical history, ECG, clinical 
biochemical screening tests of blood and urine, eye and physical examination. Physical 
screenings by the study physician were normal, general health exam results were normal, 
medications, as well as acute, chronic, or debilitating conditions were absent.  Psychological 
screening scores from the MMPI and the BDI were within normal ranges (Butcher et al., 
1989; Beck et al., 1996), and the subject passed an interview with the study psychologist.  
 
 
2.1.6 Exclusion criteria – acute study 
 
If there was a lack of sleep:wake stability on visual inspection of the actigraphy data or if 
there was more than one significant deviation from standard bed times, the subject was 
excluded from starting the protocol at that time.  If the subject’s routine bedtime shifted 
significantly past midnight, or they made plans to travel beyond three time zones during the 
length of the active protocol, or they began evening or night-time shift work the subject was 
excluded from starting the protocol at that time. Any positive results of the urine toxicology 
screen for drugs of abuse resulted in the subject being excluded from the study. If the subject 
reported a history of abusing alcohol or drugs they were also excluded from the study. 
 
Normal color vision was a requirement. If Ishihara and Farnsworth Munsell D-100 tests 
discerned that a color anomaly was present, the subject was excluded.  Female subjects who 
showed evidence of premenstrual dysphoric disorder were excluded. If a female subject was 
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using birth control medication for less than three months prior to the beginning of the study 
or discontinued use during the study, she was excluded.  If the ophthalmologic evaluation 
included failures of a visual acuity test, abnormal intraocular pressure, abnormal slit lamp 
exam, abnormal external exam, abnormal fundus exam, or an abnormal ophthalmological and 
medical history of the volunteer or volunteer’s family, the subject was excluded. 
 
 
2.1.7 Exclusion criteria – multi day studies 
 
Exclusion criteria for the multiday studies were inclusive of all of the criteria from the acute 
studies described above (section 2.1.6) with additional exclusions listed below.  Furthermore, 
any subject with symptoms of acute or active illness upon entering the protocol was excluded 
from study.  Individuals who were unaware of specific psychiatric diagnoses but who had a 
history of having been treated with antidepressant, neuroleptic medications or major 
tranquilizers were excluded from studies.  Given the wide range of illnesses that are 
encountered in medical practice, it would not have been possible to provide a comprehensive 
list of each and every disease that could have served as grounds for exclusion for the subject. 
The following was a list, however, of current illnesses that would have certainly been 
grounds for exclusion: 
 
• Prescription medications: At the discretion of the study physician; 
• Sleep disorders: narcolepsy, sleep apnea, periodic limb movement, nocturnal 
paroxysmal dystonia, REM-sleep behavior disorder and nocturnal eneuresis; 
• Diseases of the cardiovascular system: hypertension, heart failure, cardiomyopathy, 
ischemic heart disease, valvular heart disease, history of heart transplantation, cardiac tumors 
and pericardial disease; 
• Disorders of the respiratory system: asthma, cystic fibroses, chronic bronchitis, 
emphysema and airway obstruction, interstitial lung diseases, pulmonary hypertension, lung 
neoplasm; 
• Disorders of the kidney and urinary tract: acute or chronic renal failure, history of 
renal transplantation, tubulointerstitial diseases of the kidney, urinary tract obstruction, and 
tumors of the urinary tract; 
• Infectious diseases: infective endocarditis, HIV infection, sexually transmitted 
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diseases, osteomyelitis, brucellosis, tuberculosis, leptospirosis, Lyme disease, mononucleosis, 
parasitic infections; 
• Disorders of the gastrointestinal system: esophagitis, peptic ulcer and gastritis, 
disorders of absorption, inflammatory bowel disease, diseases of the small and large intestine, 
acute appendicitis, hepatitis, liver cirrhosis, history of liver transplantation, diseases of the 
gallbladder and bile ducts, and pancreatic disease; 
• Disorders of the immune system, connective tissue and joints: AIDS, systemic lupus 
erythematosus, rheumatoid arthritis, scleroderma, ankylosing spondylitis, vasculitis and 
sarcoidosis, fibromyalgia; 
• Disorders of the hematopoietic system: anemia, leukemia, myeloproliferative 
diseases, and history of bone marrow transplantation; 
• Neoplastic diseases: lymphoma, carcinoma, melanoma, or any other neoplastic 
diseases; 
• Endocrine and metabolic diseases: thyroid disease, Addison's Disease, Cushing's 
Syndrome, aldosteronism, hypoaldosteronism, pheochromocytoma, diabetes, disorders of 
sexual differentiation, disorders of neuroendocrine regulation, diseases of the anterior 
pituitary and hypothalamus, hemochromatosis porphyria, Wilson's Disease, glycogen storage 
diseases, diseases of the parathyroid gland, metabolic bone disease, disorders of phosphorus 
or magnesium metabolism and Paget's Disease; 
• Neurologic disorders: epilepsy and disorders of consciousness, dementia, amnesic 
disorders, demyelinating diseases, Parkinson's Disease, muscular dystrophy, myasthenia 
gravis, periodic paralysis, dermatomyositis, polymyositis, infections of the nervous system, 
stroke, history of transient ischemic attacks, hydrocephalus, tumors of the pituitary gland, 
pinealoma, intervertebral disc disease, ataxia, Gilles de la Tourette Syndrome, Huntington's 
Disease, tardive dyskinesia, history of recurrent migraine or cluster headaches, and 
neuromuscular disease. 
• Mental health:  Each subject completed a MMPI II, Symptom Checklist-90, BDI and 
State Anxiety Scale (Butcher et al., 1989; Beck et al., 1996) and received a comprehensive 
psychological examination by the study psychologist. Individuals with evidence of 
psychopathology on the standardized questionnaires or in a structured clinical interview were 
excluded from study. 
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2.2 Radiometry and photometry 
  
The spectral power distribution measurements were taken using a Model FSHH 325-1075P 
FieldSpec handheld spectroradiometer (Analytical Spectral Devices, Inc., Boulder, CO). 
Irradiance measures were taken using an IL-1400BL radiometer/photometer (International 
Light Technologies, Inc., Peabody, MA).  This irradiance meter has a silicon diode detector 
head (Model #SEL033) wide angle input optic (W#6874) and a filter (F#14299) to provide a 
flat response and was annually given a full scanned calibration between 250 and 1100 nm.  
The meter was received in tolerance (standard readings within 5% of previous year) when 
calibrated during the course of running this protocol.  All calibrations were traceable to the 
U.S. National Institute of Standards and Technology.   
 
Illuminance measures were taken using an IL-1400BL radiometer/photometer (International 
Light Technologies, Inc.).  This meter has a silicon diode detector head (Model #SEL033) 
with a wide angle input optic (W#11437) and a filter (Y#27475) to provide a photopic 
illuminance response and was annually given a full scanned calibration between 400 and 700 
nm.  This meter was also received in tolerance when calibrated during the course of running 
this protocol.  All calibrations were traceable to the U.S. National Institute of Standards and 
Technology.    
 
 
2.3 Blood samples 
 
In multiday studies, blood samples (2-3 ml) were collected every 20-60 minutes through an 
indwelling intravenous catheter located in a forearm vein into 3 ml polystyrene tubes which 
contained K2 ethylenediaminetetraacetic acid (EDTA) (BD Diagnostics, Franklin Lakes, NJ).  
In the acute study, blood samples (10-12 ml) were collected before and after the 90 minute 
light exposure via antecubital venipuncture into 7 ml glass tubes which contained K2 EDTA 
(BD Diagnostics, Franklin Lakes, NJ).  Plasma was separated by refrigerated centrifugation 
(2,000 RPM for 15 minutes), aliquoted into polypropylene cryogenic vials (Thermo Fisher 
Scientific, Rochester, NY) and stored at -20˚ C until assay. Plasma samples were shipped 
overnight on dry ice to the laboratories running the radioimmunoassays.  
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2.4 Saliva samples 
 
In multiday studies, saliva samples (1-2 ml) were collected at the same time as the blood 
draws to serve as backup for the measurement of plasma melatonin should indwelling 
intravenous lines fail to flow.  The saliva samples were collected with the Salivette sampling 
device (Sarstedt, Inc., Hayward, CA) which consisted of a small cotton swab and two plastic 
tubes.  Any drinks or food with the exception of water were removed from the subject for 30 
minutes prior to sampling. The swab was left in the mouth for 2-5 minutes while the subjects 
gently chewed on it to stimulate saliva flow.  After collection the Salivette was centrifuged at 
3000 RPMs for 2 minutes to yield clear and watery samples.  Aliquots of at least 1.2 ml were 
placed into cryogenic vials described above and stored at -20˚ C. 
 
 
2.5 Urine samples 
 
Urine was collected during each void for the entire duration of the multiday studies subject 
for possible later analysis of the major metabolite of melatonin, 6-sulphatoxymelatonin. Total 
urine volume was recorded for each sample and a 10 ml aliquot stored at -20˚ C in sterile 
polypropylene tubes (Thermo Fisher Scientific, Rochester, NY). 
 
 
2.6 Melatonin radioimmunoassays 
 
Melatonin concentrations were assayed in one of the multiday studies (section 3.2.6) and the 
acute study (section 5.3.4) by radioimmunoassay using antiserum described by Rollag and 
Niswender (1976). I was trained in this assay system by Dr. Rollag but did not run the assays 
for this thesis.  
 
Melatonin concentrations were assayed in other multiday study (section 4.3.6) by 
radioimmunoassay using the Kennaway G280 antimelatonin antibody in an assay system 
modified by Vaughan (1993). I was never trained in this assay system and did not run the 
assays for this thesis.  
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2.6.1 Rollag radioimmunoassay 
 
The Rollag radioimmunoassay was performed in the Departement of Anatomy at the 
Uniformed Services University of Health Sciences located in Bethesda, Maryland. 
Radiolabled ligand was prepared by adding 100 µl of pyridine containing 60 nmole 5-
methoxytryptamine to 250 µCi (0.1 nmole) Bolton-Hunter Reagent (New England Nuclear 
Corp., Boston, MA) in approximately 100 µl benzene.  The reaction was allowed to proceed 
for 20 minutes before adding 500 µl of water. After waiting five minutes to ensure that the 
unreacted Bolton Hunter reagent was destroyed, the radioactivity was diluted to 
approximately 200 cpm/µl with assay buffer (Rollag and Niswender, 1976).  Duplicate 
aliquots of 200 µl of each unknown plasma sample and quality control sample were extracted 
into 2 ml of chloroform.  The chloroform was removed in a centrifuge (SpeedVac, Savant 
Instruments, Holbrook, NY) and the residue resuspended in 200 µl of assay buffer (phosphate 
buffered saline, pH 7.4, containing 0.1% gelatin with 100 mg thimerosal/liter as a 
preservative).  The extracts were washed twice with 3 ml of petroleum ether, and then 
evaporated to dryness in a centrifuge before being resuspended in 100 µl of deionized water.  
Approximately 10,000 cpm of radiolabled ligand in 50 µl Phosphate Buffered Saline-Gel and 
50 µl of a 1:64,000 dilution of antiserum (R1055, 9/16/74; 1:300,000 final dilution) was 
added to each unknown and a triplicate 2-fold geometric series of standards ranging in 
concentration from 250 to 0.5 pg melatonin per 100 µl assay buffer.  The final assay volume 
of buffer in each tube was 200 µl.  At the end of the 48 hour incubation period, three ml of 
95% ethanol (4˚ C) was added to each assay tube and the bound radioactivity precipitated by 
centrifugation at 2000 x g for 30 minutes.  The supernatant was decanted and radioactivity in 
the precipitate was quantified.  The quantity of melatonin immunoreactivity in the samples 
was calculated with the use of a computer program to give a four parameter logistical fit of 
the data (M.L. Jaffe and Associates, Silver Spring, MD; see Davis et al., 1980).  All solutions 
were maintained at 4˚C throughout the radioimmunoassay procedure.  Assay results were not 
corrected for recovery (which has proven to be >95% in independent trials).  The minimum 
detection limit of the assay is 0.5-2.0 pg/ml melatonin. 
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2.6.2 Modified Kennaway radioimmunoassay 
 
The modified Kennaway radioimmunoassay was performed in the Division of 
Endocrinology, Diabetes and Hypertension at the Brigham and Women’s Hospital in Boston, 
Massachusetts. The melatonin radioimmunoassay kit made by American Laboratory Products 
Company (Windham, NH) measures melatonin by a double-antibody radioimmunoassay 
based on the Kennaway G280 antimelatonin antibody.  Reversed-phase column extracted 
samples and controls and reconstituted calibrated dilutions are incubated with the anti-
melatonin antibody and 125I-melatonin. 125I-melatonin competes with melatonin present in 
samples, calibrators and controls.  After 20 hours of incubation, solid-phase second antibody 
is added to the mixture in order to precipitate the antibody-bound fraction. After aspiration of 
the unbound fraction, the antibody bound fraction of 125-I-melatonin is counted.  Assay 
results were not corrected for recovery (which has proven to be >95% in independent trials).  
The minimum detection limit of the assay is < 0.2 pg/ml melatonin. 
 
 
2.7 Behavioral measures 
 
The behavioral measures included in the multiday studies (sections 3.2.7 and 4.3.7)  included 
KSS (Akerstedt & Gillberg, 1990), 5 and 10 minute Psychomotor Vigilance Tasks (PVT) 
(Dinges and Kribbs, 1991; Dinges and Powell, 1985), Neurobehavioral Test Batteries (Profile 
of Mood States, DSST, DS Forward entry tasks, DS Reverse entry tasks) (Kane and Reeves, 
1997; McNair et al., 1992), and a side effects form (Terman and Terman, 1999; Goel and 
Etwaroo, 2006). No behavioral measures were used during the acute study.  
 
During the week prior to admission, subjects came into the laboratory and completed each of 
the individual tests at least four times to ensure familiarity prior to the start of the study. 
Additional tests occurred on baseline days in each of the multiday studies to give subjects 
additional practice. Neurobehavioral testing was done on a laptop using software from Pulsar 
Informatics, Inc. of Philadelphia, Pennsylvania. Files were uploaded to Pulsar after each 
study run, and the extracted data was then emailed to our laboratory from Pulsar. The tests in 
this battery were the DSST, DS Forward task, DS Reverse task, and Profile of Mood States 
(POMS). 
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2.7.1 Karolinska sleepiness scale 
 
The KSS is a subjective measure of a person’s perceived sleepiness based on a 9-number 
scale where 1 = very alert, 3 = alert, 5 = neither alert nor sleepy, 7 = sleepy (but not fighting 
sleep), and 9 = very sleepy (fighting sleep) ((Akerstedt & Gillberg, 1990). Subjects 
completed the KSS by pressing the appropriate number on a computer keyboard during the 
beginning of all testing batteries throughout the multiday studies.  
 
 
2.7.2 Psychomotor vigilance tasks 
 
The 5- and 10- minute PVTs are sustained-attention reaction time tasks that were developed 
by Dr. Dave Dinges (Dinges and Kribbs, 1991; Dinges and Powell, 1985). Subjects were 
given these tests visually or by audio throughout the multiday studies and were instructed to 
monitor a red rectangular box on a computer screen or listen for a beep and press a response 
button as soon as a yellow stimulus counter appears inside the box or a beep is sounded. The 
button stops the counter, which is displayed in milliseconds for a 1 second period. Subjects 
were instructed to press the button as soon as each stimulus occurs, but not to press the button 
too soon, which will register as a false start. The stimuli were presented at random intervals 
shorter in the 5-minute PVT and at much longer intervals during the 10-minute PVT. Mean 
reaction times and lapses (reaction times greater than 500 ms) were counted per testing 
session as a measure of performance impairment indicative of reduced behavioral alertness.  
 
 
2.7.3 Digit symbol substitution task 
 
The primary test of working memory was the DSST (Kane and Reeves, 1997). The DSST is a 
subject-paced task that involves the matching of digits (0–9) to symbols. The number of 
correct responses in 1.5 min was counted as a measure working memory performance. 
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2.7.4 Digit span forward and digit span reverse 
 
Secondary measures of working memory included the DS Forward and Reverse tasks (Kane 
and Reeves, 1997). In the DS test, subjects were presented with a series of digits and must 
immediately type them back in forward or reverse order. If they do this successfully, they are 
given a longer list (e.g., '9, 2, 4, 0'). The length of the longest list a person can remember is 
that person's digit span. 
 
 
2.7.5 Profile of moods states 
 
The POMS is a psychological rating scale that surveys transient mood states of subjects. Its 
six-factor scales of mood assessment can be used to track changes in mood states within a 
given subject over time, offering objective intra-subject measure of mental state tolerance and 
response to experimental exposures (McNair et al., 1992).  Each item inventory in the POMS 
is scored with a maximum of 4 points from 0-4. The 6-subscale factor analysis includes 9 
such tension-anxiety items (scored 0-36), 15 depression-dejection items (scored 0-60), 12 
anger-hostility items (scored 0-48), 8 vigor-activity items (scored 0-32), 7 fatigue-inertia 
items (scored 0-28), and 7 confusion-bewilderment items (scored 0-28). Each administration 
of the scale can be scored to reflect a subject’s “total mood disturbance” at a given point in 
time by adding the 5 subscale scores other than vigor-activity and subtracting the subscale 
score for vigor-activity from the other 5 totaled.  
 
 
2.7.6 Side effects 
 
All subjects were given, before and after all light exposures, a Systematic Assessment for 
Treatment Emergent Effects (SAFTEE) questionnaire. This questionnaire was designed to be 
used to assess effects of light in patients diagnosed with Seasonal Affective Depression 
(SAD) (Terman and Terman, 1999) and has been used in successfully in non-depressed 
subjects exposed to light (Goel and Etwaroo, 2006). A computerized version was installed on 
the subject testing laptops and  52 questions were asked, organized by organ system and body 
areas. Subjects were asked to evaluate how they felt according to the following scale: 1) - not 
at all; 2) - a little bit; 3) – moderate; 4) - quite a bit; and 5) – extreme.  
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CHAPTER 3 POLYCHROMATIC BLUE-ENRICHED 
FLUORESCENT LIGHT FOR MELATONIN SUPPRESSION, 
ALERTNESS, AND CIRCADIAN PHASE RESETTING 
 
3.1 Introduction 
 
The human circadian pacemaker is exquisitely responsive to ocular light exposure (Czeisler 
et al., 1999; Zeitzer et al., 2000) (section 1.1).  Photic information about light is carried along 
a well studied neural pathway that extends from the SCN to the pineal gland via a 
multisynaptic pathway with connections being made sequentially in the paraventricular 
hypothalamus, the upper thoracic intermediolateral cell column, and the superior cervical 
ganglion (Moore, 1983).  By way of this neuroanatomy, cycles of light and dark which are 
perceived through the eyes entrain SCN neural activity which, in turn, entrains the rhythmic 
synthesis and secretion of melatonin from the pineal gland.  In virtually all species including 
humans, high levels of melatonin are synthesized during the night with low to undetectable 
amounts produced during the day (Arendt, 1995). 
 
The elucidation of light-induced melatonin suppression in humans led to the demonstration 
that bright white light could be used to phase-shift human circadian rhythms (Czeisler et al., 
1986; Lewy et al., 1987).  Measurement of melatonin responses to light has been used 
extensively as a tool to examine the ocular, neural, and biochemical physiology of melatonin 
regulation and circadian rhythms (Klein et al., 1991; Brainard et al., 1997). Similarly, studies 
of the melatonin responses to light have been used to develop light as a treatment for 
circadian disruption, jet lag, shiftwork, sleep disturbances, and mood disorders (Lam, 1998; 
CIE, 2006; IESNA, 2008).  
 
Before 1990, most investigators thought that the photoreceptors for vision were responsible 
for circadian regulation and melatonin control. Strong evidence from animal and human 
studies, however, indicated that a novel photoreceptor is primarily responsible for 
transduction of photic stimuli in circadian regulation (Foster et al., 1991; Czeisler et al., 1995; 
Ruberg et al., 1996; Freedman et al., 1999; Lucas et al., 1999; Brainard et al., 2001a; 
Klerman et al., 2002) (section 1.2.3).  The action spectrum for melatonin suppression in 
normally sighted humans appears to be independent of each of the individual visual 
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photoreceptors (rods and cones) that support day and night vision (Brainard et al., 2001b; 
2008b; Thapan et al., 2001). Other action spectra developed in rat, mice, monkey, and human 
found a common 446-484 nm region of peak sensitivity for circadian, neuroendocrine, and 
neurobehavioral responses (Brainard and Hanifin 2005, for review; Gamlin et al., 2007, Zaidi 
et al., 2007) (section 1.6.2). Each of these action spectra suggested that a novel photopigment 
mediates circadian phototransduction.  
 
Working from the spectral sensitivity of melanopsin containing ipRGCs, multiple 
laboratories have performed wavelength comparison studies on melatonin suppression, 
circadian phase change and acute alertness using monochromatic (less than 15 nm halfpeak 
bandwidth) or narrowband (15 nm or greater halfpeak bandwidth) light sources (review, 
Brainard and Hanifin, 2005). Monochromatic blue light has been shown to cause greater 
phase delay over monochromatic green light (Lockley et al., 2003). The phase delay shift of 
the 460 nm monochromatic light presented in this study was similar to what was observed in 
a study using much more in intense (approximately 10,000 lux) polychromatic white light 
(Khalsa et al., 2003). Another study showed that very low levels of short-wavelength light 
(combined 436 nm and 456 nm) presented immediately after habitual wake time produced a 
phase-advance similar in size to very bright polychromatic light despite the large (185-fold) 
difference in light photons (Warman et al., 2003). A comparison of 440, 470 and 600 nm 
monochromatic light presented with intermittent exposure revealed that the 470 nm light was 
more effective in phase advancing than 600 nm and 440 nm light although the phase shifts 
were not conclusive (Revell et al., 2005).  
 
Studies carried out at the same time in Japan, manipulating numerous parameters, have 
documented neuroendocrine and neurobehavioral effects using different color temperature 
lamps (Jablonski et al., 2008 for review).  Specifically, higher correlated color temperature 
(CCT) (richer in blue wavelengths) lamps evoked stronger melatonin suppression than lower 
CCT bulbs (Morita and Tokura, 1998; Sato et al., 2005).  Generally, these results are 
complementary to our understanding of the analytic action spectra in that higher color 
temperature fluorescent bulbs induce stronger neurobehavioral and neuroendocrine effects 
than lower color temperature lamps. 
 
More recent studies comparing polychromatic fluorescent light with more short-wavelength 
energy (8,000 K CCT) to typical fluorescent lighting (4,100 K CCT) for melatonin 
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suppression revealed differences but only at one of several low light levels that were studied 
(Figuero et al., 2006).  Smith and Eastman (2009) compared 4,100 K and 17,000 K CCT 
lamps at equal photon densities for circadian phase-delay with no greater phase-delays seen 
in the 17,000 K CCT condition.  Smith and colleagues (2009) compared 4,100 K and 17,000 
K CCT lamps at relatively equal irradiances (commonly used light therapeutic lux levels) for 
phase-advancing potential with no greater phase-advances observed in the 17,000 K CCT 
condition (Smith et al., 2009).   These studies used very high, potentially saturating, levels of 
light to mimic a real world therapeutic light situation.   
 
 
3.2 Aims and Hypothesis 
 
In the following study, we tested the hypothesis that blue-enriched polychromatic fluorescent 
light at lowered light levels (e.g. room light levels) is more effective than standard white 
polychromatic fluorescent light (4,000 K) light for eliciting a circadian phase-delay, acutely 
suppressing melatonin, and acutely reducing sleepiness and increasing alertness. 
 
 
3.3 Methods 
 
3.3.1 Test facility 
 
The study was conducted at TJU in a facility built specifically for inpatient studies with 
experimental light exposures. As illustrated in Figure 6, this facility has two identical interior 
rooms, with a hallway connecting them with a shared bathroom, an experimental control 
room, and a kitchen for preparing subject meals. A white noise machine (Cambridge Sound 
Management, Cambridge, MA) has been placed in the drop ceilings of the subject rooms and 
runs constantly. Heating, ventilating and air conditioning systems located above each of the 
doors to the subject rooms were set to 75º F (24º C) at all times. The subjects did not have 
access to the kitchen nor the control room, where there is a wet laboratory bench for 
processing samples and the lighting controls.   
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Each subject room contained a bed which can be raised to a 45˚ angle, a dresser, and a desk 
with an ophthalmological head holder 11.8’’ in front of a 4’ x 4’ lighting panel. A television 
and DVD player were also included in each subject room and allowed to be used during the 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Floor plan of the laboratory study facility. Subject areas were equipped with a 
remotely controlled zone lighting system, audio/video monitors and a dedicated heating, 
ventilating and air conditioning system. 
 
periods of normal room lighting. Each room also had a video camera connected to a monitor 
in the control room, as well as several intercom buttons to signal the staff in the control room 
when the subject needed something or had completed testing. 
 
Subjects were not permitted to know the date nor time throughout the study. The subject 
rooms have neither windows nor clocks, and subjects were forbidden to have time pieces, cell 
phones, or any other electronics displaying date and/or time. Portable music players were 
permitted, but any clock functions were disabled by laboratory staff upon admission. 
Laboratory staff members were instructed not to use any day, time, or time of day specific 
language when interacting with subjects. The windows in the bathroom that the subjects were 
allowed to use at specific points in the study as well the windows in the hallway were 
covered in blackout shades. The staff members were also not permitted to wear watches or 
carry cell phones into subject rooms. Scrubs and laboratory coats were provided for the staff 
to wear to further eliminate weather or other cues from the outside world. 
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3.3.2 Ambient light stimuli and measurement 
 
Ambient light in the facility was produced by ceiling-mounted standard cool-white (4,100 K 
CCT) 40 watt fluorescent lamps (F40T12/841ALTO, Philips Lighting, B.V., Eindhoven, 
Netherlands) placed above matte white acrylic 0.080 inch diffuser panels and controlled by a 
full range dimming system (Model #HLT-2000/3 Dimmer Module with HILUME Electronic 
dimming ballast OPSCU Series, DP-1 dimmer panel, VA-3-4A Control Panel, Lutron Corp., 
Coopersburg, PA). 
 
The light intensities in the study rooms were < 80 lux in any direction of gaze on study day 1 
as well as during the first eight hours of study day 2.  For the rest of the waking hours of the 
study until the day of release, subjects were kept in constant dim light with illuminances < 5 
lux in any direction of gaze.  Sleep opportunities totaling 8 h were in complete darkness in 
the study rooms.  Daily illuminance/irradiance measures were taken using meters described 
earlier in section 2.2 that were centered in the room pointed in the horizontal direction of 
gaze at approximately 4’ from the floor.  Four readings were taken facing each of the four 
walls in the room and averaged. 
 
 
3.3.3 Experimental light stimuli and measurement 
 
Polychromatic light exposures occurred on the night of study day 4 and subjects underwent a 
6.5 hour light exposure that began 9.25 h before their habitual wake time. Light exposure was 
timed to start 9.25 h before habitual waketime which was assumed to correspond to 
approximately 6.75 h before core body temperature minimum, a phase where previous studies 
of polychromatic white light produced phase delays (Zeitzer et al., 2000; Lockley et al., 
2003).  Two 4’ x 4’ light exposure systems pictured in Figure 8 held both sets of 54 W 
fluorescent lamps in each. A diffuser cover on the front of the panel allowed for a uniform 
light exposure for the subject. The panel was attached to an analog dimmer switch to adjust 
intensity. The lamps, as well as the lighting panel unit, diffuser cover, and dimmers were 
constructed and donated by Philips Lighting, B.V. (Eindhoven, Netherlands). An additional 
neutral density filter panel (0.3 ND 50% transmission) that covered the entire light panel 
surface was used to further adjust the intensity of the 17,000 K light source (Rosco 
Laboratories, Stamford, CT).  Experimental illuminance/irradiance measures were taken 
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using an IL-1400BL radiometer/photometer (International Light Technologies, Inc., Peabody, 
MA) previously described which was held in place by a clear, plastic holder attached in an 
ophthalmologic head holder 11.8 inches from the panel at approximate eye level. The spectral 
power distribution measurements determinations shown in Figure 7 were taken using a Model 
FSHH 325-1075P FieldSpec handheld spectroradiometer (Analytical Spectral Devices, Inc., 
Boulder, CO). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Spectral power distribution for 17,000 K (upper panel) and 4,000 K (lower panel) 
light sources. Profiles are relatively similar, with the primary difference between 400 and 500 
nm. Compared to the 4,000 K light source, the 17,000 K light source emitted substantially 
more power in the short wavelength part of the spectrum. 
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The target intensity of the 17,000 K lamp was chosen from previous melatonin suppression 
testing, which resulted in a fluence-response curve (Brainard et al., 2007). The ED90, or 90% 
of the saturating dose of light for melatonin suppression for the 17,000 K lamp, was chosen 
for this study.  It was assumed based on laboratory pilot data that this would give a partial 
(approximately 50%) suppression of melatonin for the 4,000 K exposure condition yielding a 
clear difference in melatonin suppression between the two light conditions. This resulted in 
an equal photon density of 1 x 1014 photons/cm2/s for both exposure conditions. The 
equivalent irradiance/illuminance of light for the 4,000 K and 17,000 K lamps were 40.7 
μW/cm2 (134.3 lux) and 50.0 μW/cm2 (128.9 lux), respectively.   
 
 
3.3.4 Subject screening 
 
Over 400 subjects contacted the study recruiter in response to local newspaper or internet 
advertisements via phone (63%) or e-mail (37%).  Approximately 50% of the respondents 
who were given additional study requirements and details over e-mail or  phone either 
declined to proceed further or never contacted the laboratory again.  Initial general 
questioning on age, health, work schedule and medications eliminated approximately 30% of 
the contacts.  Of the 123 individuals who participated in a full phone screen, 87 were found to 
have exclusion criteria or declined to further participate in the screening process.  Thirty-five 
individuals met with the study recruiter to tour the laboratory facility.  At this point, 33 
subjects were instructed to schedule appointments with the study physician and study 
psychologist, have a urine drug screen for drugs of abuse performed, have a blood drawn for 
a basic metabolism panel and keep a strict sleep/wake cycle with daily phone calls to the 
laboratory voicemail upon sleeping and waking.  For at least 10 days prior to entry into the 
seven day protocol subjects maintained a self-selected 8-hour sleep/wake schedule with calls 
to a time- and date-stamped voicemail at bedtime and wake.   Subjects also wore an actigraph 
(BASIC Motionlogger, Ambulatory Monitoring, Inc., Ardsley, NY) to verify bed and wake 
times during this time period.  The inclusion criteria for medication were no recreational, 
over-the-counter, or prescription medications inclusive of caffeine and alcohol.  
Toxicological screening of blood and urine for caffeine, pregnancy in females, basic 
metabolic panel, alcohol, drugs of abuse, thyroid function, and a CBC was conducted during 
screening and on the day of entry in the facility. 
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Figure 8. The two 4’ x 4’ light exposure systems used are shown above (17,000 K top; 4,000 
K bottom). Please note that during actual light exposure the subjects head would be in an 
ophthalmologic head holder 11.8’’ from the panel.   
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 Three subjects were eliminated due to physical or psychological exclusion criteria.  Nine 
subjects failed to keep regular sleep/wake times, tested positive for drugs of abuse, or 
declined to participate further.  After undergoing psychological, toxicological, physical, 
ophthalmological examinations including color vision testing, and sleep/wake cycle 
screenings the remaining 21 subjects met study requirements and chose to be entered into the 
seven day inpatient study protocol. On the day of the study, I reviewed in great detail all that 
was expected of the research subject and consented the subject. As proposed, 20 healthy men 
and women completed the full study. One subject asked to be released from the protocol on 
the 5th day of the study.  A total of 11 males and 9 females ranging in age from 19 to 26 years 
old, with a mean age (± SEM) of 22.1 ± 1.8 years were studied in the Light Research 
Laboratory of TJU.   
 
 
3.3.5 Study protocol 
 
This study was approved by the IRB of TJU and all subjects gave written informed consent 
prior to entering the protocol.  Figure 9 provides a diagrammatic representation of the 7-day 
study protocol.  The phase shifting protocol used in this study was adapted from the 9-day 
protocol used at the Brigham and Women’s Hospital (BWH) (Zeitzer et al., 2000). Subjects 
were kept in a time-free environment (no windows, timepieces, TV, or internet access with 
continual supervision by trained staff) and remained in their assigned room for the duration of 
the study, except for scheduled showers or when they were allowed bathroom breaks in the 
suite bathroom.  If a second subject was in the facility, there was no interaction between the 
subjects at any point during the study.  The schedule consisted of a 2-day baseline (8-
hour:16-hour sleep-wake cycle based on each subject’s self-selected sleep-wake times), an 
initial 26 hour constant routine, a 16 hour light-exposure day, and a second 30 hour constant 
routine, each preceded and followed by an 8-hour sleep opportunity.  During the constant-
routine period, subjects remained awake in dim light in a semirecumbent position while under 
direct supervision with isocaloric meals (basal energy expenditure x 1.3) being served every 
two hours. Basal energy expenditure calculations were done by dieticians from the Nutrition 
and Dietetics department at TJU Hospital and were corrected for age and gender. 
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 Figure 9. Overview of 7-day phase-shifting protocol for a subject with a midnight to eight 
AM sleep:wake schedule. This protocol was adapted from the 9-day phase-shifting protocol 
frequently used by Brigham and Women’s Hospital (Zeitzer et al., 2000). 
 
Subjects were randomly assigned in groups of 4 throughout the length of the protocol to 
polychromatic light exposure from either the 4,000 K or the 17,000 K fluorescent lamps 
(N=10, 5 females, both conditions).  Subjects were seated for 140 minutes prior to, and for 
the full duration of the 6.5 h light exposure. Subjects wore blindfolds for approximately 30 
minutes prior to light exposure while the lights stabilized and intensities were verified.  
Subjects were seated 11.8 inches in front of the light panel with their chin placed in an 
ophthalmologic head holder and monitored continuously. Subjects were asked to maintain a 
fixed gaze toward the panel for 90 minutes before resting their head and neck out of the 
headholder for 10 minutes while remaining seated. This sequence was repeated throughout 
the entire 6.5 hour exposure. 
 
 
3.3.6 Measurement of melatonin 
 
Blood samples (3 ml) were collected through an indwelling intravenous catheter located in a 
forearm vein into 3 ml polystyrene tubes which contained 5.4 mg of K2 EDTA (BD 
Diagnostics, Franklin Lakes, NJ).  Plasma was separated by refrigerated centrifugation (2,000 
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RPM for 15 minutes), aliquoted into polypropylene cryogenic vials (Thermo Fisher 
Scientific, Rochester, NY) and stored at -20˚ C until assay (section 2.3). Plasma melatonin 
samples were collected every 60 minutes during the constant-routine periods on Days 3/5 and 
every 20 minutes during light exposure (Figure 9). Plasma melatonin concentrations were 
assayed by radioimmunoassay using antiserum described by Rollag and Niswender (1976).  
A full description of the method can be found in section 2.6.1. 
 
Salivary samples were collected as backup to the primary plasma measure and were used 
when there were problems with patency of the intravenous catheter. Salivary samples (1.2-2 
ml) were collected with the "Salivette" sampling device (Sarstedt, Inc., Hayward, CA). The 
specific protocol for this is described in section 2.4.  Salivary melatonin samples were 
collected every 60 minutes during the constant-routine periods on Days 3/5 as well as during 
light exposure.  Salivary melatonin concentrations were assayed by radioimmunoassay 
(Vaughan, 1993). A full description of the method can be found in section 2.6.2.   
 
 
3.3.7 Neurobehavioral testing 
 
Neurobehavioral testing was organized and initiated by collaborators at Brigham and 
Womens Hospital (BWH) in Boston. I was trained on this laboratory technique but did not do 
the preparation of the instruments for the protocol. 
 
 
3.3.7.1 Visual psychomotor vigilance task  
 
During every hour of wakefulness, subjects completed a 5-min visual psychomotor vigilance 
tasks (PVT) (Dinges and Powell, 1985; Dinges and Kribbs, 1991). The visual PVT was done 
on a personal digital assistant (PDA) (Tungsten E2, Palm, Inc, Sunnyvale, CA).  The screen 
showed successive black bull's eye targets on white backgrounds; the subject was asked to 
press the button at the bottom of the right hand side of the PDA as quickly as possible once 
the target appeared (section 2.7.2). The subject's reaction time in milliseconds appeared 
overlaid on the target briefly before the screen went blank white until the next target 
appeared.  This modified visual PVT lasted for five minutes, at the end of which the mean 
reaction time for that trial was displayed for the subject. The main measures for each trial for 
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each subject were mean reaction time in milliseconds and number of lapses greater than 500 
milliseconds (i.e. number of times the subject took 500 milliseconds or longer to react to the 
target appearing) (Dinges and Powell, 1985; Lim and Dinges, 2008; Lamond et al., 2008). 
 
 
3.3.7.2 Auditory psychomotor vigilance task  
 
During every hour of wakefulness, subjects completed a 10-min auditory psychomotor 
vigilance task (PVT) (Dinges and Powell, 1985; Dinges and Kribbs, 1991). The auditory PVT 
was completed on a PVT-192 by Ambulatory Monitoring, Inc. (Ardsley, NY). Subjects were 
instructed to complete the KSS on the PDA first, then the auditory PVT using the PVT-192, 
and finally the visual PVT on the PDA. Subjects completed the auditory PVT by wearing a 
set of headphones attached to the PVT-192 and pressing a button on the right side of the 
device as quickly as possible when a tone was heard (section 2.7.2). The auditory PVT trial 
was 10 minutes in length. The LED panel at the top of the device that can be used for a visual 
PVT was covered in several layers of tape so that any visual changes were not visible to the 
subject. The main measures for each trial for each subject were mean reaction time in 
milliseconds and number of lapses greater than 400 milliseconds (Dinges and Kribbs, 1991). 
 
 
3.3.7.3 Karolinska sleepiness scale 
 
The first screen on the PDA prior to the visual PVT asked the subject to rate their subjective 
sleepiness at that point using the KSS (Akerstedt and Gillberg, 1990). The KSS is a 
subjective measure of a person’s perceived sleepiness based on a 9-number scale where 1 = 
very alert, 3 = alert, 5 = neither alert nor sleepy, 7 = sleepy (but not fighting sleep), and 9 = 
very sleepy (fighting sleep).  
 
 
3.3.8 Data reduction and statistics 
 
Neurobehavioral testing results were analyzed by collaborators at BWH. I was trained on this 
laboratory technique but did not do analysis. 
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 3.3.8.1 Melatonin data reduction and statistics 
 
The plotting of the melatonin rhythm of each subject for CR1 and CR2 was determined 
through the use of a three-harmonic fit program created by collaborators at BWH.  Phase-
shift was determined from differences in clock time between 25% dim light onset of 
melatonin secretion during the first constant routine (CR1) as compared to the second 
constant routine (CR2) (Duffy et al., 1996). Unpaired, two tailed Student’s t-tests were used 
to compare differences in phase shifts as well as differences in variance by exposure to 
17,000 K lamps compared to 4,000 K lamps. 
 
Melatonin suppression (mean ± SD) was calculated from the difference in area under the 
curve (AUC) between melatonin profiles during light exposure and the corresponding clock 
times during the previous melatonin cycle on CR1 (Lockley et al., 2003). Unpaired, two 
tailed t-tests were used to compare differences in melatonin suppression by exposure to 
17,000 K lamps compared to 4,000 K lamps. 
 
 
3.3.8.2 PVT data reduction and statistics 
 
The data from the visual PVT and the auditory PVT-192 devices were extracted by our 
collaborators at BWH using the PVTCOMM for Windows Version 2.10.1.1 software from 
Ambulatory Monitoring, Inc (Ardsley, NY). The extracted data was then read using the 
REACT Version 1.105 software from Ambulatory Monitoring, Inc. The data for each trial 
were copied from REACT and transferred into an Excel spreadsheet for each subject.  Date 
and time stamps were converted to h since CR1 began, light exposure began, and CR2 began, 
respectively. Mixed analysis of variance (ANOVA) comparing light sources and time was 
completed using SAS 9.0 (SAS, Cary, NC). Graphs were made using SigmaPlot 10.0 (Systat, 
San Jose, CA) after binning the data by hour since the respective block of the study began 
and taking the average value of each measure per hour.  
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 3.3.8.3 KSS data reduction and statistics 
 
KSS data were also binned by the hour with Mixed ANOVA analysis comparing light 
sources and time completed using SAS 9.0 (SAS, Cary, NC). Graphs were made using 
SigmaPlot 10.0 (Systat, San Jose, CA) after taking the average value of each measure per 
hour.  
 
 
3.3.8.4 Sample size determination 
 
To determine sample size a priori, data from a previous study of the phase-shifting effects of 
460 nm and 555 nm monochromatic light on melatonin rhythms were used (Lockley et al., 
2003) to perform a power analysis. The power analysis was performed by our colleagues at 
BWH. Using these data, a 1 h phase shifting difference was assumed, with a standard 
deviation of 0.62 h, α value of 0.05, and β value of 0.9. With these assumptions, 10 subjects 
per group were calculated to be needed to detect the 1 h phase difference (Cohen, 1988). 
 
 
3.4 Results 
 
3.4.1 Ambient light stimuli measurement 
 
The measured illuminances (± SEM) for the baseline days were 52.7 ± 1.6 lux and for the CR 
conditions illuminances were 1.6 ± 0.1 lux. 
 
 
3.4.2 Experimental light stimuli measurement 
 
The measured irradiances (± SEM) over the 6.5 h exposure were 40.9 ± 0.1 μW/cm2 for the 
4,000 K exposure and 50.0 ± 0.1 μW/cm2 for the 17,000 K exposure. 
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 3.4.3 Measurement of melatonin 
 
Polychromatic fluorescent light exposure caused a phase-delay of the DLMO in all but of the 
one of the subjects.  Exposure to 6.5 hours of 17,000 K light caused a greater phase-delay 
shift (mean (±SD) 2.1 ± 0.6 h, n=10) than did exposure to 4,000 K light (mean (± SD) 1.7 ± 
1.3 h, n=10).  This phase-delay shift, however, was not statistically significant (p=0.22) 
(Figure 10).  Further comparison of the data revealed that 17,000 K light provided a more 
consistent phase-delay than 4,000 K light when comparing standard deviations (p<0.05). 
 
As shown in Figure 11, all subjects exposed to 17,000 K polychromatic fluorescent light at 1 
x 1014 photons/cm2/s had at least 29% suppression of the melatonin as calculated by AUC 
during the 6.5 h light exposure (range 29-91%) compared to the corresponding clock times 
during the previous melatonin cycle on CR1. Suppression was more variable among subjects 
exposed to the 4,000 K polychromatic fluorescent light at 1 x 1014 photons/cm2/s (range 0-
82%), including 2 individuals with 1% and 0% melatonin suppression.  On average, exposure 
to 6.5 hours of 17,000 K light caused a significantly greater suppression of melatonin (mean 
(±SD) 70.9 ± 19.6%; n=10) compared with 4,000 K light (mean (±SD) 42.8 ± 29.1%; n=10) 
(p<0.05). 
 
The inter-assay coefficient of variation from the 15 plasma assays run for this experiment 
using the assay from Rollag and Niswender (1976) was 15.9% for 50 pg/ml and 14.9% for 
125 pg/ml control samples (n=4 replicates). Coefficient of variation calculated from a control 
sample of 100 pg/ml assayed had 12.3% for intra-assay coefficient of variation (n=4 
replicates). The minimum detection limit of the assay is 0.5-2.0 pg/ml melatonin.  The inter-
assay coefficient of variation from the 7 salivary assays run for this experiment using the 
assay from Vaughan (1993) was 11.6% for 2.1 pg/ml and 8.4% for 18.5 pg/ml control 
samples (n=20 replicates). Coefficient of variation calculated from control samples of 1.83 
and 18.99 pg/ml assayed had 2.7% and 6.9% intra-assay coefficient of variation respectively 
(n=2 replicates). The minimum detection limit of the assay is 0.5-2.0 pg/ml melatonin. 
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Figure 10. Phase-delay shift (±SD) of the plasma (filled circles) or salivary (empty circles) 
melatonin rhythm as assessed by DLMO following exposure to 6.5 h of white 4,000 K 
fluorescent light and blue-enriched 17,000 K fluorescent light.  There was not a significant 
difference between DLMO’s (p=0.22). There was, however, a significantly more consistent 
delay in DLMO under the 17,000 K fluorescent light compared to 4,000 K fluorescent light. 
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 Figure 11. Melatonin suppression (±SD) as calculated by AUC with plasma (filled circles) or 
salivary (empty circles) levels following exposure to 6.5 h of white 4,000 K fluorescent light 
or blue-enriched 17,000 K fluorescent light compared to corresponding clock times during 
the previous melatonin cycle on CR1.  A significantly greater suppression of plasma 
melatonin occurred under 17,000 K fluorescent light compared to 4,000 K fluorescent light 
(p<0.05).   
 
 
3.4.4 Neurobehavioral testing 
 
3.4.4.1 Visual psychomotor vigilance task  
 
As shown in Table 6, the mean reaction time (RT) for the visual PVT for each hour since 
light exposure began were compared between the two light groups using ANOVA and were 
not significantly different. There was a significant difference over time for the light exposure 
period (p<0.02), but no interaction between light source and time. Figure 12 shows the mean 
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RT averaged per hour. Note that mean RT remained low before and throughout light 
exposure for both light groups.  There was no significant difference over time or between 
light sources for the 3 hours post light exposure as shown in Table 7.  
 
Table 6. Mixed repeated ANOVA on mean RT for visual PVT during light exposure. 
 
Effect Num DF Den DF F value Pr > F 
light source 1 16 1.36 0.260 
time 6 83 2.88 0.014 
light source*time 6 83 0.75 0.612 
 
 
Table 7. Mixed repeated ANOVA on mean RT for visual PVT 3 hours post light exposure. 
 
Effect Num DF Den DF F value Pr > F 
light source 1 16 2.64 0.124 
time 2 30 1.88 0.169 
light source*time 2 30 0.90 0.418 
 
 
80 
 
 Figure 12. Average mean RT (±SE) of the 17,000 K fluorescent light group (empty circles) or 
the 4,000 K fluorescent light group (filled circles) per hour for visual PVT before, during, and 
after light exposure. The period of light exposure is indicated by the box.  
 
As shown in Tables 8 and 9, the lapses greater than 500 milliseconds for the visual PVT for 
each hour since light exposure began were compared between the two light groups using 
ANOVA and were not significantly different for the light exposure period (p=0.70) or for 3 
hours post light exposure (p=0.35). There was a significant difference over time for the light 
exposure period (p<0.02) and for 3 hours post light exposure (p<0.03), but no interaction 
between light sources and time. As seen in Figure 13, the number of lapses for both groups 
increase linearly before, during, and for 3 hours post light exposure. 
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Table 8. Mixed repeated ANOVA of lapses for visual PVT during light exposure. 
 
Effect Num DF Den DF F value  Pr > F 
light source 1 16 0.15 0.704 
time 6 83 2.90 0.013 
light source*time 6 83 0.55 0.767 
 
 
Table 9. Mixed repeated ANOVA of lapses for visual PVT for 3 hours post light exposure. 
 
Effect Num DF Den DF F value  Pr > F 
light source 1 16 0.90 0.356 
time 2 30 4.43 0.021 
light source*time 2 30 1.29 0.290 
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Figure 13. Average visual PVT lapses (±SE)  of the 17,000 K fluorescent light group (empty 
circles) or the 4,000 K fluorescent light group (filled circles) per hour during the exposure 
day. The period of light exposure is indicated by the box. 
 
3.4.4.2 Auditory psychomotor vigilance task  
 
Three subjects were eliminated from the auditory PVT analysis for the 4,000 K light group as 
their data files were corrupted due to equipment malfunction. The mean RT for each hour 
during light exposure were compared between the two groups using ANOVA and were not 
significantly different for the light exposure period for light source, time, nor an interaction 
between light source and time, as shown in Table 10. There was a significant difference 
(P<0.03) between light sources, however, for the 3 hours post light exposure, but no 
interaction between light sources and time, also shown below in Table 11.  Figure 14 shows 
that the mean RTs were consistently low for both light source groups before and during light 
exposure, as with the visual PVT. 
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Table 10. Mixed repeated ANOVA of mean RT for auditory PVT during light exposure.  
 
Effect Num DF Den DF F value Pr > F 
light source 1 13 0.03 0.861 
time 6 68 0.95 0.467 
light source*time 6 68 0.56 0.759 
 
 
Table 11. Mixed repeated ANOVA of mean RT for auditory PVT 3 hours post light 
exposure.  
 
Effect Num DF Den DF F value Pr > F 
light source 1 13 6.60 0.023 
time 2 19 1.32 0.290 
light source*time 2 19 0.65 0.531 
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Figure 14. Average mean RT (±SE) of the 17,000 K fluorescent light group (empty circles) or 
the 4,000 K fluorescent light group (filled circles) per hour for auditory PVT during light 
exposure study day, light exposure indicated by box 
 
The lapses greater than 400 milliseconds for each hour since light exposure began were 
compared between the two groups using ANOVA and were not significantly different for the 
light exposure period for light source, time, nor an interaction between light source and time, 
as shown below in Table 12. Figure 15 shows the number of lapses was consistently low for 
both groups before and during light exposure.  Also seen in Figure 15 and Table 13 below, 
the number of lapses for both groups increased linearly for 3 hours post light exposure with a 
significant difference between light sources (p<0.003). 
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Table 12. Mixed repeated ANOVA for lapses of auditory PVT during light exposure. 
 
Effect Num DF Den DF F value Pr > F 
light source 1 13 0.03 0.861 
time 6 68 0.95 0.467 
light source*time 6 68 0.56 0.759 
 
 
Table 13. Mixed repeated ANOVA for lapses for auditory PVT 3 hours post light exposure. 
 
Effect Num DF Den DF F value Pr > F 
light source 1 13 14.1 0.002 
time 2 19 0.79 0.469 
light source*time 2 19 0.52 0.601 
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Figure 15. Average auditory PVT lapses (±SE) of the 17,000 K fluorescent light group 
(empty circles) or the 4,000 K fluorescent light group (filled circles) per hour before, during, 
and after light exposure. The period of light exposure is indicated by box. 
 
 
3.4.4.3 Karolinska sleepiness scale 
 
The results of a mixed ANOVA for the KSS values are shown in Tables 14 and 15. As shown 
in Figure 16, subjective, self-rated sleepiness as measured by the KSS revealed that scores 
were lower during light exposure for the 17,000 K group versus the 4,000 K group (both 
p<0.04).  Subjects reported getting sleepier over time (p<0.05) with the 4,000 K light group 
consistently reporting being sleepier at all time points (p<0.05) compared to the 17,000 K 
light group.  KSS scores were lower during light exposure and for 3 hours post light exposure 
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for the 17,000 K exposure group versus the 4,000 K exposure group (both p<0.05) indicating 
lower subjective sleepiness levels in the 17,000 K exposure group. 
 
Table 14. Mixed repeated ANOVA for KSS during light exposure; Num DF = numerator 
degrees of freedom (number of groups in effect - 1); Den DF = denominator degrees of 
freedom (number of data points for each effect - 2). 
 
Effect Num DF Den DF F value Pr > F 
light source 1 16 8.49 0.010 
time 7 101 5.68 <0.0001 
light source*time 7 101 1.55 0.159 
 
Post-hoc analysis showed that this effect of lighting condition and time continued through for 
the 3 hours post light exposure (p<0.05). 
 
Table 15. Mixed repeated ANOVA for KSS 3 hours post light exposure. 
 
Effect Num DF Den DF F value Pr > F 
light source 1 16 5.65 0.030 
time 3 33 3.45 0.028 
light source*time 3 33 0.88 0.459 
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Figure 16. KSS scores before, during and after light exposure (17,000 K fluorescent light 
group (empty circles) or the 4,000 K fluorescent light group (filled circles)). The period of 
light exposure is indicated by box. 
 
 
3.5 Discussion 
 
One limitation of the study design was fact that two active conditions were compared without 
a control condition. A variety of logistics made the inclusion of a control group not possible. 
If we did involve a control, no light exposure group, results would likely have shown a group 
small phase-delay due to their tau or natural freerunning circadian period known to be 
24.2 on average in humans (Czeisler et al., 1999). Some laboratories have accounted for this 
in reporting their data (St. Hilaire et al., 2012), however, we chose not to adjust the calculated 
phase-delays. 
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 3.5.1 Melatonin suppression and phase shifting 
 
Our results demonstrate that both 4,000 K and blue-enriched 17,000 K fluorescent light at an 
equal photon density suppress plasma melatonin in healthy young subjects (42.8% and 
70.8%, respectively) with 17,000 K resulting in a significantly stronger hormonal 
suppression.  By contrast, the phase-delay data do not support the hypothesis that blue-
enriched 17,000 K fluorescent light is a more potent circadian stimulus than the white 4,000 
K fluorescent light.  The 17,000 K fluorescent light, however, provided a significantly more 
consistent phase-delay than 4,000 K fluorescent light when comparing variances suggesting a 
greater effect on the circadian system. A post study power analysis revealed that the phase-
delay study at these light intensities would need 82 subjects (41 in each lighting condition) to 
capture a significant difference between the two lights.  Thus, the a priori power analysis was 
not sufficient to properly design the present study. At the time this study was done the best 
available data set on wavelength comparisons for phase-shifting was a study comparing two 
monochromatic wavelengths at an equal photon density (Lockley et al., 2003). Perhaps 
comparisons of monochromatic lights are not appropriate for power analyses for studies 
employing polychromatic light sources. Alternatively, the light intensities selection may not 
have been optimal. The light intensities chosen for our study intensity were based on two 
dose-response curves for melatonin suppression run in our laboratory which informed our 
team as to which photon density of 4,000 K or 17,000 K light would show the most 
difference (Brainard et al., 2006; 2008; Hanifin et al., 2009).  It was decided that we would 
use the ED90 for the 17,000 K dose response curve with its matching 4,000 K dose 
(approximately ED50).   
 
A study comparing these two polychromatic light sources at high light irradiances (1,640 
μW/cm2, 17,000 K; 1,741 μW/cm2, 4,000 K) typically used for light therapy found no 
difference between the two light sources for phase advancing salivary melatonin rhythms 
(Smith, et al., 2009).  A follow up study from the same laboratory examined phase-delaying 
rhythms using similar light sources in a within subjects counterbalanced design and found no 
difference in the capacity of 17,000 K blue-enriched lamps for phase-delaying salivary 
melatonin rhythms (Smith and Eastman, 2009). This study also employed high irradiances of 
light (1,640 μW/cm2, 17,000 K; 1,475 μW/cm2, 4,000 K) that are commonly used for 
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circadian resetting. While these data are interesting, they are not surprising given the very 
high light levels tested.   
 
Monochromatic and narrowband blue light has been used in several laboratories for phase 
shifting the circadian clock (Lockley et al., 2003; Revell et al., 2005; Wright and Lack, 2001; 
Wright et al., 2004). An example is that of Warman et al. (2003) in which dim blue light (28 
μW/cm2) produced similar phase shifts as bright polychromatic white light over 150 times the 
irradiance (4,300 μW/cm2). Another laboratory was able to produce similar circadian effects 
using only a dim irradiance (65 μW/cm2) of narrowband blue LED light combined with 
advancing the wake time in delayed sleep disorder patients (Lack et al., 2007). Another study 
comparing fluorescent lamps with increased short wavelength energy (8,000 K) versus 
typical fluorescent lamps (4,100 K) and compared at much lower illuminances, more like 
evening room light levels (100 lux), showed that 8,000 K blue enriched induced a 
significantly greater melatonin suppression versus 4,100 K light. (Figuiero et al., 2006). This 
significant difference in melatonin suppression was lost at the next two higher illuminances 
of 300 and 1,000 lux. 
   
At low irradiances blue enriched lamps would be expected to produce a greater phase shift 
than typical fluorescent lighting. This difference will likely be lost as irradiance levels 
increase. Comparisons of blue enriched versus typical fluorescent lamps at higher irradiances 
typically used for circadian resetting little difference has been seen (Smith and Eastman, 
2009; Smith et al., 2009).  Our comparison was done at much lower irradiances, but further 
work is needed to determine whether polychromatic light shifted toward the shorter 
wavelengths of the spectrum is more effective for phase shifting circadian rhythms than 
standard fluorescent lighting at typical room lighting levels. Indeed several other studies have 
made comparisons of the light sources used in this study for other parameters such as daytime 
alertness, performance, mood, as well effects on SAD (Geerdrick and Schlangen, 2006; Mills 
et al., 2007,Viola et al., 2008, Meesters et al., 2011).   
 
 
3.5.2 Neurobehavioral parameters 
 
In the study reported here, objective and subjective measures of alertness yielded conflicting 
results.  Subjective sleepiness measures with the KSS supports the hypothesis that 17,000 K 
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light exposure significantly reduced sleepiness compared to 4,000 K light exposure. 
Similarly, post hoc analysis of subjective sleepiness indicated that 17,000 K light exposure 
appeared to significantly reduce sleepiness for 3 hours after light exposure compared to 4,000 
K light exposure.  By contrast, the four sets of objective PVT data during light exposure do 
not support the hypothesis that 17,000 K light is more effective at acutely enhancing 
psychovigilance reaction time than 4,000 K light during light exposure. Post hoc analysis of 
the PVT data, however, indicated that 17,000 K light exposure appears to enhance 
psychovigilance reaction time for the 3 hours after light exposure compared to 4,000 K light 
exposure. It should be noted that statistical power was lost for some of the comparisons due 
to equipment malfunction or technician error causing loss of data. 
 
Many, but not all, studies have shown that light increases alertness and improves 
performance in neurobehavioral tests.  Early studies used bright versus dim white 
polychromatic fluorescent light for evoking behavioral effects. Bright white polychromatic 
fluorescent light at 3,000 lux, when compared to 100 lux dim white light, increased measures 
of subjects’ performance on seven of ten neurobehavioral tests during a 16 hour light 
exposure (French et al., 1990).  A similar study, simulating night shift work, compared a four 
hour period of 6,000 lux white light to dim white light at less than 200 lux throughout an 8 
hour shift (Dawson and Campbell, 1991). The four hours of bright light was given during the 
first night of three consecutive nights of simulated work. The group that received the four 
hours of bright light on the first night of the study exhibited a significantly smaller decline in 
alertness during the second half of the night shift than the group that received dim light the 
entire time. Another study compared four different lighting conditions: alternating 90 minute 
exposures to 5,000 lux bright white light and 50 lux dim white light during nighttime hours, 
alternating 90 minute exposures to bright and dim light during daytime hours, continuous 
bright light, or continuous dim light (Badia et al., 1991). An EEG analysis and a 
neurobehavioral test battery were used to assess alertness and performance throughout the 
experiment. An increase in brain wave frequencies associated with alertness (beta band, 
approximately 19 Hz) and improvement in performance on the neurobehavioral test battery 
were found for the bright light exposures. 
 
Other investigators performed a dose response curve for a 6.5 h light exposure and subjective 
and objective measures of alertness, with a 50 hour CR before and 30 hour CR after the light 
exposure day (Cajochen et al., 2000). Light exposures were randomly assigned single 
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illuminances from 3 to 9100 lux of white light.  The saturation response for KSS was 
approximately 200 lux, and the saturation response for quantitative EEG was approximately 
300 lux. This coherence between KSS and quantitative EEG in saturating light level 
responses shows a similar response to light between subjective and objective alertness.  
According to these results, normal room light levels can elicit subjective and objective 
alerting responses.  
 
Selected monochromatic wavelengths have also been tested for their behavioral effects. One 
such study compared equal photon doses to either 460 nm or 550 nm monochromatic light, 
and no light (Cajochen et al., 2005).  A decrease in subjective sleepiness was found during 
460 nm light exposure, but not with 550 nm light exposure or no light exposure. In a similar 
study (Lockley et al., 2006), exposure to equal photon doses of blue (460 nm) 
monochromatic light (5.0 lux), compared to 10.0 μW/cm2 green (555 nm) monochromatic 
light (68.1 lux) for 6.5 hours, showed decreased PVT mean RT, fewer PVT lapses, increases 
in brain wave frequencies associated with alertness and decreases in brain waves associated 
with drowsiness.  
 
Like the current study, some experiments have failed to demonstrate the effect of light 
improving alertness or performance measures.  For example, in the study by French and 
colleagues described above, three tests were unaffected by bright light: column addition and 
subtraction, Wilkinson reaction time, and tower puzzle (French et al., 1990).  Another study 
compared cognitive performance on selected tests from computerized test batteries to a night 
(2100 h  to 0800 h) of either bright (5,000 lux) or dim (50 lux) common white fluorescent 
light in a counter-balanced design using young, male subjects. The majority of the 39 
performance variables tested in these two test batteries showed a trend toward bright light 
exposure improving performance with only a few reaching statistically significant 
improvement (Brainard et al., 1996). In another study, 13.5 hour light exposures of white 
fluorescent light at 300, 1,500, or 3,000 lux were compared for performance on a 
neurobehavioral test battery (Dollins et al., 1993).  Lighting condition had no effect on 
performance on a battery of neurobehavioral tests. Performance on the test battery declined 
on successive testing days, regardless of light condition.  
 
Despite the inconsistencies discussed above, the bulk of the published literature supports the 
idea that light exposure can cause significant improvement in alertness and behavioral 
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performance measures. Although the responses appear to depend on circadian timing, light 
intensity, wavelength and duration, the field does not have a complete knowledge of all 
relevant factors behind such effects.  A number of models have been developed to try to 
predict the relative efficacy of a particular light stimulus in terms of its relative circadian, 
neuroendocrine, and neurobehavioral efficacy (Gall and Bieske, 2004; Rea et al., 2005; 
D.I.N., 2009; Pechacek et al., 2008).  Caution must be exercised, however, in relying on these 
and other preliminary models of circadian phototransduction. Reasons for this include the 
fact that the models may only be based on one behavioral or biological measure, action 
spectra of the responses measured may be incomplete, and light source differences on which 
the model is based may be quite different than the application being tested. These models will 
be discussed further in the General Discussion chapter of the thesis (Chapter 6). Empirical 
verification of specific light stimuli on a defined biological parameter will remain the most 
accurate way to determine the potency of light sources. 
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CHAPTER 4 EFFECTS OF SHORT WAVELENGTH SOLID-
STATE LIGHTING ON MELATONIN SUPPRESSION AND 
ALERTNESS 
 
4.1 Introduction 
 
Daily rhythms of sleep, alertness, and physiology are controlled by the SCN in the anterior 
hypothalamus of the brain. A small subset of ipRGCs project directly to the SCN as well as 
other regulatory nuclei and synchronize the circadian timing system, ensuring that daily 
changes in behavior are timed with their photic environment.  IpRGCs contain the 
photopigment melanopsin which has a maximal response between 459-484 nm (Brainard et 
al., 2001b; Thapan et al., 2001; Lucas et al., 2001; Hankins and Lucas, 2002; Berson et al., 
2002; Hattar et al., 2003; Dacey et al., 2005; Zaidi et al., 2007; Gamlin et al., 2007).  As 
discussed earlier in section 1.7, action spectra studies and experiments on selected 
wavelength comparisons have indicated that photic melatonin suppression and alerting 
responses are strongest in the blue-appearing portion of the spectrum. 
 
Initial studies using broad spectrum white light reported alerting effects when used at night 
(French et al., 1990; Badia et al., 1991; Myers and Badia, 1993; Wright et al., 1997; Cajochen 
et al., 2000). Neurobehavioral and physiological parameters affected by nocturnal bright light 
exposure include subjective sleepiness, EEG frequencies in the beta, theta and alpha ranges, 
psychomotor vigilance performance, and a variety of cognitive tests. In addition, these effects 
were observed with exposure to bright light given during the day (Phipps-Nelson et al., 2003; 
Ruger et al., 2006). 
 
As discussed earlier in chapter 3, not all studies that assessed alertness by bright broad 
spectrum white light exposure demonstrated enhancements in all measures of alertness 
(French et al., 1990; Brainard et al., 1996; Dollins et al., 1993). The fact that Dollins and 
colleagues (1993) found no bright light effects on alertness yet achieved suppression of 
melatonin levels suggested that the two responses have different methods of action. Indeed, 
the alerting affects observed during the day by Ruger et al. (2006) and Phipps-Nelson and 
colleagues (2003) further support this theory as melatonin levels during the day are 
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negligible. Conversely, Cajochen and colleagues (2000) positively correlated the degree of 
melatonin suppression by bright light with a positive alerting response. 
 
Whether there exist differing levels of sensitivity to light responses for melatonin suppression 
and alertness remains an area of ongoing investigation. It has been shown light in the blue-
appearing portion of the spectrum (446-477 nm) is highly effective at suppressing melatonin 
levels (Brainard et al., 2001b; Thapan et al., 2001). In addition, neurobehavioral responses to 
narrow bandwidth light exposure as quantified by such objective measures as functional 
magnetic resonance imaging (fMRI), waking EEG and subjective alertness measures have 
demonstrated light in the blue-appearing portion of the spectrum to have the most enhanced 
response (Cajochen et al., 2005; Lockley et al., 2006; Revell et al., 2006; Vandewalle et al., 
2007a; 2007b; Phipps-Nelson et al., 2009; Rahman et al., 2014). 
 
Experimental light sources studied have different spectral power distributions which can be 
described as monochromatic (<15 nm half-peak bandwidth), narrowband (15-30 nm half-
peak bandwidth) or broadband (>30 nm half-peak bandwidth). Light sources used for testing 
the effects of light emitted in the blue-appearing region of the visible spectrum (446-477 nm) 
on melatonin suppression and alertness have been varied including fluorescent (Smith and 
Eastman, 2009; Smith et al., 2009), compact fluorescent (Chellappa et al., 2011), 
monochromatic light from arc lamps (Lockley et al., 2003; 2006; Brainard et al., 2001b), as 
well as solid-state (Wright et al., 2001; 2004; West et al., 2011).  
 
The development of solid-state lighting technology is advancing rapidly and will likely be the 
future of installed lighting in the home, workplace and the general built environment due to 
increased energy efficiency and durability (Schubert and Kim, 2005). Currently under 
development are adjustable lighting systems with narrow and/or broad bandwidth LEDs that 
can be controlled for changes in intensity, spectrum and duration. These lighting systems are 
predicted to be better able to regulate circadian, neuroendocrine, and neurobehavioral 
physiology, although this remains to be proven. NASA, the funding agency for this study, is 
looking to develop an in-flight lighting countermeasure for enhancing alertness in astronauts 
as well as NASA ground crew utilizing LED technology. 
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4.2 Aims and Hypotheses 
 
The overall goal of this study was to test the ability of blue-appearing narrowband solid-state 
light for its ability to acutely suppress nocturnal melatonin as well as enhance cognitive 
performance and alertness in healthy men and women. The specific hypotheses tested were 
that compared to dim light exposure, blue narrowband light would: 1) suppress nocturnal 
melatonin, 2) decrease reaction time and lower number of lapses in a 10-min auditory PVT, 
3) increase number of correct responses in two working memory tasks (DSST, DS forward 
and reverse entry), 4) lower subjective levels of sleepiness as measured by the KSS, and 5) 
show differences in EEG in delta-theta frequency band (0.5 – 5.5 Hz) and high alpha 
frequency band (9.5 – 10.5 Hz) during the KDT. 
 
 
4.3 Methods 
 
4.3.1 Test facility 
 
The study was performed at TJU in the same facility previously described in section 3.3.1. 
 
 
4.3.2 Ambient light stimuli and measurement 
 
Ambient light in the facility was produced by the same lighting system outlined in section 
3.3.2.  
 
After 4 hours in the laboratory, overhead fluorescent room lighting was dimmed to less than 4 
lux in the direction of gaze and remained at that level for the duration of the study, except for 
the 4-hour sleep opportunity on night 1 which occurred in complete darkness. Daily 
illuminance/irradiance measures were taken in the same previously described method (see 
section 3.3.2). 
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4.3.3 Experimental light stimuli and measurement 
 
The blue LED system consisted of a 122 cm2 blue LED array, λmax = 469 nm, 26 nm half-
peak bandwidth, with a lens diffuser that resulted in a relatively even distribution of narrow 
bandwidth blue light (Figure 17). The light source used in the study was identical in size as in 
the previous chapter and was designed to provide a full field retinal exposure. The light 
intensity used in this study was based on a previous melatonin fluence-response curve 
performed with this lighting system (West et al., 2011). Subjects either viewed the blue solid-
state light exposure system at 30 cm for 4 hours beginning at their habitual sleep time to 
achieve a full visual field corneal exposure of 75 µW/cm2 or they remained in dim white 
ambient room light (< 4 lux). Based on study by West and colleagues (2011), the light source 
was expected to produce a significant suppression of melatonin. Figure 18 shows the spectral 
power distribution of this polychromatic blue-appearing LED light source. The measured 
photon density was calculated to be 1.9 x 1014 photons/cm2/sec. 
 
Subjects were randomly assigned to exposures of narrow bandwidth blue LED light or dim 
white light (N=12 blue LED, N=10 dim white light).  For the full duration of the light 
exposure subjects were seated 30 cm in front of the light panel with their chin placed in an 
ophthalmologic head holder and monitored continuously. In this position, subjects 
experienced an exposure that encompassed their full retinal field. Subjects were asked to 
maintain a fixed gaze toward the panel for 125 minutes before resting their head and neck out 
of the head holder for 10 minutes while remaining seated with the light remaining on. The 
subject then went back into the head holder for the remainder of the 4 hour light exposure 
(105 minutes). 
 
Experimental irradiance measures were taken using an IL-1400BL radiometer/photometer 
(International Light Technologies, Inc., Peabody, MA) previously described in section 2.2 
which was held in place by a clear, plastic holder attached in an ophthalmologic head holder 
30 cm from the panel at approximate eye level. The spectral power distribution measurement 
shown in Figure 18 was taken using a Model FSHH 325-1075P FieldSpec handheld 
spectroradiometer (Analytical Spectral Devices, Inc., Boulder, CO). 
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Figure 17. The 122 cm2 blue LED array light exposure system that was used. Note that during 
the actual light exposure for the study reported here the subject’s head would be in an 
ophthalmologic head holder 30 cm from the panel. 
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 Figure 18. Spectral power distribution of the polychromatic blue-appearing LED light source. 
This narrow bandwidth blue LED array emitted light in three color bandwidths (CIE, 1987). 
 
 
4.3.4 Subject screening 
 
Over 300 subjects were initially contacted by the study recruiter in response to local 
newspaper or internet advertisements via e-mail.  Approximately 30% of the respondents 
who were given additional study requirements and details over e-mail either declined to 
proceed further or never contacted the laboratory again.  Initial general questioning on age, 
health, work schedule and medications eliminated approximately 60% of the remaining 
contacts.  Thirty individuals then met with the study recruiter to tour the laboratory facility.   
 
At this point, 28 subjects were instructed to schedule appointments with the study physician 
and study psychologist, have a urine drug screen for drugs of abuse, have blood drawn for a 
basic metabolism panel and keep a strict sleep/wake cycle with daily phone calls to the 
laboratory voicemail upon sleeping and waking.  Subjects chose the timing of their own 8 
hour sleep schedule. Three subjects were eliminated due to physical or psychological 
exclusionary criteria.  Nine subjects failed to keep regular sleep/wake times, tested positive 
for drugs of abuse, or declined to participate further.   
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After undergoing psychological, toxicological, physical, and sleep/wake cycle screenings the 
remaining 24 subjects met study requirements and chose to be entered into the three day 
inpatient study protocol. Twenty-two healthy men and women completed the full study. One 
subject asked to be released from the protocol on the first day of the study due to extreme 
fatigue and the other subject failed to keep their sleep/wake cycle stable for the last few 
nights prior to entry.  A total of 10 males and 12 females ranging in age from 21 to 30 years 
old, with a mean age (± SEM) of 25.1 ± 0.6 years were studied in the Light Research 
Laboratory of TJU.   
 
 
4.3.5 Study protocol 
 
The study was approved by the IRB of TJU and all subjects gave written informed consent 
prior to entering the protocol.  For at least 10 days prior to admission to the laboratory, 
subjects were asked to maintain a regular 8:16 h sleep:wake schedule and dark-light 
exposure, complete a daily sleep-wake log, and phone into a voice mailbox to record the time 
of awakening and time to bed each day. Subjects were asked to wear a wrist-borne, non-
invasive activity and light monitor for at least two weeks prior to admission to the laboratory 
study to ensure compliance with the screening criteria for maintaining a consistent sleep-
wake schedule (Motion Logger Sleep Watch-L, AMI, Ardsley, NY). The subjects’ pre-study 
sleep-wake schedule was determined from the actigraph data, the sleep logs and voice mail 
logs for the 14 days prior to admission and were used to schedule the timing of sleep during 
baseline days in the laboratory and, subsequently, all the events in the study including the 
timing of light exposure. Subjects who had a general lack of sleep-wake stability or more 
than one deviation of more than 30 minutes from their regular bedtime or wake-time were 
excluded from the study or asked to extend the pre-study sleep-wake maintenance duration. 
Subjects were restricted to 4 hours of sleep in the second half of their usual 8 h sleep period 
on the night prior to admission in the study facility. This was done because sleep and 
circadian problems have been documented in space flight missions as short as 10 days (Dijk 
et al., 2001).  The inclusionary criteria for medication were no recreational, over-the-counter, 
nor prescription medications inclusive of caffeine and alcohol.  Toxicological screening of 
blood and urine for caffeine, pregnancy in females, basic metabolic panel, alcohol, drugs of 
abuse, thyroid function, and a CBC was conducted during screening and on the day of entry 
into the facility.  
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 Figure 19 provides a diagrammatic representation of the 3-day study protocol. Subjects were 
limited to 4 hours of time in bed at home for the night prior to admission as well as Night 1 in 
the laboratory.   After entering the laboratory, subjects lived in a relatively isolated 
environment in a windowless facility but maintained either direct or intercom contact with 
the study staff. The first four hours was an adaptation period where subjects entered the 
laboratory and got acquainted with the test facility. Neurobehavioral and performance testing 
was begun 2 hours after admission and continued during all wake periods while in the 
laboratory. After 4 hours in the laboratory, overhead room lighting was dimmed to less than 4 
lux and remained at that level for the duration of the study, except for the 4-hour sleep 
opportunity on Night 1 when all lights were off. PSG leads were put on and constant posture 
(CP) was started approximately 12 hours after admission to the laboratory. CP occurred for 4 
hours on Night 1 until a four-hour sleep opportunity, which coincided with the latter half of 
the subject’s 8-hour sleep schedule. Dim room light levels, PSG recording, and performance 
and neurobehavioral testing were continued on Day 2. For the first four hours of the subject’s 
usual 8 hour sleep schedule, the subject was randomized to receive a blue light exposure or a 
control dim white light exposure. The subject was in CP during this period and the four-hour 
period following the experimental light exposure period. 
 
 
4.3.6 Measurement of melatonin 
 
Blood samples (3 ml) were collected through an indwelling intravenous (IV) catheter located 
in a forearm vein into 3 ml polystyrene tubes which contained 5.4 mg of K2 EDTA (BD 
Diagnostics, Franklin Lakes, NJ).  Plasma was separated by refrigerated centrifugation (2,000 
RPM for 15 minutes), aliquoted into polypropylene cryogenic vials (Thermo Fisher 
Scientific, Rochester, NY) and stored at -20˚ C until assay. Plasma melatonin samples were  
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Figure 19.  Overview of 3-day blue light alerting protocol for a subject with a midnight to 
08:00 sleep:wake schedule. Abbreviations are CP = constant posture, PSG = 
polysomnography, IV = intravenous blood sampling, q20, q30, q60 = taken at 20 min, 30 
min, 60 min, NTB = neurobehavioral testing battery, PVT = psychomotor vigilance task, 
KSS = Karolinska sleepiness scale, KDT = Karolinska drowsiness test 
 
 
drawn every 30 minutes before and after the 4 hour blue LED exposure or dim light condition 
and drawn every 20 minutes during the 4 hour blue LED exposure or dim light condition (see 
Figure 19). Plasma melatonin concentrations were assayed by radioimmunoassay (Vaughan, 
1993). A full description of the method can be found in section 2.6.2.   
 
Salivary samples were collected as backup to the primary plasma measure and were used 
when there were problems with patency of the IV line. Salivary samples (1.2-2 ml) were 
collected with the "Salivette" sampling device (Sarstedt, Inc., Hayward, CA). The specific 
protocol for this is described earlier in section 2.4.  Salivary melatonin samples were 
collected every 30 minutes during the 4 hour blue LED exposure or dim light condition. 
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Salivary melatonin concentrations were assayed by radioimmunoassay (Vaughan, 1993). A 
full description of the method can be found in section 2.6.2.   
 
 
4.3.7 Neurobehavioral testing 
 
Neurobehavioral testing was done on a laptop using software from our collaborators at the 
University of Pennsylvania. I was trained in this laboratory technique but testing was done by 
TJU research technicians. Subjects completed cognitive performance and working memory 
tests throughout the inpatient study. These tests included DSST), and DS forward and reverse 
entry tasks. During the week prior to admission, subjects came into the laboratory and 
completed each of the individual tests at least four times to ensure familiarity with the tests 
prior to the start of the study.  
 
 
4.3.7.1 Psychomotor vigilance task  
 
Subjects completed a 10-min auditory PVT at regular intervals during wakefulness (Dinges 
and Powell, 1985). These intervals were more frequent prior to, during, and post the four 
hours of blue light exposure or a control dim light exposure. Subjects were instructed to listen 
via headphones placed over their entire ear and press a response button as soon as a beeping 
sound was heard. The button stops the counter, which is displayed in milliseconds for a 1 
second period. Subjects were instructed to press the button as soon as each stimulus sounded, 
but to not press the button too soon, which would register as a false start. The auditory 
stimulus was presented at random intervals during the 10-minute PVT. Mean reaction times 
and lapses (reaction times greater than 400 ms) were counted per testing session as a measure 
of performance impairment indicative of reduced behavioral alertness.  
 
 
4.3.7.2 Digit symbol substitution task digit span forward and reverse entry tasks 
 
The primary test of working memory was the DSST (Kane and Reeves, 1997). The DSST is a 
subject-paced task that involves the matching of digits (0–9) to symbols. The number of 
correct responses in 1.5 min was counted as a measure of working memory performance. 
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Secondary measures of working memory included the D Span Forward and Reverse tasks 
(Kane and Reeves, 1997). In the DS test, subjects were presented with a series of digits and 
must immediately type them back in forward or reverse order. If they do this successfully, 
they are given a longer list (e.g., '9, 2, 4, 0'). The length of the longest list a person can 
remember is that person's digit span. 
 
 
4.3.8 Karolinska sleepiness scale 
 
The KSS is a subjective measure of a person’s perceived sleepiness based on a 9-number 
scale where 1 = very alert, 3 = alert, 5 = neither alert nor sleepy, 7 = sleepy (but not fighting 
sleep), and 9 = very sleepy (fighting sleep) (Akerstedt & Gillberg, 1990). Subjects completed 
the KSS by marking next to the appropriate number on a printed KSS scale every 30 minutes 
during waking hours. 
 
 
4.3.9 Karolinska drowsiness test 
 
An objective assessment of sleepiness was attained with the KDT which is a non-invasive test 
based upon EEG in specific spectral power bands monitored over an extended period of hours 
or days (Aeschbach et al., 1999; Cajochen et al., 2000; Lockley et al., 2006). Subjects were 
asked to perform the KDT periodically during waking hours. During the KDT, subjects were 
instructed to relax and fixate on a 5-cm black dot 1-m away for 3 minutes with their eyes 
open.  These tests were performed every 60 minutes during what would have been the 
subject’s 4-hour sleep period, and every two hours during all other waking hours. The 
increased frequency of testing during light exposures was to potentially capture alerting or 
non-alerting effects of the light changes. 
 
 
4.3.10 Profile of mood states 
 
The POMS is a psychological rating scale that surveys transient mood states of subjects. Its 
six-factor scales of mood assessment can be used to track changes in mood states within a 
given subject over time, offering an objective intra-subject measure of mental state tolerance 
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and response to experimental exposures. These scales are intended not for global or clinical 
diagnosis of pathological states, but rather to reflect snapshot assessments of complex mood 
factors in quantifiable terms within a given subject over time (McNair et al., 1992). 
 
Each item inventory in the POMS is scored with a maximum of 4 points from 0-4, with 0 
reflecting endorsement of the given mood state as “very slightly or not at all”, 1 reflecting “a 
little” endorsement of a state, 2 reflecting “moderately” endorsing a given mood state, 3 
reflecting “quite a bit,” and 4 reflecting “extremely” experiencing the mood state item 
surveyed. The 6-subscale factor analysis include 9 tension-anxiety items (scored 0-36), 15 
depression-dejection items (scored 0-60), 12 anger-hostility items (scored 0-48), 8 vigor-
activity items (scored 0-32), 7 fatigue-inertia items (scored 0-28), and 7 confusion-
bewilderment items (scored 0-28). Finally, each administration of the scale can be scored to 
reflect a subject’s “total mood disturbance” at a given point in time by adding the 5 subscale 
scores other than vigor-activity and subtracting the subscale score for vigor-activity from the 
other 5 totaled.  
 
For the purposes of this study, the intended purpose of POMS administration was one of 
monitoring subjects’ mood states as a secondary measure of tolerance and mood responses to 
experimental protocol, rather than as a primary outcome measure. Thus, subjects having 
already been screened by the study protocol for the absence of clinical-level mood conditions 
were used as their own controls for POMS variability comparisons throughout the study.  
 
 
4.3.11 Side effects 
 
All subjects were given before and after the experimental period, a SAFTEE questionnaire. 
This questionnaire was designed to be used to assess effects of light in SAD patients (Terman 
and Terman, 1999) although it has been used successfully in non-depressed subjects exposed 
to light of shorter durations (Goel and Etwaroo, unpublished). Subjects were asked to 
evaluate how they felt according to the following scale: 1) - not at all; 2) - a little bit; 3) - 
moderate; 4) - quite a bit; and 5) -extreme. Fifty-two different questions were asked 
organized by organ system and different areas of the body.  Although probing for side effects 
has potential importance, this was not a primary dependent variable of the study. 
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4.3.12 Data reduction and statistics 
 
Data for the various tests used in this experiment was separated into three groups prior to 
analyses; Day 2 pre-light exposure period, light exposure period, and post-light exposure 
period. There was variability in the number and frequency of tests run throughout this 
experiment and, therefore each of the tests had a distinct breakdown. 
 
The neurobehavioral data analysis was completed by co-investigator Namni Goel, Ph.D. from 
the University of Pennsylvania using within subjects repeated measures ANOVAs. The tests 
analyzed by Dr. Goel were the DSST, DS Forward task, DS Reverse task, and POMS. I am 
familiar with the analyses used but did not do the analysis for this part of the study. 
 
 
4.3.12.1 Melatonin data reduction and statistics 
 
Light-induced melatonin suppression (mean ± SEM) was measured after 120 and 240 
minutes of light exposure. Unpaired, two tailed Student’s t-tests were used to compare 
differences between initial melatonin values at the beginning of light exposure between the 
two groups as well as 120 and 240 minute post-exposure values.  The change in melatonin for 
each condition was expressed as a percent change from the pre-exposure melatonin level, 
with a positive percent change indicating an increase and a negative percent change 
demonstrating a decrease in melatonin levels.  Percent change values were then analyzed by 
unpaired, two tailed Student’s t-tests (Gaddy et al., 1993; Ruberg et al., 1996; Brainard et al., 
2001a; 2001b).   
 
For each subject’s partial melatonin profile, dim light melatonin onset (DLMO) was 
calculated by calculating where DLMO reaches a 25% threshold rise in plasma melatonin 
from peak to trough in the pre-light exposure condition (Benloucif et al., 2007). 
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4.3.12.2 PVT data reduction and statistics 
 
The data from the auditory PVT were downloaded by research technicians at TJU throughout 
the study using the PVTCOMM for Windows Version 2.10.1.1 software from Ambulatory 
Monitoring, Inc. The extracted data were then read using the REACT Version 1.105 
software, also from Ambulatory Monitoring, Inc. (Ardsley, NY). The data for each trial were 
copied from REACT and transferred into an Excel spreadsheet for each subject by research 
technicians at TJU. Mixed-model ANOVAs (time: within-subjects factor; experimental 
group: between-group factor) were run by co-investigator Namni Goel, Ph.D. on PVT lapses 
(> 400 ms reaction times) for pre-light exposure period, light exposure period, and post-light 
exposure periods.  Greenhouse-Geisser corrections were applied to all within-subjects effects. 
 
 
4.3.12.3 Digit symbol substitution task, digit span forward and reverse entry tasks data 
reduction and statistics 
 
Mixed-model ANOVAs (time: within-subjects factor; experimental group: between-group 
factor) were run by co-investigator Namni Goel, Ph.D. mean number of correct responses for 
pre-light exposure period (pre-LE), light exposure (LE) period, and post-light exposure 
periods (post-LE).  Greenhouse-Geisser corrections were applied to all within-subjects 
effects. Graphs were made using Excel. 
 
 
4.3.12.4 KSS data reduction and statistics 
 
Mixed-model ANOVAs (time: within-subjects factor; experimental group: between-group 
factor) were run by co-investigator Namni Goel, Ph.D. on KSS scores for pre- LE, LE, and 
post-LE.  Greenhouse-Geisser corrections were applied to all within-subjects effects. 
 
 
4.3.12.5 KDT data reduction and statistics 
 
The KDT data analysis was performed by co-investigator John Balaicuis, M.D. from TJU. 
The waking EEG signals derived from Cz/Ax during the KDT were visually inspected, and 2-
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second epochs containing muscle artifact, eye blinks, and eye movements were discarded 
from further analysis. Artifact-free 2-second epochs were subjected to off-line spectral 
analysis using a fast-Fourier transformation and a 10% cosine window. Data were further 
reduced by discarding spectra above 20 Hz. I was trained in this technique but did not 
perform the tests or analysis. Frequencies were compared in the delta-theta band (0.5 – 5.5 
Hz) and high alpha band (9.5 – 10.5 Hz). 
 
 
4.3.12.6 Profile of mood states data reduction and statistics 
 
Mixed-model ANOVAs (time: within-subjects factor; experimental group: between-group 
factor) were run by co-investigator Namni Goel, Ph.D. for all 6-subscales as well as the total 
mood disturbance scores for Day 2, during light exposure and post-light exposure periods.  
Greenhouse-Geisser corrections were applied to all within-subjects effects. 
 
 
4.4 Results 
 
 
4.4.1 Ambient light stimuli measurement 
 
The measured illuminance (± SEM) for the baseline day was 69.7 ± 1.3 lux and for the dim 
light condition illuminance was 2.5 ± 0.1 lux. The measured irradiance (± SEM) for the 
baseline day was 19.6 ± 0.5 μW/cm2 and for the dim light condition irradiance was 0.8 ± 0.02 
μW/cm2. 
 
 
4.4.2 Experimental light stimuli measurement 
 
The measured irradiance at subject’s corneas (± SEM) over the 4 h exposure was 75.2 ± 0.1 
μW/cm2 for the blue LED exposure and 0.7 ± 0.1 μW/cm2 for the dim light control exposure. 
Illuminance measures were not recorded during the 4 h blue LED exposure. Data from a 
previous study run in this laboratory with illuminance measures taken identically averaged (± 
SEM) 79.5 ± 1.7 lux for the blue LED exposure (West et al., 2011). The measured 
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illuminance for the dim light control exposure (± SEM) was 2.1 ± 0.1 lux for the dim light 
control exposure.   
 
 
4.4.3 Measurement of melatonin 
 
One female subject was eliminated from the analysis due to an error in giving the appropriate 
intensity of the narrowband blue LED light.  Two of the subjects yielded very high melatonin 
levels that were outliers from the mean (greater than two standard deviations). Three subjects 
had only salivary melatonin data due to intravenous line failure and staffing issues. In total, 
sixteen (eight in each group) subjects were included for plasma melatonin data analysis. 
Please see the subject information table in the Appendix. 
 
Typical melatonin profiles observed in this study from dim white ambient light and blue LED 
light exposures are shown in Figure 20.  The group data are shown in Figures 21 and 22. 
Unpaired, equal variances, two-tailed Student’s t-tests indicated no significant variations 
across mean melatonin pre-light exposure values (t=0.69, p=0.50) between the dim light and 
blue LED exposure groups. Exposure to narrow bandwidth blue LED light at 75 µW/cm2 
caused a significant suppression of melatonin when measured after 2 and 4 hours while dim 
white ambient light allowed the normal rise in melatonin to progress. Unpaired, equal 
variances, two-tailed t-tests indicated significant suppression of melatonin with blue LED 
exposure after 2 hours (t=6.17, p<0.0001) and 4 hours (t=5.02, p<0.0005) when compared to 
the dim light condition. In addition, percent melatonin changes were significantly different 
after exposure to narrow bandwidth blue LED light at 75 µW/cm2 after 2 hours (t=6.45, 
p<0.0001) and 4 hours (t=3.62, p<0.005) when compared to the dim condition. 
 
DLMOs were calculated for the subjects included in the melatonin analyses by 25% threshold 
rise in plasma melatonin from peak to trough and are given in Table 16 below. No significant 
differences were found between exposure groups (t=2.36, p=0.92) 
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Figure 20. Plasma melatonin profiles from two different individuals: a) subject (NA03) 
exposed to dim white ambient fluorescent light (4,000 K) at 0.7 μW/cm2; b) subject (NA16) 
exposed to narrow bandwidth blue LED light at 75 μW/cm2. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 21. Plasma melatonin values (mean ± SEM) after exposure to a blue LED panel light 
exposure 2 hours (a) and 4 hours (b) at 75 µW/cm2 or dim white ambient fluorescent light 
(4,000 K) in the control condition (0.7 μW/cm2). Unpaired, equal variances, two-tailed t-tests 
indicated significant suppression of melatonin with blue LED exposure after 2 hours (t=6.17, 
p<0.0001) and 4 hours (t=5.02, p<0.0005) when compared to the dim light condition. 
 
a) b) 
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Figure 22. Group mean (± SEM) plasma percent melatonin change scores after 120 minutes 
or 240 minutes of exposure to blue LED light exposure at 75 µW/cm2 or from dim white 
ambient fluorescent light (4,000 K) at < 4 lux. Significant differences were found after 120 
minutes (t=6.45, p<0.0001) and 240 minutes (t=3.62, p<0.005). 
Table 16. DLMOs calculated in decimal hours by condition. 
BLUE LED DIM WHITE 
Subject DLMO 25% Subject DLMO 25% 
NA01 21.52 NA04 22.22 
NA02 23.38 NA05 22.83 
NA07 21.95 NA06 21.82 
NA08 22.53 NA09 22.23 
NA10 22.00 NA14 23.02 
NA16 21.35 NA15 20.88 
NA18 23.20 NA19 19.92 
NA22 21.53 NA20 22.13 
Mean 22.18 Mean 22.13 
SE 0.28 SE 0.35 
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4.4.4 Auditory psychomotor vigilance task 
One female subject was eliminated from the auditory PVT analysis for the dim light group as 
her performance data were non-compliant as determined by co-investigator Namni Goel, 
Ph.D. The mean number of lapses for each of the three time periods (Day 2 Pre- LE, LE, and 
post-LE) were compared separately between the two groups using mixed-model ANOVAs 
(time: within-subjects factor; experimental group: between-group factor). Greenhouse-
Geisser corrections were applied to all within-subjects effects. The results are presented in 
Table 17. 
Lapses were not significantly different in any of the time periods for light source, nor were 
there significant interactions between light source and time, as shown in Table 17 and Figure 
23. There was a significant difference (p<0.05) over time during the LE period and post-LE
period as shown in Table 17 and Figure 23. Mean lapses significantly increase over time in 
the LE and post-LE time periods indicating a deterioration of objectively measured 
performance. 
Table 17. Mixed model ANOVA on lapses for auditory PVT Day 2 pre-LE, during LE and 
post-LE. 
Pre LE Effect DF F value P value 
light source 1 0.08 0.79 
time 2.9 0.63 0.60 
light source*time 2.9 0.63 0.59 
LE Effect DF F value P value 
light source 1 0.17 0.69 
time 2.3 4.99 0.01 
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Pre LE Effect DF F value P value 
light source*time 2.3 0.16 0.87 
Post LE Effect DF F value P value 
light source 1 0.07 0.80 
time 2.7 4.07 0.02 
light source*time 2.7 0.70 0.55 
Figure 23. Average PVT lapses (±SE) of the blue LED light group (empty circles, dashed 
line) or the dim white light group (filled circles, solid line) before, during, and after light 
exposure. The period of light exposure is indicated by box. 
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4.4.5 Digit Symbol Substitution Task (DSST), Digit Span (DS) Forward and Reverse 
Entry Tasks 
For both the DSST and DS the mean number correct for each of the three time periods (Day 2 
pre-LE, LE, and post-LE) were compared separately between the two groups using mixed-
model ANOVAs (time: within-subjects factor; experimental group: between-group factor). 
Greenhouse-Geisser corrections were applied to all within-subjects effects. The following 
tables show these results. N=21 for this set of tests. 
The mean number correct for DSST were not significantly different in any of the time periods 
for light source, nor were there significant interactions between light source and time, as 
shown in Table 18 and Figure 24. There were non-significant trends observed for the 
interactions between light source and time prior to (p=0.06) and through the light exposure 
periods (p=0.09) with the blue LED outperforming the dim light group prior to and through 
the LE time periods. 
Table 18. Mixed model ANOVA on total correct for DSST Day 2 pre-LE, during LE and 
post-LE. 
Pre LE Effect DF F value P value 
light source 1 0.44 0.51 
time 1 0.17 0.68 
light source*time 1 4.00 0.06 
LE Effect DF F value P value 
light source 1 1.36 0.26 
time 1.9 0.25 0.76 
light source*time 1.9 2.61 0.09 
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Post LE Effect DF F value P value 
light source 1 0.80 0.40 
time 1.9 1.68 0.22 
light source*time 1.9 0.40 0.67 
Figure 24. Mean number of correct answers on the DSST (±SE) of the blue LED light 
group (empty circles, dashed line) or the dim white light group (filled circles, solid line) 
before, during, and after light exposure. The period of light exposure is indicated by box. 
The mean number correct for DS forward and reverse task were not significantly different in 
any of the time periods for light source, nor were there significant interactions between light 
source and time, as shown in Table 19 and Figure 25. The data from the post-LE period, 
however, did reveal a significant effect of time (p<0.05) indicating a worsening of 
performance over time. 
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Table 19. Mixed model ANOVA on total correct for DS Day 2 pre-LE, during LE and post-
LE. 
Pre LE Effect DF F value P value 
light source 1 0.87 0.36 
time 1 0.70 0.41 
light source*time 1 0.002 0.97 
LE Effect DF F value P value 
light source 1 0.14 0.71 
time 2.0 1.01 0.37 
light source*time 2.0 0.16 0.85 
Post LE Effect DF F value P value 
light source 1 0.42 0.54 
time 1.9 5.48 0.02 
light source*time 1.9 0.70 0.51 
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Figure 25. Mean number of correct answers on the DS (±SE) of the blue LED light 
group (empty circles, dashed line) or the dim white light group (filled circles, solid line) 
before, during, and after light exposure. The period of light exposure is indicated by box. 
4.4.6 Karolinska sleepiness scale 
Subjective sleepiness as measured by the Karolinska sleepiness scale for each of the three 
time periods (Day 2 pre-LE, LE, and post-LE) were compared separately between the two 
groups using mixed-model ANOVAs (time: within-subjects factor; experimental group: 
between-group factor). Greenhouse-Geisser corrections were applied to all within-subjects 
effects. These analyses are shown in the following Table 20 and Figure 26. N=17 for this set 
of scores. 
The Day 2 Blue LED exposure group had significantly higher average scores than the dim 
light exposure group on Day 2 before LE (p<0.05) and showed a non-significant trend in 
increasing sleepiness over time across the day (p=0.08). During the LE period, there were no 
group differences, though there was a significant time difference with scores increasing over 
time (p<0.005). During the post-LE period there were no group differences, nor time of day 
differences. There were no significant interactions between light source and time of day in 
any of the exposure periods. These data are shown below in Table 20 and Figure 26. 
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Table 20. Mixed model ANOVA on KSS scores Day 2 pre-LE, during LE and post-LE. 
Pre LE Effect DF F value P value 
light source 1 6.14 0.03 
time 5.5 1.97 0.08 
light source*time 5.5 0.94 0.47 
LE Effect DF F value P value 
light source 1 1.64 0.22 
time 2.8 7.31 0.001 
light source*time 2.8 0.43 0.71 
Post LE Effect DF F value P value 
light source 1 0.56 0.50 
time 1 2.50 0.19 
light source*time 1 0.28 0.63 
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Figure 26. KSS scores (±SE) before, during and after light exposure blue LED light group 
(empty circles, dashed line) or the dim white light group (filled circles, solid line). The 
period of light exposure is indicated by box. 
4.4.6 Karolinska drowsiness test 
Of the 21 subjects recorded, only KDTs from 8 subjects (4 each in dim and Blue LED 
exposure conditions) were analyzed due to an unexpected reduction in funding for the 
project. Given the dramatically reduced data set, no significant differences were expected for 
KDT. Indeed, there were no significant differences between nights or light exposure groups 
in the delta-theta (0.5 – 5.5 Hz) or high alpha (9.5 – 10.5 Hz) frequencies recorded during 
KDTs on Night 1 and 2. The results from the limited data set are summarized below in Tables 
21 and 22. 
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Table 21. Repeated mixed model ANOVA on delta-theta band during KDTs on Nights 1 and 
2 
Effect DF F value P value 
light source 1 0.11 0.75 
night 1 0.84 0.39 
light source*night 1 1.45 0.27 
Table 22. Repeated mixed model ANOVA on high alpha band during KDTs on Nights 1 and 
2 
Effect DF F value P value 
light source 1 0.90 0.38 
night 1 0.00 0.99 
light source*night 1 1.01 0.92 
4.4.7 Profile of mood states 
Mixed model ANOVAs were run for all 6 subscales for POMS as well as the total mood 
disturbance scores for Day 2 during LE in both the dim and blue LED groups. Shown below 
are results of 2 of the 6 subscales that were near significant or significant. The remaining 4 
subscales for POMS were not statistically significant: anger/hostility (light source p=0.15, 
time p=0.63, light source*time p=0.93); vigor/activity (light source p=0.61, time p=0.16, 
light source*time p=0.88); fatigue/inertia (light source p=0.60, time p=0.89, light 
source*time p=0.46) and confusion/bewilderment (light source p=0.17, time p=0.77, light 
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source*time p=0.14). Total mood scores were also not significant (light source p=0.29, time 
p=0.67, light source*time p=0.46). N=17 for this set of scales. 
The blue LED LE group had a non-significant trend for higher tension/anxiety (Table 23) 
scores during LE (p=0.06) compared to the dim light group. As shown in Table 24, when 
inclusive of the post-LE period with the LE period, the blue LED LE group had significantly 
higher depression/dejection ratings (p=0.05) compared to the dim light group. 
Table 23. Mixed model ANOVA on tension/anxiety subscale for POMS during LE. 
Effect DF F value P value 
light source 1 4.21 0.06 
time 1.54 1.33 0.28 
light source*time 1.54 0.28 0.70 
Table 24. Mixed model ANOVA on depression/dejection subscale for POMS during LE and 
post LE combined. 
Effect DF F value P value 
light source 1 4.87 0.05 
time 1.23 1.54 0.24 
light source*time 1.23 2.47 0.13 
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4.4.8 Side effects 
One subject failed to complete a side effect form in the baseline portion of the dim test 
condition due to a technician oversight. Very few side effects scaled moderate or greater were 
reported in any light exposure condition (less than 8% of all responses). Table 25 lists 
number of responses scaled moderate to extreme reported by the two lighting conditions. No 
analysis was necessary to compare across or within light conditions due to the overall lack of 
side effects observed. Tiredness and fatigue were reported in 21 of 22 subjects studied. 
Trouble thinking was the next most common complaint occurring in approximately half the 
individuals studied. Other, less reported, side effects such as eye issues, restlessness, 
muscular pain, anxiousness, and irritability comprised the remainder of side effects reported. 
Table 25. Number of responses scaled moderate to extreme reported on the SAFTEE 
questionnaire at baseline and in the different light exposure groups.  
Class Symptom Baseline Dim White Blue LED 
Head Headaches - - 2 
Dizziness/faintness 1 1 2 
Eyes Eye irritation 1 - 1 
Eye swelling - - 1 
Blurred vision 2 1 2 
Double vision 1 - 3 
Poor vision 1 - 1 
Light bothersome 1 1 - 
Mouth Dry mouth 1 2 4 
Excess salivation - - 1 
Stomach Discomfort 2 1 2 
Musculoskeletal Pain 2 4 4 
Numbness - - 1 
Restlessness 3 3 5 
Rigidity - - 2 
Skin Itching - 1 2 
Depression Fatigue 14 8 10 
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Excessive energy - - 1 
Jittery 1 1 2 
Excited 1 - 1 
Thought problems 4 3 5 
Depression 1 2 2 
Anxiety 2 1 4 
Irritability 2 2 3 
4.5 Discussion 
The overall goal of this study was to test the hypothesis that blue-appearing narrowband 
solid-state light would acutely suppress nocturnal melatonin as well as enhance cognitive 
performance and alertness in healthy men and women. The results clearly demonstrate that 
narrowband blue LED light has a strong effect on melatonin suppression when compared to 
dim white light. The data demonstrate that both the dim light control group and blue LED 
exposure groups had similar evening rises in melatonin levels with no differences in DLMOs 
between the two groups. The blue LED exposure significantly suppressed plasma melatonin 
after 2 h and continued through 4 h while the dim control light exposure permitted a 
continued rise in plasma melatonin. Monochromatic blue light, narrowband blue light as well 
as polychromatic light enhanced with blue light can suppress melatonin production (Brainard 
et al., 2001a;b; Thapan et al., 2001; Wright et al., 2001; 2004; Lockley et al., 2003; 2006; 
Smith and Eastman, 2009; Smith et al., 2009; Revell et al., 2010; Chellappa et al., 2011). The 
current results are consistent with the published data as well as a previous dose-response 
study performed on this identical lighting system in our laboratory (West et al., 2011). As 
reported in the present study, a corneal exposure of 75 µW/cm2 of the blue LED light 
significantly suppressed melatonin as was the case in the dose-response study (West et al., 
2011). 
Data on subjective alertness as measured by KSS and objective assessments of alertness as 
measured by auditory PVT did not support the hypothesis that blue LED exposure would 
shorten reaction time and lower number of lapses in a 10-min auditory PVT or lower 
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subjective levels of sleepiness. Exposure to narrowband blue LED light for 4 h did not 
significantly improve auditory PVT performance during both the day and night as compared 
dim white light exposure. Both groups, however, showed a significant time effect during the 
LE and post LE periods with increasing number of lapses and higher KSS scores (p<0.05).  
No significant differences were found between the blue LED light group and the dim light 
control group during the light exposure period or the post-light exposure interval for either 
KSS or PVT measures. There were also no significant time x group interactions. With very 
limited data, EEG correlates of alertness as measured by KDT also did not reveal any 
differences in a small group comparison between the narrowband blue LED light group when 
compared to the dim white light group. 
 
Data on cognitive throughput as measured by DSST and DS did not support the hypothesis 
that blue LED exposure would increase the number of correct responses in those working 
memory tasks. DSST and DS data showed no significant differences between the light groups 
before or during LE but post-LE there was an effect of time for DS but not for DSST. 
 
The observed significant time effect on PVT number of lapses, higher KSS scores and lower 
correct responses on DS could be representative of a circadian effect and homeostatic 
sleep/wake buildup as described by Borbely (Borbely et al., 1984). The homeostatic 
sleep/wake-dependent process (Process S) would interact with the intrinsic circadian signal 
for sleep timing (Process C) such that there likely would be a high need for sleep at this point. 
Elements of Process S that would have contributed to this need for sleep includes the fact that 
subjects were restricted to 4 hours of sleep in the second half of their usual 8 h sleep period 
on the night prior to testing and the subjects would have been awake for 16 to 24 h during the 
LE and post LE periods. Relevant to Process C, the LE and post LE periods are inclusive of 
circadian times where the subjects normally would be sleeping. Perhaps the effects of sleep 
restriction were too great to overcome by a lighting intervention. 
 
Numerous studies examining the effects of blue light sources, both monochromatic and 
polychromatic, on both melatonin suppression and alerting effects, have yielded similar 
results for melatonin suppression and mixed results for alertness. Exposure to compact 
fluorescent light of 6500 K led to greater melatonin suppression and faster reaction times on 
PVT yet yielded negative results on a Paced Visual Serial Addition Task –a task relying on 
executive function similar to the DS and DSST used in our study (Chellappa et al., 2011). 
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Similarly, in a study using a monochromatic source peaking at 479 nm, significant melatonin 
suppression was observed yet this wavelength failed to yield any significant alerting 
enhancement (Revell et al., 2010). Conversely, in a study using a blue LED source (460 nm) 
at a much dimmer intensity (2 µW/cm2) than used in our study showed no significant 
melatonin suppression yet had a significant effect on alertness as measured by PVT (Phipps-
Nelson et al., 2009). 
 
With regard to mood states, both groups showed increases in fatigue scores across time. The 
blue LED group experienced some tension and anxiety during the light exposure period. 
Depression/dejection ratings were higher both during the light exposure and the post 
exposure period in the blue LED group. This result at first may be puzzling as blue LEDs and 
blue-enriched fluorescent lighting has been used for therapy in Seasonal Affective Depressed 
(SAD) patients but the intensity of light presented here (70 lux) was at least a factor of 2 
lower than the lowest intensity used in the SAD trials (Glickman et al., 2006; Anderson et al., 
2009; Strong et al., 2009). Perhaps the introduction of the blue light stimulus versus 
remaining in a more comfortable dim lighting environment could be a reason why this was 
not observed in the dim condition. 
 
Notably, tiredness and fatigue were the most common side effects reported which is 
attributable to the partial sleep deprivation conditions that the subjects in both groups were 
asked to maintain. Interestingly, common side effects such as headache and nausea which are 
often noted as the two major side effects to bright light therapy (Lam and Levitt, 1999) were 
not widely reported in the current study perhaps due to the fact that all light intensities used 
in the study were well below standard bright light therapy levels (2,500 – 10,000 lux of white 
light). 
 
Limitations of the study include the small sample size and a non-crossover study design. 
There is strong evidence that inter-individual differences in neurobehavioral deficits during 
sleep deprivation exist and can contribute to variation in sustained attention performance tests 
such as the PVT (Van Dongen et al., 2004). In addition, the intensity of testing was reported 
to be too much by many of the subjects and perhaps fatigued our subjects. Indeed, the POMS 
fatigue scores increased across time in both groups. Future investigations into the effects of 
light wavelength on alertness would benefit from larger sample sizes, a crossover study 
design, and fewer tests with better pacing between the tests. 
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 As mentioned earlier (section 3.4), in examining the published data on the effects of light on 
alertness, some, but not all, studies show enhancements of alertness. Multiples studies have 
shown that light exposure can positively influence alertness. The timing of the light exposure 
during the day or night did not affect these responses differently. For nighttime light exposure 
effects on alertness, it has been hypothesized that the mechanism of action is related to the 
suppression of melatonin (Cajochen et al., 2003; 2005; Perrin et al., 2004; Lockley et al., 
2006; Chellappa et al., 2011) while others have shown that there is no relationship between 
melatonin suppression and alertness (Ruger et al., 2006; Revell et al., 2010).  Daytime 
improvements in alertness to bright white light exposure cannot be explained in a similar 
manner as daytime melatonin levels are undetectable. Further, another study suggested an 
alternate pathway, with different neural processing as well as spectral sensitivity for the two 
light responses (Revell et al., 2006). It was observed in this study that exposure to short 
wavelength light of 420 nm had a greater effect on subjectively measured alertness and mood 
than the 470 nm light exposure. Indeed, acute effects of light on circadian phase and alertness 
may not be mediated by melatonin suppression. The data reported here are consistent with the 
hypothesis that the alerting effects of light are independent of the melatonin suppression 
effects of light. Indeed, alerting effects of light may be mediated by independent neural 
pathways with differing spectral sensitivities. 
 
As outlined in the Introduction (section 1.1.3), one of the SCN’s major output pathways leads 
to the vSPZ which has been shown to contribute to the alerting effects of light presented at 
night (Saper et al., 2005) in rats. Also in rodents, this area, as well as the VLPO, has been 
shown to receive direct input from the ipRGCs (Hattar et al., 2006). As mentioned earlier 
(section 1.1.1.2), the VLPO is known to be integral in the sleep/arousal state (Lu et al., 2002). 
The anatomical circuitry is thus in place, at least in rodents, to serve as a separate pathway 
with likely independent wavelength sensitivities and regulation for alerting effects of light. 
 
Studies on healthy human subjects who have had their brains imaged during the daytime have 
shown that exposure to blue light (470 nm or 473 nm) when compared to green light (550 nm 
or 527 nm) has a greater activation of certain neural structures such as the hypothalamus, 
thalamus, amygdala, brainstem and hippocampus (Vandewalle et al., 2007a; 2007b). These 
fMRI studies suggest the existence of previously unidentified retinal pathways in humans that 
may be involved in the behavioral or alerting effects of light independent of the pineal gland. 
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These additional networks remain under investigation. Further research is needed to clarify 
which of the biological and behavioral responses to light share common underlying neural 
physiology. 
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CHAPTER 5 ADDITIVE AND OPPONENT SPECTRAL 
EFFECTS ON MELATONIN REGULATION IN HEALTHY 
HUMANS 
 
5.1 Introduction 
 
As previously mentioned in parts of the thesis (sections 1.7, 3.1, 4.1), numerous studies have 
confirmed that shorter wavelength monochromatic light in the blue portion of the spectrum is 
more potent than equal photon densities of longer wavelength light for evoking circadian 
phase shifts, suppressing melatonin, enhancing subjective and objective correlates of 
alertness, increasing heart rate, and increasing body temperature (Brainard et al., 2001b; 
Thapan et al., 2001; Lockley et al., 2003; Warman et al., 2003; Cajochen et al., 2005; Revell 
et al., 2005; Lockley et al., 2006; Revell et al., 2006). 
 
Also, as reviewed earlier (section 1.2.3), despite abundant evidence that melanopsin-
containing ipRGCs provide the primary input for circadian and neurobehavioral 
phototransduction, it is clear from studies on rodents, monkeys, and humans that the visual 
rod and cone photoreceptors also play a role in this physiology (Berson et al., 2002; Hattar et 
al., 2003; Lockley et al., 2003; Lucas et al., 2003; Figueiro et al., 2004; Smith et al., 2004; 
Dacey et al., 2005; Jasser et al., 2006; Gooley et al., 2010; Lucas et al., 2014).   
 
In addition, as mentioned earlier (section 1.2.2), melanopsin does not behave like a typical 
vertebrate opsin. The response to light is delayed compared to rods and cones, though once 
engaged, the response to light is strong and ongoing (Berson et al., 2002; Wong et al., 2005). 
The structure of melanopsin more closely resembles an invertebrate opsin, both in form and 
function. Invertebrate opsins have the capacity to regenerate the chromaphore that is initially 
photoisomerized from the 11-cis to all-trans configuration back to 11-cis by absorbing a 
second, different wavelength of light (Hillman et al., 1983), known as bistability. 
Observations in mouse SCN single cell recordings (Mure et al., 2007) as well as the pupil 
light response in humans (Mure et al., 2009) have shown that pre-exposure to 620 nm light 
increases the response to doses of monochromatic blue light at 480 nm administered 
afterwards. This increased response to blue light was explained by the authors as being due to 
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the increased pool of melanopsin in the 11-cis state. With regard to polychromatic light 
sources, one would expect an increase in melatonin suppression due to the increase 
availability of melanopsin in the 11-cis state. Not all studies, however, have shown bistability 
to be present (Mawad and Van Gelder, 2008; Papamichael et al., 2012) and its biological 
significance has yet to be determined.  
 
Typical daily lighting conditions in homes and workplaces are comprised of broadband 
polychromatic light.  In such lighting conditions, melanopsin would be stimulated by long 
and short wavelength light simultaneously. Previous melanopsin bistability studies mentioned 
above employed consecutive exposures of short and long wavelength monochromatic  light 
(Mure et al., 2007; 2009). Revell and colleagues (2010), when examining the predicative 
qualities of their melanopsin photosensitivity function for nocturnal melatonin suppression, 
employed simultaneous exposures of narrowband wavelengths (437, 479 and 532 nm) but 
found no significant additive or opponent interactions of these combinations of 
monochromatic wavelengths. When polychromatic sources (4,000 K and 17,000 K) were 
compared, however, melatonin suppression response was significantly lower than predicted 
by the melanopsin photosensitivity function suggesting an involvement of the cone 
photopigments (Revell et al., 2010). 
 
Different models of interaction between the melanopsin ganglion cells and classical rod and 
cone visual photoreceptors have been proposed, including the ideas that these photoreceptors 
are additive (Revell and Skene, 2007; Dkhissi-Benyahya et al., 2007; Mure et al., 2009; 
Revell et al., 2010) , opponent (Figueiro et al., 2004; Rea et al., 2005; Dacey et al., 2005), 
complementary (Lucas et al., 2003; Lockley et al., 2003; Zaidi et al., 2007) or dynamic over 
time and intensity (Gooley et al., 2010).  These interactions span a variety of species and 
physiological measures. Due to the current uncertainty about these interactions, it is 
imperative to continue to empirically measure circadian, neuroendocrine and neurobehavioral 
efficacies of various combinations of light wavelengths presented at the same time.  
 
Specifically, in order to assess the type of short wavelength cone (S-cone) retinal opponency 
physiology that may be responsible for contribution to acute plasma melatonin suppression, 
combinations of narrow bandwidth light with nominal peaks at 460 nm combined with 570 
nm versus narrow bandwidth light with nominal peaks at 500 nm combined with 570 nm 
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were used in the experiment. In the opponency model proposed by Figueiro et al. (2005), 
460/570 nm would show a reduced suppression of melatonin, while condition 500/570 nm 
would show an increased suppression of melatonin compared to 460 nm alone.  The opposite 
responses would be observed, however, if the conclusions of Dacey and colleagues (2005) 
opponency model held true.  
  
 
5.2 Aims and Hypothesis 
 
The overall goal of this study was to test whether specific combinations of wavelengths 
indicate an opponent cone contribution to the suppression of nighttime synthesis of the pineal 
hormone, melatonin, in healthy human subjects. Specifically, we tested whether the acute 
suppression of melatonin by short-wavelength light at 460 nm and 500 nm could be reduced 
by simultaneous exposure of long-wavelength light at 570 nm. 
 
 
5.3 Methods 
 
5.3.1 Experimental light stimuli and measurement  
 
A Kilo Arc Illumination system using a 1000 W Xenon compact arc lamp source with a 
grating monochromator from Optical Building Blocks (OBB) Corporation (Birmingham, NJ) 
was used. The system was fitted with an optical mask system capable of providing two 
variable narrow spectral bands simultaneously. The development of a dual wavelength mask 
was based on our prior work with Peter Smith, Ph.D. and Rigel Woida at the Lunar and 
Planetary Lab (LPL) at the University of Arizona. A diffraction grating first spreads out the 
spectrum prior to contacting the mask, which blocks the undesired wavelengths. Using 
MatLab computer software from MathWorks (Natick, MA), a mask was designed for each of 
the two dual wavelength conditions and transferred onto acetate.  The acetate mask was 
attached at the exit port of the optical array which was coupled to an eight inch diameter 
Ganzfeld integrating sphere engineered by Labsphere (North Sutton, NH) to give a full visual 
field patternless exposure (see Figure 27 for diagram). I trained in using this optical system 
and mask design but the construction of additional masks was done by Michael Jablonski, a 
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research technician in our laboratory. Michael also staffed the majority of nighttime exposure 
conditions along with several technicians from the Light Research Program at TJU. I have 
visited the LPL and interacted with both Dr. Smith and Rigel Woida where this unique 
optical system was constructed. 
 
The six light exposure conditions were:  1) no light exposure, 2) narrow bandwidth light with 
a peak of 460 nm at 12.1 µW/cm2 (Stimulus A), 3) narrow bandwidth light with a peak of 
500 nm at 8.9 µW/cm2 (Stimulus B), 4) narrow bandwidth light with a peak of 570 nm at 
18.5 µW/cm2 (Stimulus C), 5) Stimulus A & C combined at 31.0 µW/cm2, and 6) Stimulus B 
& C combined at 26.7 µW/cm2.  A more detailed explanation can be found in section 5.3.3 
below and is diagramed in Figure 27 below. 
 
 
Figure 27. Diagram of the light exposure system used in the study. A 1000 W Xenon compact 
arc lamp source generated the light that then passed through a grating monochromator. An 
acetate mask was attached at the exit port of the optical array which was coupled to an eight 
inch diameter Ganzfeld integrating sphere. 
 
Irradiance measures were taken using an IL-1400BL radiometer/photometer (International 
Light Technologies, Inc., Peabody, MA) previously described in section 2.2 which was held 
in place at the front of the Ganzfeld dome by a clear, plastic holder. The spectral power 
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distribution measurements were taken using a Model FSHH 325-1075P FieldSpec handheld 
spectroradiometer (Analytical Spectral Devices, Inc., Boulder, CO) (section 2.2). 
 
Relative spectral power distribution measurements were made on the three single peak 
spectra and on the two double peak spectra.  Figure 28 illustrates one measurement of a 
double peak spectrum with peaks at 460 nm and 570 nm.  Absolute radiometric 
measurements were made on each of the five test spectra in terms of irradiance on the plane 
of the pupil at the eye exposure position in front of the Ganzfeld integrating sphere.  These 
absolute values together with the relative spectral distributions were used to develop the 
absolute spectral irradiance distributions.  Figure 29 shows the five spectra used in these 
experiments.  Because the double peak spectra were generated independent of the single peak 
spectra generation, there are slight displacements of the respective peaks.  The three 
individual peaks are identified as A, B, and C while the double peak spectra are identified as 
A + C and B + C. Table 26 shows the spectral and irradiance characteristics of the light 
sources used in the study. 
 
These measures were taken by Michael Jablonski who worked with our Co-investigator 
Robert Levin, Ph.D. on Figure 29. Further, Robert Levin, Ph.D. first proposed to fund our 
laboratory to study spectral opponency in melatonin regulation, provided funding through 
Osram-Sylvania and teamed with Joel Pokorny, Ph.D. to define experimental lighting 
conditions. 
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Figure 28.  The figure shows the wavelength peaks at 460 nm and 570 nm with the 
appropriate intensity contribution from each peak.  Irradiance was determined based on the 
melanopsin sensitivity curve. 
 
The irradiance of the 460 nm light source (12.1 µW/cm2) was chosen based on our 
laboratory’s action spectrum for melatonin suppression (Brainard et al., 2001b). Joel 
Pokorny, Ph.D. (Co-Investigator) calculated equal melanopsin absorptions for our 
experimental conditions based on the 483 nm nomogram for melanopsin absorption of visible 
light (Gamlin et al., 2007; Dacey et al., 2005). He also provided the estimated contributions 
of each light stimulus for activating cone photoreceptors.  The results of his analysis were the 
basis for the irradiance settings for the various light exposure conditions.  This information 
then was applied to the optical mask making system.   
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 Figure 29.  Absolute spectral irradiance distribution on the plane at the eye position in front 
of the Ganzfeld sphere.  This figure was developed by Robert Levin, Ph.D (Co-Investigator). 
 
Table 26.  Spectral and irradiance characteristics at the plane of the subjects’ eyes in front of 
the Ganzfeld integrating sphere. 
 
Stimulus A B C A + C B + C Units 
Nominal Peak 460 500 570 460 + 570 500 + 570 nm 
Actual Peak 465 497 568 463 + 572 500 + 566 nm 
FWHM 26.5 26 27.5 28.5 + 34.5 26.5 + 26.5 nm 
Irradiance 12.1 8.9 18.5 31.0 26.7 µW/cm2 
Photon 
Irradiance 
2.82E13 2.23E13 5.29E13 8.23E13 7.32E13 
photons/
s/cm2 
 
FWHM = Full Width at Half Maximum 
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5.3.2 Subject screening 
Healthy volunteers of either sex between the ages of 18 and 30 were included.  A cohort of 8 
subjects was selected from a pool of subjects who had recently completed other similar 
nighttime studies in the laboratory for this project. Initial screening questions on age, health, 
work schedule and medications were on file and were updated to exclude any individuals 
who had changes to these conditions. No factor of race or ethnic background was used for 
acceptance or rejection of a volunteer.  Ocular health of subjects was determined by eye 
examination from our consulting physician, Edward Gerner, M.D.  Color vision of all 
subjects was tested by the Ishihara test for color-blindness and Farnsworth Munsell D-100 
tests. A total of 4 males and 4 females ranging in age from 21 to 28 years old, with a mean 
age (± SEM) of 24.0 ± 1.0 years were studied in the Light Research Laboratory of TJU.   
 
 
5.3.3 Study protocol 
 
The study was approved by the Institutional Review Board of TJU and all subjects gave 
written informed consent prior to entering the protocol.  The study protocol is shown in 
Figure 30.  
 
Each subject was studied on six different nights in a randomized order, with at least one week 
between study nights.  The six exposure conditions were described in the previous section. 
Each experiment began at approximately 23:45 when subjects had their pupils dilated with 
one drop in each eye of 0.5% HCl Cyclopentolate.  The subjects were then blindfolded.  Just 
before 02:00 h, a blood sample was taken by venipuncture in the arm.  The subjects' heads 
were then placed in a head holder in front of the experimental light and blindfolds were 
removed.  The subjects were exposed to the light from 02:00 until 03:30 h. During this 90 
minute exposure, the subjects sat quietly, keeping their eyes open and looking at a fixed 
target dot in the center of this light field.  At 03:30 h, a second blood sample was taken and 
the subjects were permitted to leave the laboratory.  Each subject was randomly exposed to 
the different combinations of light and one night they remained blindfolded throughout the 
night with no exposure to light.   
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 5.3.4 Measurement of melatonin 
 
Blood samples for this acute study were collected as described earlier (section 2.3). Plasma 
melatonin concentrations were assayed by radioimmunoassay using antiserum described by 
Rollag and Niswender (1976).  Mark Rollag, Ph.D. assayed the samples in his laboratory at 
the Uniformed Services University of Health Sciences (USUHS). Previously, Dr. Rollag 
trained me to perform this assay in his laboratory at USUHS. A full description of the method 
can be found in section 2.6.1. 
 
5.3.5 Melatonin data analysis and statistics 
 
Two-tailed paired Student’s t tests were used to determine statistical significance of the 
change in raw melatonin levels from 02:00 to 03:30 h.  Next, change in melatonin levels and 
percent change were calculated for each subject using the data for subject plasma melatonin 
levels at 02:00 and 03:30 h for each study night.  The mean and the standard error of the 
mean were then calculated for each light exposure condition.  Percent change in melatonin 
data values were then normalized to percent control-adjusted change scores.  This was done 
by subtracting percent change scores for each subject’s control condition (no light exposure) 
from the percent melatonin change value for each condition for that same subject.  This 
adjusts the plasma melatonin values to account for the normal rise in melatonin levels during 
this time of night (Gaddy et al., 1993; Brainard et al., 1997). Sets of pre-exposure melatonin 
values, percent change and percent control-adjusted melatonin change scores were analyzed 
with one-way repeated measures ANOVA.  Significant differences between light exposure 
groups were assessed with post-hoc Fisher PLSD test with alpha set at 0.05. The statistics 
were run in StatView (SAS Institute Inc, Cary, NC). 
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Figure 30. The study protocol for each experimental light exposure and the dark, control 
night.  The light stimulus nights corresponded to either the single narrow bandwidth 
exposures or the combined two-peak exposures, as listed above. 
 
A power analysis for a future study based on collected data was performed using G*Power 
(freeware):  http://www.gpower.hhu.de. Training on this statistical technique was provided by 
research assistant Melissa Ayers. 
 
 
00:00 02:00 03:30 
Darkness (Blindfolded) 
Experimental Light 
Exposure 
Plasma 
Sample 
Plasma 
Sample 
 
Dark Control 
Stimulus A 
(460 nm, 12.1 µW/cm2) 
 
Stimulus B 
(500 nm, 8.9 µW/cm2) 
 
Stimulus C 
(570 nm, 18.5 µW/cm2) 
 
Stimulus A + C 
(460 nm + 570 nm, 31.0 µW/cm2) 
 
Stimulus B + C 
(500 nm  + 570nm, 26.7 µW/cm2) 
 
Pupils 
Dilated 
Time of Day 
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5.4 Results 
A comparison of the pre-light exposure values across all light conditions showed no 
statistically significant variation in plasma melatonin based on exposure night indicating that 
baseline levels of melatonin were consistent for all nights of the study (Figure 31). 
 
Figure 31.  Pre-treatment plasma melatonin values (mean + SEM, n=8) for each light 
exposure group. There was no significant difference between the pre-treatment melatonin 
values (p = 0.85).  
 
When comparing pre-treatment melatonin values to post-treatment melatonin values, there 
was a significant rise in plasma melatonin in the control night (p < 0.05, no light exposure) as 
shown in Figure 32. As expected based on the human action spectrum for melatonin 
regulation in humans (Brainard et al., 2001b), there was a significant suppression of plasma 
melatonin in the 460 nm condition (p < 0.01) and there was slight suppression in the 500 nm 
and 570 nm conditions, although not statistically significant. In the comparisons between pre-
treatment and post-treatment values in the 460 nm + 570 nm condition and the 500 nm + 570 
nm condition, there was significant suppression of plasma melatonin (p < 0.05). 
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Figure 32.  Plasma melatonin values (mean + SEM, n=8) before and after light exposure. 
 
Based on the percent change scores of plasma melatonin (Figure 33), there was significant 
melatonin suppression of the 460 nm light condition compared to the no light control (p < 
0.001). There was no significant melatonin suppression by 500 nm, 570 nm, or 460 + 570 nm 
light conditions compared to the no light control. There was, however, a significant melatonin 
suppression in the 500 + 570 nm light condition compared to the no light control (p < 0.05).  
 
 
Figure 33.  Plasma melatonin percent change scores (mean + SEM, n=8). Compared to the 
control night, both the 460 nm and 500 + 570 nm light groups exhibited significantly 
suppressed melatonin (p<0.001 and p<0.05, respectively). 
*p<0.001 
†p<0.05 
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 When considering the control adjusted plasma melatonin percent change scores (Figure 34), 
there was no significant differences between the light exposure conditions (p=0.08). 
Figure 34. Plasma melatonin percent control-adjusted change scores (mean – SEM, n=8). 
Differences between the light exposure groups were not significant. 
 
Table 27 lists the mean ± SEM for Figures 31, 32, 33 and 34. 
 
A sample size, post-hoc power analysis on the five means from the control-adjusted change 
score data from Table 27 when powered at 0.95 with an alpha of 0.05 determined that a 
sample size of 10 would be sufficient to detect significant differences between the light 
exposure conditions. 
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Table 27. Mean (± SEM) plasma melatonin values (pg/mL), percent change scores and 
control adjusted percent change scores in the different light exposure groups.  
 
 Control 460 nm 500 nm 570 nm 460+570 nm 500+570 nm 
 
Pre-Exposure Mean 
 
102.5 
 
92.5 
 
103.5 
 
102.8 
 
90.1 
 
90 
Pre-Exposure SEM 12.9 18 17.9 19.7 25.1 13.9 
       
Post-Exposure Mean 123.5 48.8 90.4 93 55.8 67.9 
Post-Exposure SEM 18.6 10.9 14 11.9 15.8 13.9 
        
% Change Mean 18.7 -46.4 -5.6 6.7 -11.6 -20.5 
% Change SEM 5.2 7.6 10.9 18.8 18 13.3 
        
% Control Adjusted 
Mean 
 -65.2 -24.4 -12.1 -30.3 -39.2 
% Control Adjusted 
SEM 
 10.6 15.2 18.8 17.1 12.4 
 
 
5.5 Discussion 
 
A novel human light exposure system was developed that permits exposure of the eyes to 
either single wavelengths of narrow bandwidth light or simultaneous exposure to two narrow 
bandwidth wavelengths. Based on the raw pre-treatment plasma melatonin values obtained 
from the 8 subjects on each of their 6 nighttime exposures, the data indicate that baseline 
nocturnal melatonin levels were consistent across the different nights of the study (p=0.85).  
This indicates that the subjects had normal, elevated levels of nocturnal melatonin during 
their participation in the study.  Furthermore, in accordance with previous data, the narrow 
bandwidth light wavelength conditions of equal photon density at 460 nm (12.1 µW/cm2), 
500 nm (8.9 µW/cm2), and 570 nm (18.5 µW/cm2), produced anticipated results, showing 
strong melatonin suppression in the short wavelength portion of the spectrum (460 nm) and 
moderate suppression in the longer wavelength ranges (500 and 570 nm).  These results 
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indicate that the study is coherent with our prior studies as well as data published by other 
laboratories (Brainard et al., 2001b; Thapan et al., 2001). 
 
For the conditions with combined narrow bandwidth stimuli, plasma melatonin percent 
indicated that there was strong melatonin suppression with the 460 nm light condition that 
was significantly different from control values. By contrast, the combined 460 nm + 570 nm 
stimulus did not significantly suppress melatonin compared to control values.  This result is 
suggestive that the addition of the 570 nm wavelength blunted the strong response to 460 nm.  
Unfortunately, this finding is uncertain since post hoc analysis does not demonstrate a 
statistical difference between the 460 nm condition alone versus the 460 nm + 570 nm 
condition.  Further, when examining the percent control-adjusted change score data, the 
ANOVA approaches, but does not reach statistical significance (p = 0.08).  Hence, at this 
level of analysis, none of the groups are significantly different from one another. Importantly, 
in more than 20 years of peer-reviewed publications, our research group has used the control 
adjusted plasma melatonin percent change scores as our most definitive assessment of the 
efficacy of light stimuli for melatonin suppression in human subjects (Gaddy et al., 1993; 
Brainard et al., 2013). 
 
A previous study using simultaneous exposures of narrowband wavelengths (437, 479 and 
532 nm) found no significant additive or opponent interactions of these combinations of 
wavelengths (Revell et al., 2010). Similarly, another study using simultaneous administration 
of narrowband sources in the blue (479 nm) and red (627 nm) wavelength ranges showed no 
evidence of opponent or additive responses (Papamichael et al., 2012). The longest 
wavelengths used (532 nm and 627 nm, respectively) in these studies, however, perhaps were 
far enough removed from the wavelengths used previously by Figueiro and colleagues (2004) 
(546 nm and 578 nm) the spectral peaks of a mercury vapor lamp, as well as the long 
wavelength narrowband used in the study presented here (570 nm) to not have an opponent 
effect.  
 
The results reported here do not provide evidence that is consistent with a theory of spectral 
opponency for light regulation of the normal human neuroendocrine system. While there is a 
trend approaching statistical significance between the light exposure conditions, these 
findings cannot be interpreted as a significant difference.  This data is consistent with an 
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earlier publication that compared melatonin suppression with either a broadband LED source 
or high pressure mercury vapor lamp with 3 distinct narrowband emissions (Figueiro et al., 
2004). In that study, the irradiance at the eye was significantly higher for the mercury vapor 
lamp yet the melatonin suppression was only half that of the LED source. This reduction in 
the effectiveness of short wavelength light from the 436 nm peak for the melatonin 
production at night was interpreted as evidence that the circadian system does not work 
additively and indeed suggested an opponent mechanism to the spectral sensitivity to light for 
melatonin suppression (Figueiro et al., 2004). Specifically, the same group concluded that a 
S-on, blue minus yellow (b-y) mechanism provided input to the ipRGCs (Rea et al., 2005). 
By contrast, Dacey and colleagues identified a S-off, blue minus yellow (b-y) response in the 
LGN in the primate using electrophysiology (Dacey et al., 2005). While the data reported 
here are more suggestive of the model proposed by Rea and colleagues (2005), they are not 
conclusive. The challenge of using a melatonin suppression paradigm so far removed from 
the retinal circuitry and involving many intervening processes may prove to be too much. 
Indeed, electrophysiological recording such as used by Dacey and colleagues (2005) yields a 
higher degree of certainty. 
 
Two follow up approaches are worthy of consideration.  One approach would be simply to 
repeat the study with a larger set of subjects to the exact protocol described above. Indeed, 
the power analysis performed from the control-adjusted change score data indicated that a 
sample size of 10 would be sufficient to see significant differences. Alternatively, a 
parsimonious experimental design could be conducted that employs only three study 
conditions: 1) a control, dark exposure night; 2) exposure to narrow bandwidth light peaking 
at 460 nm; and 3) simultaneous exposure to two narrow bandwidths of light with one peak at 
460 nm and one at 570 nm. While the former design could potentially yield evidence as to 
which type of color opponency is operating, the latter design could substantially lend further 
evidence of the existence of opponency in light-induced melatonin suppression. In either 
case, and based on the data presented here, certain assumptions that polychromatic light 
sources will suppress melatonin modeled on the two action spectra published on 
monochromatic exposures (Thapan et al., 2001; Brainard et al., 2001b) alone are likely prone 
to error. This conclusion is in harmony with a study based on predicting the effects of 
broadband light sources on light-induced melatonin suppression (Revell et al., 2010).  
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CHAPTER 6 GENERAL DISCUSSION 
 
The overarching aim of this set of studies was to examine the biological and behavioral 
effects of short wavelength light in the blue-appearing portion of the visible spectrum either 
in combination with other light wavelengths or refined to specific blue wavelengths. These 
studies assessed immediate alerting responses, acute melatonin suppression, or longer term 
circadian effects in healthy human subjects. Three experiments outlined in Chapters 3, 4 and 
5 were performed with different light stimuli. 
 
 
6.1 Polychromatic blue-enriched light 
 
This first study (Chapter 3) tested the hypothesis that white polychromatic fluorescent lamps 
have increased efficacy for melatonin suppression, alertness, and circadian phase-shifting 
when they are enriched in the blue-appearing portion of the visible spectrum. This was done 
by comparing the magnitude of melatonin suppression, changes in alertness, and phase 
resetting of circadian melatonin rhythms in healthy male and female subjects following 
exposure to equal photon densities of blue-enriched fluorescent lights (17,000 K) compared 
to standard cool white fluorescent light (4,000 K). 
 
 
6.1.1 Circadian and neuroendocrine effects 
 
Blue-enriched polychromatic fluorescent light presented at relatively low room lighting levels 
was more effective than standard white polychromatic fluorescent light for acutely 
suppressing melatonin. This comparison proves that blue-enriched polychromatic fluorescent 
light is more efficient at this low light level than typical fluorescent lighting. There was a 
non-significant result for circadian phase-delay in melatonin timing. In previous studies that 
have compared blue-enriched versus typical fluorescent lamps at higher irradiances, both 
light sources caused circadian phase-shifts with little difference in the degree of effect (Smith 
and Eastman, 2009; Smith et al., 2009).   
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By contrast, the data reported here are not in line with a number of studies showing that 
monochromatic or narrowband light in the blue region of the spectrum is more efficient than 
other wavelengths for phase-shifting the circadian system (Wright & Lack, 2001; Warman et 
al., 2003; Lockley et al., 2003; Wright et al., 2004; Revell et al., 2005).  
 
Our results reveal that both polychromatic 4,000 K and blue-enriched 17,000 K fluorescent 
light at equal photon density of 1 x 1014 photons/cm2/s suppress plasma melatonin in healthy 
young subjects (42.8% and 70.8%, respectively), with 17,000 K exposure condition resulting 
in a significantly stronger hormonal suppression.  The equivalent irradiance/illuminance of 
light for the 4,000 K and 17,000 K lamps were 40.7 μW/cm2 (134.3 lux) and 50.0 μW/cm2 
(128.9 lux), respectively.   
 
When examining the magnitude of phase-delay shifts of the 4,000 K and blue-enriched 
17,000 K fluorescent light at equal photon density of 1 x 1014 photons/cm2/s, the 17,000 K 
condition caused a mean phase-delay shift of 2.1 h while the 4,000 K condition caused a 
mean phase-delay shift of 1.7 h.  Statistical testing indicated no significant difference for this 
number of subjects likely due to the variability of the 4,000 K condition. The spread of the 
data points was nearly twice as much for the 4,000 K condition when compared to the 17,000 
K condition. Nonetheless, our study found that blue-enriched polychromatic light did not 
produce larger phase-delays than bright white polychromatic light of equal photon density of 
1 x 1014 photons/cm2/s.   
 
Previous studies support these findings.  In a within-subjects crossover design, 13 healthy 
young subjects were given 4,100 K and blue-enriched 17,000 K polychromatic fluorescent 
light at an equal photon density of 4.2 x 1015 photons/cm2/s. In this study, an inpatient 
circadian phase assessment on salivary melatonin levels was performed after 4 consecutive, 2 
h exposures beginning on Day 1, 3 h after their predetermined DLMO with each light 
exposure being delayed by 2 h. Phase-delay shifts after 17,000 K condition (-4.45 h) were not 
significantly different than the 4,100 K condition (-4.48 h) (Smith and Eastman, 2009). In 
another study on elderly subjects, using the same fluorescent lamps as above in a similar 
phase-delaying protocol (2 h experimental light exposures on 4 consecutive days) at an equal 
photon density of 1 x 1015 photons/cm2/s, a phase-delay of -1.93 h was observed in the 
146 
 
17,000 K condition and -1.67 h in the 4,100 K condition with no significant difference 
detected (Munch et al., 2011). 
 
Eighteen young subjects (18-30 years) were studied in a similar protocol to construct a phase 
response curve (PRC) to monochromatic blue (480 nm) light (Ruger et al., 2013). Results 
were compared with a prior white light PRC (Khalsa et al., 2003) and indicated that the 
monochromatic blue light stimulus achieved approximately 75% of the resetting response of 
the much brighter (3,000 µW/cm2) white light stimulus with the maximum phase-delay of -
2.6 h. The authors went on to suggest that monochromatic blue light was more efficient at 
phase resetting as the blue light used comprised approximately 4% of the energy of the white 
light stimulus yet achieved similar results. Examining our data for the 17,000 K exposure we 
found the average phase-delay of -2.1 h which approached 80% of maximum potential phase 
resetting. In our study, we used only 1.7% (50 µW/cm2) of the energy of the white light 
stimulus, so the 17,000 K blue-enriched stimulus appears to be similarly efficient at 
producing photic resetting as observed in previous studies.  
 
When comparing our melatonin suppression data to a study using 17,000 K polychromatic 
fluorescent light mounted in an experimental light box, our melatonin suppression data values 
are approximately twice as much as reported for their blue-enhanced condition (Santhi et al., 
2012). Santhi and colleagues reported half-hourly averaged area under the curve (AUC) 
plasma melatonin concentrations multiplied by duration of exposure (pg/ml*min) represented 
graphically in the 1,200-1,400 range. Calculation of our averaged 17,000 K AUC values of 
plasma melatonin captured in the first 4 hours of light exposure multiplied by the total 
exposure yielded a value of 2,844 pg/ml*min. One possible reason for this difference is the 
timing of light exposure. Our exposure was 9.25 h before habitual wake time, well into the 
evening rise of endogenous melatonin while their evening timing occurred 4.25 before the 
subject’s habitual sleep time, an approximate 3 h difference. Consequently, their evening 
melatonin values were suppressed from what would naturally be an already low daytime 
value while our initial starting values were after the normal evening rise in melatonin and 
were much higher. 
 
When assessing the melatonin suppression data of unpublished dose-response curves run at 
similar intensities on the same 4,000 K and 17,000 K fluorescent lights in our laboratory 
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(Brainard et al., 2007), it was not possible to perform a reasonable comparison since the 
exposure time of a 1.5 h light exposure was given from 0200 h to 0330 h in the unpublished 
fluence-response studies, while a 6.5 h exposure was given 9.25 h prior to habitual waketime 
in the phase-shift study (Chapter 3). Essentially, the phase-shift study examines the rising 
part of the melatonin curve versus the fluence-response study where the timing of light 
exposure was close to the peak of the melatonin rhythm. In addition, the prior photic histories 
were different; dim polychromatic fluorescent light at <4 lux in the phase-shift study for 4.75 
h versus a 2 h blindfolded period in the fluence-response study. In the dose-response study, 
4,000 K light at 39.5 μW/cm2 caused a percent suppression of melatonin of 29.7% compared 
to the phase-shifting study, where the 40.9 μW/cm2 exposure elicited melatonin suppression 
of 42.8%. Similar to the phase-shift study where a significantly higher melatonin suppression 
of 70.9% was found with the 17,000 K, 50 μW/cm2 light exposure, the exact same intensity 
17,000 K light in the dose-response study elicited 54.9% melatonin suppression. These 
differences in melatonin suppression emphasize the importance of the circadian time of light 
exposure and prior photic history in determining the neuroendocrine response to light as 
noted in previous studies (Hebert et al., 2002; Khalsa et al., 2003; Smith et al., 2004).  
 
 
6.1.2 Neurobehavioral effects 
 
Measures of both objective and subjective alertness gave varying results (Chapter 3). KSS 
data supported the hypothesis that 17,000 K light exposure significantly reduces sleepiness 
compared to 4,000 K light exposure. Post hoc analysis of subjective sleepiness revealed that 
17,000 K light exposure significantly reduced sleepiness for 3 hours after light exposure 
compared to 4,000 K light exposure.  PVT data during the light exposure, however, do not 
support the hypothesis that 17,000 K light is more effective at acutely enhancing reaction 
time than 4,000 K light. Post hoc analysis of the PVT data indicated that 17,000 K light 
exposure appears to statistically enhance psychovigilance reaction time significantly for the 3 
hours after light exposure compared to 4,000 K light exposure. 
 
Our results for alerting effects found with the 17,000 K light are in harmony with some of the 
results from Chellappa and colleagues (2011) who found alerting responses to polychromatic 
light exposure in the evening with 6,500 K light versus exposure to 2,500 K or 3,500 K light. 
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Subjective sleepiness was reduced and cognitive performance enhanced after 90 minutes of 
exposure continuing 3 h into post-light exposure. As with their results, our data showed post 
light exposure effects for 3 h in auditory PVT lapses and reaction time as well as subjective 
sleepiness as measured by KSS. 
 
In a crossover field trial in an office setting that used the same polychromatic fluorescent 
sources employed in our study, significant reductions in sleepiness measured during the day 
were detected in the 17,000 K light group versus the 4,000 K light group (Viola et al., 2008). 
The results were consistent across 4 weeks, yet the time of day that they were acquired was in 
the morning, only a few hours after awakening, which differed greatly from when our data 
was collected. 
 
Smith and colleagues (2008) used the Stanford Sleepiness Scale during 2 h morning 
exposures of the same polychromatic fluorescent sources in a phase advancing protocol and 
showed no significant difference in subjective alertness between the two light stimuli (Smith 
et al., 2008). This is in contrast to our KSS findings but the timing of testing (upon 
awakening) was in stark contrast to ours (beginning after several hours of being awake). 
 
 
6.2 Narrowband blue light 
 
The overall goal of the second project (Chapter 4) was to study the efficacy of blue-appearing 
narrowband solid-state light versus dim white light exposure for acutely suppressing 
melatonin as well as enhancing alertness and cognitive performance in healthy men and 
women.  Multiple types of data were collected including PSG, KSS, KDT, 10 minute 
auditory PVT, and a modified NTB.  Results from subjects exposed to the blue solid-state 
light source were compared to subjects who remained in a standard dim white fluorescent 
lighting condition. 
 
With the current exploding development of solid state technology for lighting, many recent 
studies have employed narrowband blue LEDs as a readily available experimental blue light 
source. The light emitted from many commercially available blue LEDs have peaks that 
approximately match the spectral sensitivity of melanopsin (Lucas et al., 2014). 
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6.2.1 Neuroendocrine effects 
 
Narrowband blue LED light at 75 μW/cm2 exhibited a strong suppressive effect on melatonin 
levels when compared to dim white light at 0.7 μW/cm2. Plasma melatonin was suppressed 
after 2 h and continued for 4 h while the dim white light exposure permitted a rise in 
endogenous plasma melatonin. Blue light, both monochromatic and narrowband, as well as 
polychromatic light sources with enhanced output in the blue-appearing part of the spectrum 
can suppress melatonin production (Brainard et al., 2001a;b; Thapan et al., 2001; Wright et 
al., 2001; 2004; Lockley et al., 2003; 2006; Smith and Eastman, 2009; Smith et al., 2009; 
Revell et al., 2010; Chellappa et al., 2011). Our results are consistent with these published 
data as well as a dose-response study performed earlier in our laboratory (West et al., 2011). 
A corneal exposure of 75 µW/cm2 of the blue LED light used in the current study, elicited 
similar significant melatonin suppression as in the earlier study (West et al., 2011).  
 
Taking LED technology into everyday application by testing a low intensity blue LED light 
(λmax=465 nm) indirectly illuminating the interior automobile space, Lerchl and colleagues 
(2009) found no effect on salivary melatonin levels. This finding was compared incorrectly 
with our action spectrum of melatonin suppression data (Brainard et al., 2001b) with a claim 
that the intensities used were comparable. Indeed this is not the case for three reasons. The 
intensities used (0.22 and 1.25 lx) in the Lerchl study were comparable to the only the 2 
lowest monochromatic exposures used in the 460 nm dose-response curve (Brainard et al., 
2001b). Pupils were freely reactive as no mydriatic agent was employed so indeed 
corresponding retinal illuminances were quite different. Lastly, the indirect exposure of the 
eyes also led to much lower retinal illuminances when one considers the exposures used in 
our study were full field given in an integrating sphere. 
 
Similar findings were reported by Phipps-Nelson and colleagues (2009) using low intensity 
LED sources at 460 nm (25 nm half-peak bandwidth) with a reported irradiance of 2.05-2.07 
μW/cm2 in an interior automobile space. Salivary melatonin was found not to be significantly 
suppressed by these irradiances. The authors’ conclusions resonate with those above 
regarding the use of mydratic agents, full field versus partial field exposure and fixed versus 
variable gaze behavior (Phipps-Nelson et al., 2009). 
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 6.2.2 Neurobehavioral effects 
 
Alertness as measured objectively by auditory PVT revealed no statistically significant 
results in reaction time or lapses during light exposure between the blue LED light subjects 
compared to subjects exposed to dim white light conditions. Cognitive performance testing 
using DSST and DS tests showed that the blue LED light subjects outperformed the dim 
white light subjects prior to and throughout light exposure. With regard to subjective 
sleepiness as measured by KSS, the blue LED group was sleepier prior to light exposure, 
remained sleepier through light exposure when compared to the dim white light subjects. 
 
The study of narrowband blue LED sources with regard to alertness reaffirms that the link 
between exposure to short wavelength light and reduction in subjective sleepiness is tenuous. 
The assumption that because short wavelength light is more effective than other wavelengths 
at suppressing melatonin than it is equally effective at causing a reduction in subjective 
sleepiness and alertness may be flawed. 
 
The mechanism by which sleepiness is reduced by light exposure has been suggested to be 
through melatonin suppression (Badia et al., 1991; Cajochen et al., 1999; 2000). More recent 
studies have suggested that the mechanism may be independent of melatonin suppression and 
may involve the VLPO which innervates key brain areas that play a role in wakefulness (Lu 
et al., 2002; Saper et al., 2005). The discovery of neuroanatomical pathways existing from 
ipRGCs to the VLPO confirm this is feasible (Hattar et al., 2006). 
 
Indeed, light presented during the daytime, when melatonin levels are generally undetectable, 
enhanced alertness (Phipps-Nelson et al., 2003; Ruger et al., 2006; Vanderwalle et al., 
2007a;b). Similarly, in a fMRI study, a brief bright light pulse prevented sleepiness while 
subjects were in continuous darkness (Vandewalle et al, 2006). Light exposures given during 
this study induced increased activity in the cortical brain areas involved in whatever task the 
subject were performing at the time of fMRI. 
 
Cognitive performance results in the current study revealed that the blue LED subjects 
outperformed dim white light subjects prior to and throughout light exposure. Differential 
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effects of light on subjective sleepiness, behavioral and physiological measures of alertness 
and sleepiness have also been observed in individuals in other studies (Galliaud et al., 2008; 
Leproult et al., 2003). As was the case with earlier studies performed with bright white 
fluorescent light, not all studies show alerting effects of narrowband blue light.  
 
Cajochen and colleagues (2011) tested computer screens that were backlit by LEDs versus 
being backlit by cold cathode fluorescent lamps on alertness and cognitive performance. LED 
backlit computer screens emitted 3.32 times more light in the blue range between 440 and 
470 nm. In contrast to our findings, alertness levels were sensitive to this portion of the 
spectrum with the LED-backlit computer screens significantly improving sustained attention 
reaction times as measured in the GO/NOGO task (Cajochen et al., 2011). Notably, this result 
was achieved using a relatively dim, narrowband LED light source in contrast to previous 
studies which employed higher intensity monochromatic light sources. There are several 
differences between the studies that could explain our differential findings. We performed 
our testing in sleep-deprived individuals kept awake during the middle of their normal sleep 
episode while in the Cajochen study subjects were regularly rested individuals performing 
testing in the evening prior to their normal bedtime. Also, a 30 minute adaptation period of 
dim, red light was included prior to testing (Cajochen et al., 2011). Prior photic history, 
particularly, the use of red light prior to short wavelength exposure possibly impacted the 
results attained (Hebert et al., 2002; Smith et al., 2004; Mure et al., 2009; Chang et al., 2013; 
Chellappa et al., 2014). 
 
Studies testing the neurobehavioral effects of short wavelength light presented as part of 
either broadband polychromatic fluorescent light or narrowband blue LED light exposure 
often give varying, conflicting results. A well-rested experimental group tested in the early 
portion of their day may not show differences in contrast to a sleep deprived group who are 
tested in the middle of the habitual sleep time. Clearly, the timing of testing and the test 
subject’s time awake inherently play major roles in the resulting data. In fact, it is plausible 
that many studies designed to detect an alerting effect of short wavelength light do not see a 
significant effect. This could be due to the effect being a subtle –hard to measure- outcome in 
which a large sample size would be needed to see a difference. In fact, this is a limitation of 
this study as the logistics demanded a small sample size and a non-crossover study design. 
Inter-individual differences in neurobehavioral deficits during sleep deprivation do exist and 
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can contribute to variation in sustained attention performance tests such as the PVT (Van 
Dongen et al., 2004). Due to the bias of some journals only publishing positive results, 
studies that fail to detect effects of light on alertness may not reach the scientific community. 
 
 
6.3 Combinations of narrow bandwidth light 
 
The third study (Chapter 5) tested whether certain combinations of wavelengths are additive 
or opponent to the circadian photoreceptor system that mediates the suppression of nighttime 
synthesis of the pineal hormone, melatonin, in human subjects.  Specific narrowband 
wavelength combinations were given under highly controlled experimental conditions to 
healthy men and women and melatonin content of plasma samples was quantified. 
 
6.3.1 Neuroendocrine effects 
 
Narrow bandwidth light wavelength conditions of 460 nm, 500 nm, and 570 nm showed 
strong melatonin suppression in the short wavelength portion of the spectrum and moderate 
suppression in the longer wavelength range.  These results are in parallel with melatonin 
action spectra data (Brainard et al., 2001b; Thapan et al., 2001). For the conditions with 
combined narrow bandwidth stimuli, there was strong melatonin suppression with the 460 nm 
light condition that is significantly different from control values. By contrast, the 460 nm + 
570 nm stimulus did not significantly suppress melatonin compared to control values.  This 
result suggests that the addition of the narrow bandwidth light wavelength at 570 nm 
wavelength blunted the strong response of the narrow bandwidth light wavelength at 460 nm 
and is suggestive of opponency. However, the results are in agreement with previous studies 
where simultaneous exposure of short and long narrowband wavelengths found no significant 
interaction in the form of additivity or opponency (Revell et al., 2010; Papamichael et al., 
2012).   
 
Spectral opponency in the visual system occurs in the layers of bipolar, amacrine and 
horizontal cells (Rodieck, 1999).  Since rod and cone cells do not directly connect to the 
ipRGCs then the theoretical likelihood of detecting oppenency is high.  Exquisite murine 
work has revealed that opponent processes involving ipRGCs are at play but they do not use 
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chromatic processes evident in primates as described by Dacey (Weng et al., 2013; Dacey et 
al., 2005).  If opponent physiology is found to exist in the ipRGC circuitry then broad 
spectrum polychromatic light environments that are enriched in the blue portion of the 
spectrum would not have greater neuroendocrine efficacy than standard fluorescent light 
(4,000 K). Unpublished fluence-response curves for melatonin suppression with 17,000 K 
and 4,000 K broad spectrum fluorescent light, however, show stronger melatonin suppression 
for 17,000 K blue enriched light exposures versus 4,000 K light exposure (Brainard et al., 
2007; 2009). Revell and Skene (2007) also found that polychromatic light was more effective 
at suppressing melatonin than monochromatic blue light when matched for melanopsin 
stimulation, implying that the melatonin suppression response is not solely driven by 
melanopsin. Hence, the full spectrum of a light source’s distribution must be considered 
when speculating on its biological efficacy.   
 
Clearly the ipRGCs are key to phototransduction to the circadian system as determined by 
suppression of melatonin synthesis. How the classic photoreceptors participate in this 
phototransduction process remains an area of intensive investigation. Recent finding of 
different types of ipRGCs with distinct retinal connections (Schmidt and Kofuji, 2010) 
further complicate the picture as these differing classes are likely to combine rod and cone 
inputs differentially leading to changing spectral sensitivities for the different evoked light 
responses. 
 
 
6.4 Measurement models of circadian photoreception 
 
Several laboratories have developed light measurement models based on data obtained in 
studies that were either run in their laboratory or based on an analysis of available data or 
some combination of both. These models have sought to develop functions to quantify the 
biological and behavioral effects of light mediated by melanopsin within the ipRCGs in terms 
a single measurement unit. It is challenging, however, to specify the contribution of classic 
photoreceptors and melanopsin containing ipRGCs across intensities in these models. 
 
An initial attempt to design a measurement model for circadian photoreception was based 
strictly on the first two human action spectra for melatonin suppression (Brainard et al., 
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2001b; Thapan et al., 2001). The circadian action function c(λ), claimed to give a quick 
estimation effect of different light sources on the circadian system (Gall and Bieske, 2004). 
Published in an international standards proceeding (CIE, 2004), this function garnered much 
attention in the scientific community. 
 
Rea and colleagues have continued to attempt to model the spectral sensitivity of the human 
circadian system based on the two published action spectra on human melatonin suppression 
along with one small (N=4) study run in their facility by combining the spectral efficiency of 
rods, cones and melanopsin and combining it with the known neurophysiology of the retina 
for supporting vision (Rea et al., 2005; 2012).  
 
Revell and Skene (2007) compared polychromatic light to monochromatic light when 
matched for equal “melanopsin stimulating” photons for melatonin suppression. Their 
comparison assumed a human melanopsin sensitivity curve with a lambda max of 480 nm. 
Their data revealed that melanopsin cannot be the only photopigment to contribute to 
melatonin suppression in humans with cones being implicated as contributing to this 
physiology at the wavelengths and intensities used in this study (Revell and Skene, 2007). 
 
Furthering their work on the predictive ability of a melanopsin photosensitivity function with 
a lambda max of 480 nm, Revell and colleagues compared multiple monochromatic and 
polychromatic light sources for acute neurobehavioral and neuroendocrine effects (Revell et 
al., 2010). The results confirmed their previous findings that this melanopsin photosensitivity 
function at 480 nm cannot predict nocturnal neuroendocrine and neurobehavioral responses 
to polychromatic light. Further, the potential influence of short and middle wavelength cones 
on this physiology could not be determined at the intensities studied. 
 
Gooley and colleagues (2010), however, were able to determine the relative contributions of 
cones to phototransduction for melatonin suppression and circadian phase-shifting of two 
selected monochromatic exposures of 460 and 555 nm. Cones were shown to contribute to 
melatonin suppression at onset lasting with a calculated half-life of 37.85 min and for 
circadian phase-shifting at low irradiance (< 13 log photons cm-2 s-1) levels. As the light 
exposure continues or increases in intensity this contribution was no longer sustained (Gooley 
et al., 2010).   
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 Turning to rodent studies to further identify the relative contributions of rods and cones to 
phototransduction for non-visual responses, several laboratories have made tremendous 
contributions (Panda et al., 2002; Lucas et al., 2003; Hattar et al., 2003; Panda et al., 2003; 
Dkhissi-Benyahya et al., 2007; Altimus et al., 2010; Lall et al., 2010; Brown et al., 2013). By 
genetically lesioning rod and cone or melanopsin input to circadian photoreception, these 
animal studies offer more power than human studies to delineate the relative contributions of 
the three photoreceptor types. 
 
Using mice that lack functional rods or where rods are the lone functional photoreceptor, rods 
were found to operate in two distinct retinal circuits to provide circadian photoentrainment 
over an extensive range of light intensities (Altimus et al., 2010).  One circuit for the rods 
was found to operate through cones at high light intensities (500 lux) but not at low light 
intensities (1 lux of less) where they signal through a rod-bipolar cell circuit. 
 
In order not to disrupt the integrity of a normally functioning retina, as may be the case in 
retinally degenerate or knockout mice, Lall and colleagues (2010) carried out a series of 
experiments on mice in which their normal M-cone opsin was transgenically changed to a 
human red cone opsin. This shift to a longer wavelength cone spectral response also enabled 
a delineation of rod, cone and melanopsin contributions. They observed distinct phases of rod 
(approximately 107 photons/cm2/sec), cone (approximately 108 photons/cm2/sec) and 
melanopsin (approximately 1012 photons/cm2/sec) input to non-visual photoreception with 
stimulus irradiance at 500 nm (Lall et al., 2010). 
 
Using electrophysiology and pupillometry on rodless and coneless mice, a VZλ melanopic 
sensitivity function was first described and tested by al Enezi and colleagues (al Enezi et al., 
2011; Brown et al., 2013). The VZλ melanopic sensitivity function is based on a Vitamin A 
opsin nomogram at 480 nm corrected for prereceptoral filtering by the lens and ocular media.  
Their data demonstrated that under diverse lighting conditions their VZλ function accounted 
for responses in mice under diverse lighting conditions. Further, they tested light-driven 
firing activity of the LGN in mice with rods and cones and found VZλ provided the best 
available predictor. 
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The many, assorted studies on physiological responses in both animals and humans have led 
to varied, sometime opposing conclusions (e.g. Gooley et al., 2010; Altimus et al., 2010). 
One should remain cognizant of the fundamental structural and physiological differences 
between nocturnal rodent and diurnal human retinae, with nocturnal animals having rod 
dominated retinas and diurnal species having cone-rich retinas. The number and structure of 
cones between rodents and humans are also quite different (Mustafi et al., 2009).  
 
Abundant evidence shows that the melanopsin ipRGCs are anatomically and functionally 
interconnected with the rods and cones that support vision. Light-induced physiological 
responses reflect input from all of the retinal photoreceptor classes, with the relative 
importance of each being highly labile within and between response types. This complex 
interconnection is represented nicely in Figure 35 below from Lucas and colleagues (Lucas et 
al., 2014). 
 
Figure 35. A) Schematic of the relevant retinal circuitry in humans. On cone bipolar cells (on 
CBCs) amacrine cells (AII) and rod bipolar cells (RBC); B) photoreceptive mechanisms R (rod 
opsin) M (melanopsin) SC (S-cone opsin) MC (m-cone opsin) LC (l-cone opsin) with plots of 
log sensitivity against wavelength to generate a distinct measure of illuminance (Lucas et al., 
2014). Figure reprinted with permission from Elsevier. 
 
The lack of a consistent and adequate method of quantifying light between different 
laboratories publishing data on photic regulation of biological and behavioral responses can 
make it challenging to replicate experimental conditions or to compare across studies. The 
leading researchers in the field have met and developed a consensus paper about measuring 
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light for circadian, neuroendocrine and neurobehavioral regulation based on current and 
accepted sensitivity functions for rods, cones and melanopsin integrating the spectral power 
distribution of the source (Lucas et al., 2014). To this end, source data from Chapter 3 is 
reported in the Appendix using the Toolbox described by Lucas and colleagues (Lucas et al., 
2014). While quantification of the biological potency of light for non-visual photoreception 
remains elusive, collecting source descriptions on one platform will help for comparing and 
developing testable hypotheses that predict spectral characteristics for targeted physiological 
responses to polychromatic light. 
 
6.5 Conclusion and future directions for lighting 
 
Within the last decade and half, a new photosensory system in the eye has been discovered; a 
truly remarkable development in human physiology. A small set of retinal ganglion cells, 
previously thought to function as an output neuron, have been shown to be directly 
photosensitive and act quite differently from the classic photoreceptors of the visual system.  
Since the discovery of melanopsin  (Provencio et al., 1996) and then the localization of that 
photopigment to ipRGCs (Berson et al., 2002; Hattar et al., 2002) there has been a dramatic 
increase in studies utilizing light as an independent variable for testing hypotheses. With the 
peak wavelength sensitivity of melanopsin in the blue portion of the visible spectrum, there 
has been a focus on studying blue light for physiological effects in animals and humans. The 
aim of the studies in this thesis was to test polychromatic light, inclusive of specific blue 
wavelengths thought to stimulate melanopsin maximally, in experiments on circadian, 
neuroendocrine and neurobehavioral effects in humans. 
 
White polychromatic fluorescent lamps enriched in the blue portion of the spectrum were 
tested for increased efficacy for melatonin suppression, alertness, and circadian phase. Blue 
enriched fluorescent light resulted in a significantly stronger hormonal suppression and 
enhanced subjectively measured alertness.  The phase-delay data did not support the 
hypothesis that blue-enriched fluorescent light is a more potent stimulus for the circadian 
system nor did objective alertness responses increase under blue-enriched fluorescent lights 
compared to standard white fluorescent lights. 
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Next we examined the efficacy of blue-enriched narrowband solid-state light for acutely 
enhancing alertness and cognitive performance in healthy men and women. The results 
demonstrated that narrowband blue light has a strong effect on melatonin suppression when 
compared to dim white light while objective and subjective measures of alertness, however, 
did not show any significant enhancement. 
 
Lastly focusing strictly on a single neuroendocrine parameter, we tested combinations of 
narrow-bandwidth light wavelengths on melatonin suppression in healthy human subjects. 
Results showed strong melatonin suppression in the short wavelength portion of the 
spectrum, moderate suppression in the longer wavelength range of the spectrum with a 
nonsignificant attenuation of the strong short wavelength melatonin suppression with the 
addition of long wavelength light. Demonstration that the melatonin suppression response to 
this bichromatic light combination was lower than expected suggests that melanopsin 
sensitivity is not the sole consideration when trying to predict the efficacy of broadband 
lighting. In general, the different effects of short wavelength enriched polychromatic light on 
alertness, circadian phase-shift and melatonin suppression imply a differential involvement of 
the classical photoreceptors. 
 
The results also show, as several parameters approached statistical significance, that there is 
need for focused, larger sample studies to tease out the answers to specific questions related 
to clarifying circadian, neuroendocrine and neurobehavioral effects in humans. Smaller 
numbers of research subjects have been adequate over the years for melatonin suppression 
studies due to the large amplitude of the physiological response. The lower amplitude 
response inherent in circadian phase-shift and neurobehavioral testing coupled with 
significant inter-individual variability to performance testing, however, require larger, 
targeted studies, preferably in a cross-over design. 
 
This tradeoff between tightly controlled, laboratory based studies with small numbers of 
participants (typically N=20 or lower) and larger, field based, limited control studies (N=50 
or more) is not a new dilemma but often emerges when bringing a basic research finding into 
application. The dilemma faced by the scientific photobiological community is that LED 
technology is evolving at an exponential rate, lighting companies are scrambling for 
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diminishing profits, and claims of healthy lighting for improving human wellbeing are not 
entirely based on sufficiently powered studies or peer-reviewed data.    
 
Not surprising to any research scientist who studies human physiology, the more one looks at 
a sensory system, the more complex the system becomes. In a little over a decade since first 
being discovered, ipRGC’s contribution to phototransduction for circadian, neuroendocrine 
and neurobehavioral effects continues to be elucidated. At least five distinct types of ipRGCs 
have been identified with each having distinct central projection patterns. Indeed biological 
and behavioral effects are likely governed one or more ipRGCs in combination with classic 
photoreceptors. The likelihood that the many downstream physiological responses share the 
same sensitivity to light irradiance, the same spectral sensitivity, and the same adaptation rate 
is remote. The most prudent course that photobiological researchers can take is to carefully 
measure the incident light spectrum being studied and report this in a systematic way. To this 
end, the consensus methodology described by Lucas and colleagues (2014) with use of a 
common nomenclature based on current and accepted sensitivity functions will open the door 
for researchers to continue to unravel this complex photosensory system.  
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Appendix I 
Chapter 3 Subject Information 
Subject Code Sex Age Condition Comments 
PS01 Male  21 4,000 K 
PS02 Male  23 17,000 K 
PS03 Female 24 4,000 K 
PS04 Female 23 17,000 K I.V. line failure 
PS05 Female 23 17,000 K I.V. line failure 
PS06 Disempaneled Too fatigued to continue 
PS07 Male  26 4,000 K 
PS08 Female 22 4,000 K 
PS09 Male  21 17,000 K 
PS10 Male  23 4,000 K 
PS11 Male  21 17,000 K 
PS12 Female 24 4,000 K 
PS13 Male  22 17,000 K 
PS14 Male  19 17,000 K 
PS15 Female 21 17,000 K 
PS16 Female 21 4,000 K 
PS17 Male  22 4,000 K I.V. line failure 
PS18 Female 19 4,000 K 
PS19 Female 21 17,000 K I.V. line failure 
PS20 Female 22 4,000 K I.V. line failure 
PS21 Female 25 17,000 K I.V. line failure 
Individual melatonin profiles are presented on the following pages. The top graph shows the 
two constant routine days overlayed. CR1 shown with filled circles and CR2 shown with 
empty circles. The bottom graph illustrates melatonin values following exposure to 6.5 h of 
white 4,000 K fluorescent light or blue-enriched 17,000 K fluorescent light (empty circles) 
compared to corresponding clock times during the previous melatonin cycle on CR1 (filled 
circles).  The type of fluorescent light source is indicated in the upper right corner. 
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Appendix II 
Chapter 4 Subject Information 
Subject Code Sex Age Condition Comments 
NA01 Male  27 Blue LED 
NA02 Male  24 Blue LED 
NA03 Female 22 Dim White Outlier 
NA04 Male  25 Dim White 
NA05 Female 29 Dim White 
NA06 Male 21 Dim White 
NA07 Male 23 Blue LED 
NA08 Male 25 Blue LED 
NA09 Female 29 Dim White 
NA10 Female 26 Blue LED 
NA11 Female 23 Dim White I.V. line failure 
NA12 Female 22 Blue LED Light intensity issue 
NA13 Female 26 Blue LED Outlier 
NA14 Male  27 Dim White 
NA15 Male  23 Dim White 
NA16 Female 30 Blue LED 
NA17 Disempaneled Too fatigued to continue 
NA18 Male  23 Blue LED 
NA19 Female 27 Dim White 
NA20 Female 25 Dim White 
NA21 Disempaneled Actigraphy non-compliance 
NA22 Female 26 Blue LED 
NA23 Male  27 Blue LED No blood collected –staffing issue 
NA24 Female 23 Blue LED No blood collected –staffing issue 
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Appendix III 
Chapter 5 Subject Information 
Subject Code Sex Age 
OS01 Male 23 
OS02 Female 22 
OS03 Female 21 
OS04 Female 21 
OS05 Male 24 
OS06 Male 28 
OS07 Male 26 
OS08 Female 27 
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Appendix IV 
Sample Toolbox Source Comparison 
Below are toolbox calculations for the two sources used in Chapter 3. 
Calculated irradiances, photopic illuminances v(λ), and human photopigment illuminances 
relative to the two polychromatic light source used in Chapter 3 (Lucas et al., 2014). 
Radiometric and Photometric Values 
(380 -780 nm inclusive) 
Retinal Photopigment Weighted 
Illuminances 
(α-opic lux) 
Photon Flux 
(photons/cm²/
s) 
Irradiance 
(µW/cm2) 
Photopic 
Illuminance 
(lux) 
S 
Cone 
Melanopsin 
ipRGC Rod 
M 
Cone 
L 
Cone 
4,000 K 
Light 1.01E+14 36.3 123 83 79 91 109 120 
17,000 K 
Light 1.00E+14 39.0 96 190 133 122 107 96 
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